Sphingosine-induced alterations in membrane biophysical properties: biological relevance in the pathophysiology of human disease by Carreira, Ana Cláudia Nunes
 Universidade de Lisboa 
Faculdade de Farmácia 
 
 
 
 
 
 
 
 
 
Sphingosine-induced alterations in membrane biophysical 
properties: biological relevance in the pathophysiology of 
human disease 
 
 
 
Ana Cláudia Nunes Carreira 
 
Orientadores:    
Doutora Liana Casquinha da Silva 
Doutor Rodrigo de Almeida 
Doutor Emyr Lloyd-Evans 
 
 
Tese especialmente elaborada para a obtenção do grau de Doutor em Farmácia, especialidade em 
Tecnologia Farmacêutica. 
 
2019 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Universidade de Lisboa 
Faculdade de Farmácia 
 
 
 
 
Sphingosine-induced alterations in membrane biophysical properties: biological 
relevance in the pathophysiology of human disease 
 
Ana Cláudia Nunes Carreira 
Orientadores: Doutora Liana Casquinha da Silva 
                           Doutor Rodrigo de Almeida 
                           Doutor Emyr Lloyd-Evans 
 
Tese especialmente elaborada para a obtenção do grau de Doutor em Farmácia, especialidade em 
Tecnologia Farmacêutica 
 
Júri: 
Presidente: 
Doutor António José Leitão das Neves Almeida, Professor Catedrático da Faculdade de Farmácia da 
Universidade de Lisboa 
Vogais: 
Doutora Maria João Martins Sarmento, Posdoctoral Researcher 
J. Heyrovský Institute of Physical Chemistry - CAS, Czech Republic; 
Doutora Otília Vitoriana Vieira, Investigadora principal 
Faculdade de Ciências Médicas da Universidade Nova de Lisboa 
Doutor Nuno Fernando Duarte Cordeiro Correia dos Santos, Professor Associado com Agregação 
Faculdade de Medicina da Universidade de Lisboa 
Doutora Helena Maria Cabral Marques, Professora Associada com Agregação 
Faculdade de Farmácia da Universidade de Lisboa 
Doutora Maria Luísa Teixeira de Azevedo Rodrigues Corvo, Investigadora Aixiliar 
Faculdade de Farmácia da Universidade de Lisboa 
Doutora Liana Casquinha da Silva, Investigadora FCT nível inicial com Agregação, Faculdade de Farmácia 
da Universidade de Lisboa, Orientadora 
 
Trabalho financiado pela Fundação para a Ciência e a Tecnologia através da bolsa de doutoramento 
SFRH/BD/88194/2012 
2019 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dedicated to my family.  
For all their love and support. 
  
 
 
 
 
 
 
 
 
 
 
 
 I 
 
ACKNOWLEGMENTS 
In the beginning of this project it was an adventure to enter and explore the complex 
world of membrane biophysics. These last couple of years were full of new challenges and 
discoveries, and at this point I feel it is necessary to acknowledge to all the entities that in a way 
or another helped me to put this PhD project in practice. 
I will start to direct my first thanks to the institutions that supported the realization of this 
doctoral project: to Fundação para a Ciência e Tecnologia (FCT) for believing in the potential of 
the project and giving financial support to its progress (PhD Scholarship - 
SFRH/BD/88194/2012), to Faculdade de Farmácia (FFUL) and Faculdade de Ciências (FCUL) from 
Universidade de Lisboa (UL) and School of Biosciences from Cardiff University, for facilities and 
equipment provided. 
I would also like to thank Dr. Helena Florindo, for allowing me to perform this project in 
the BioNanoSciences – Drug Delivery and Immunotherapy group (iMed.ULisboa, FFUL). 
A special acknowledgment to my advisors, Dr. Liana Silva, Dr. Rodrigo de Almeida and Dr. 
Emyr Lloyd-Evans, for having provided all necessary conditions for the realization of this work. 
For the sharing knowledge, incentive and constructive opinions that have been fundamental for 
the progress of my performance and my scientific training. I also thank all the friendship and 
availability to support me in this scientific journey. 
To my FFUL colleagues, Ester, Tânia, Carina, Vanessa, Nuno, João, Joana, Raquel, Eva, 
Andreia, Ana Matos and Melissa for the friendship and all shared experiences. A special thanks 
to Eva, Raquel and Andreia for the valuable tips and availability to help in the first steps of this 
work. 
I would like to express a special acknowledgment to my colleagues at the School of 
Biosciences (Cardiff University): Mat, Kim, Helen, Luke, Emily C., Emily M., Chris, Laura, Jule and 
Naomi for the friendliness and the good work environment that provided an easy adaption to 
the laboratory. 
Most of the experimental work was performed in the Molecular Biophysics laboratory, 
FCUL. Thus, I would like to express my gratitude to the colleagues and friends that I met there. 
The excellent working environment and the team spirit would not be possible if you did not 
 II 
 
exist. Therefore, Filipa, Catarina, Joaquim, André, Telmo, Andreia Sousa, António, Telma, Hugo 
and Carla thank you for all shared moments. A special acknowledgment to Filipa, Carla and 
Joaquim, whose support was fundamental for the conclusion of this journey.  
Last, but not least I want to thank to my wonderful family. To my parents, grandparents, 
sister and brother and you Fábio for the unconditional support, encouragement and patience at 
all times. A special thanks to my baby daughter Maria Luísa that despite consuming much of my 
energy (day and night), was able to encourage me in the final steps of this journey with her 
sweet and magnificent smiles. Love you all!  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 III 
 
THIS WORK WAS DEVELOPED UNDER THE SUPERVISION OF: 
 
 Dr. Liana C. Silva (Supervisor) 
Assistant Researcher 
Research Institute for Medicines (iMed.ULisboa), Faculdade de Farmácia, 
Universidade de Lisboa, Portugal 
 
 Dr. Rodrigo de Almeida (Co-supervisor)  
Principal Investigator 
Centro de Química e Bioquímica, Faculdade de Ciências, Universidade de Lisboa, 
Portugal 
 
 Dr. Emyr Lloyd-Evans (Co-supervisor) 
Research Group Leader, Senior Lecturer 
School of Biosciences, Cardiff University 
 
THIS WORK WAS DEVELOPED AT: 
iMed.ULisboa – Research Institute for Medicines (grupo BioNanoSciences), Faculdade de 
Farmácia, Universidade de Lisboa, Av. Professor Gama Pinto, 1649-003 Lisboa, Portugal 
 
Centro de Química e Bioquímica (grupo de Biofísica molecular), Faculdade de Ciências, 
Universidade de Lisboa, Campo Grande, 1749-016 Lisboa, Portugal 
 
School of Biosciencies (Neuroscience division), Cardiff University, Sir Martin Evans Building, 
Museum Avenue, Cardiff, CF10 3AX 
 
 
 
 IV 
 
Ana Cláudia Nunes Carreira was financially supported by Fundação para a Ciência e a 
Tecnologia (FCT) with a PhD grant SFRH/BD/88194/2012. The work in this thesis was supported 
by FCT grants PTDC/BBB-BQB/0506/2012, UID/DTP/04138/2013, UID/00612/2013, PTDC/BBB-
BQB/3710/2014. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 V 
 
LIST OF PUBLICATIONS 
My contribution to the articles/chapters included in the thesis: 
1. Carreira A.C., Santos T.C., Lone M.A., Zupančič E., Lloyd-Evans E., de Almeida R.F.M., 
Hornemann T., Silva L.C. Mammalian sphingoind bases: biophysical, physiological and 
phatological properties. Progress in Lipid Research. 2019 (submitted) 
Took an active part in the writing and revision of the review. 
2. Ana C. Carreira, Rodrigo F. M. de Almeida and Liana C. Silva. Development of lysosome-
mimicking vesicles to study the effect of sphingosine abnormal accumulation on membrane 
properties. Scientific Reports. 2017. 7: 3949 
Took an active part in the planning of the work and performed all the experiments. Took an 
active part in the writing of the paper. 
3. Ana E. Ventura, Tânia Santos, Ana C. Carreira, Nuno M. Martinho, J. Conniot, Ana R. Varela, 
Rogério Gaspar, Helena F. Florindo, Liana C. Silva. 2016. Drugs, delivery systems and 
membrane organization in model and cell membranes. In: Angel Catala (Eds) “Membrane 
organization and lipid rafts in the cell and artificial membranes”, Nova Science Publishers Inc, 
New York. 
Took an active part in the writing of the two first sections of the chapter and gave a 
contribution in the revision of the other sections. 
4. Ana C. Carreira, Ana E. Ventura, Ana R. P. Varela and Liana C. Silva. Tackling the biophysical 
properties of sphingolipids to decipher their biological roles. Biological Chemistry. 2015. 396: 
597–609 
Took an active part in the planning and writing of the paper. 
5. Eva Zupančič, Ana C. Carreira, Rodrigo de Almeida, Liana Silva. Biophysical Implications of 
Sphingosine Accumulation in Membrane Properties at Neutral and Acidic pH. Journal of 
Physical Chemistry B. 2014. 118: 4858–4866 
 Took an active part in the planning of the work and performed the majority of the 
experiments. Wrote the paper.  
 
 
 VI 
 
Papers to which I have contributed that are not included in the thesis: 
Ana R.P. Varela, Ana E. Ventura, Ana C. Carreira, Alexander Fedorov, Anthony H. Futerman, 
Manuel Prieto, Liana C. Silva. Pathological levels of glucosylceramide change the biophysical 
properties of artificial and cell membranes. Phys Chem Chem Phys. 2017. 19: 340-346  
A. G. dos Santos, J. T. Marquês, A. C. Carreira, I. R. Castro, A. S. Viana, M.-P. Mingeot-
Leclercq, R. F. M. de Almeida and L. C. Silva. The molecular mechanism of Nystatin action is 
dependent on the membrane biophysical properties and lipid composition. Phys Chem Chem 
Phys. 2017. 19: 30078-30088 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 VII 
 
ABSTRACT 
The study of biological and model membrane systems currently represents an important 
area of scientific research. Lipids are involved in the regulation of multiple cellular processes, 
being fundamental for the mantainance of cell homeostasis. Sphingosine (Sph) belongs to this 
group of biologically active lipids and is an important signaling molecule. When abnormally 
accumulated in the lysosomes and late endosomes (LE), Sph is associated to one of the most 
complex lysosomal storage diseases (LSD), Niemann-Pick type C (NPC). Despite this, little is 
known about its role in the lysosome, in particular with respect to the biophysical effects of its 
accumulation. By understanding the interactions of Sph with other lipids and their effect on the 
physical state of model and cell membranes, new insights into its mode of action may arise. 
Using complementary established techniques (fluorescence spectroscopy, dynamic (DLS) and 
electrophoretic (ELS) light scattering), a thorough biophysical characterization of membranes 
containing Sph was performed. This study revealed that Sph is able to decrease membrane 
fluidity both in fluid 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) and lipid raft-
mimicking (POPC/SM/Chol) membrane models in a concentration dependent way. Sph-induced 
changes on membrane fluidity are highly dependent on pH and membrane lipid composition. It 
was observed that Sph has a more dramatic impact on membrane organization and 
permeability in vesicles with a pH gradient resembling the lysosome - the lysosome mimicking 
vesicles - LMVs (pH 5.0in/7.4out) - particularly in those with a lipid composition mimicking NPC1 
conditions (i.e. higher Chol, SM and Sph content), compared to physiological-like situations. In 
the biological context, it was shown that cells displaying the NPC phenotype have an altered 
membrane fluidity when compared with the wild-type (WT) cells and that these changes are 
complex and cell type dependent. Moreover, it was observed that Sph has the ability to 
decrease the fluidity of biological membranes in accordance with model membrane data. 
Overall the results suggest that Sph abnormal accumulation in cells is associated with 
alterations in membrane biophysical properties, likely affecting different membrane associated 
cellular processes. These changes could urderly some Sph biological actions. In particular, Sph-
induced biophysical alterations might affect the endocytic trafficking and consequently the 
normal cell function in NPC disease.  
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RESUMO 
As membranas biológicas são responsáveis em primeira instância pela separação física 
entre o interior e o exterior das células e dos organelos celulares, no caso de células eucariotas. 
Para além desta função de compartimentalização, as membranas são essenciais para a 
manutenção da homeostasia celular, estando envolvidas em diversos processos celulares tais 
como: produção de energia, controlo de entrada e saída de iões e outras moléculas da 
célula/organelos, comunicação celular, entre outros. Em termos de composição estrutural, as 
membranas biológicas são compostas por uma grande diversidade de lípidos, proteínas e 
hidratos de carbono, todos eles com funções específicas. Diferentes composições destes 
componentes permitem diferentes morfologias membranares, que por sua vez, estão 
associadas a funções especializadas na célula (p.e. junções apertadas). Cada membrana 
apresenta, portanto, uma composição estrutural única que está na base da sua função 
específica na célula. Diferentes interações entre os componentes membranares, lípido-lípido, 
proteína-proteína, lípido-proteína conferem à membrana uma organização complexa 
constituída por diversos domínios cujas propriedades biofísicas diferem entre si. Esta noção de 
compartimentalização da membrana, só se conseguiu devido aos avanços tecnológicos que 
permitiram uma caracterização mais detalhada da membrana a nível microscópico e sub-
microscópico. Hoje em dia, o modelo do mosaico fluído, inicialmente proposto em 1972, é 
ainda considerado o conceito principal de biomembrana abrangendo, no entanto, novos 
aspectos, como é o caso da formação de domínios especializados na membrana. Um exemplo 
destes domínios são as jangadas lipídicas, regiões enriquecidas em colesterol e esfingolípidos 
saturados que conferem à membrana uma natureza menos fluída. Estas são plataformas 
transientes e funcionais, as quais estão presumivelmente envolvidas no recrutamento de 
moléculas sinalizadoras e na criação de condições para a activação de eventos de sinalização 
celular. Atualmente, um dos campos mais ativos de estudo entre as comunidades biofísica e 
biológica, é precisamente a organização lateral das biomembranas em domínios e as suas 
implicações em diversos processos celulares. 
A complexidade das membranas biológicas implica que se tenha de recorrer a sistemas 
modelo de membrana mais simples e mais adequados à análise biofísica molecular. Os 
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lipossomas, são exemplos comuns de sistemas modelo utilizados na caracterização das 
propriedades dos lípidos e respetivas funções na estrutura da bicamada lipídica. Com o 
acumular de evidências de que os lípidos são mais do que meros componentes estruturais da 
célula, surge a necessidade de se explorarem os mecanismos subjacentes ao papel ativo que 
estas moléculas desempenham na manutenção do equilíbrio celular. Dentro do grupo de lípidos 
biologicamente ativos, encontra-se a esfingosina, um dos lípidos mais simples e 
simultaneamente mais potente em termos de sinalização celular. Apesar de estar envolvida na 
regulação de vários processos biológicos, quando anormalmente acumulada nos lisossomas e 
endossomas tardios, a esfingosina pode ser responsável por alterações na homeostasia do 
cálcio, conduzindo ao desenvolvimento de uma das mais complexas doenças de acumulação 
lisossomal, a doença de Niemann Pick do tipo C (NPC). Esta é uma doença hereditária rara 
transmitida de forma autossómica recessiva. O desenvolvimento desta patologia está associado 
maioritariamente a mutações no gene NPC1 (cerca de 95% dos casos), enquanto alguns casos 
estão também associados a mutações no gene NPC2. As proteínas NPC1 e NPC2 desempenham, 
concomitantemente, um papel no transporte intracelular de colesterol e podem também estar 
envolvidas no transporte de outras moléculas (possivelmente também facilitam o transporte 
das moléculas de esfingosina positivamente carregadas) através do sistema endo-lisossomal. O 
quadro clínico pode ser muito heterogéneo, sendo que a doença se pode manifestar no período 
perinatal mas também já em idade adulta. O funcionamento de vários órgãos pode ser afetado, 
sendo o prognóstico da doença mais complicado quando as manifestações neurológicas são 
precoces. Atualmente, não existe um tratamento eficaz para a doença e é importante que 
sejam desenvolvidos estudos, na tentativa de melhor compreender os mecanismos moleculares 
que estão na base do desenvolvimento da mesma. Existem evidências de que a esfingosina é o 
primeiro metabolito a desencadear a doença, no entanto, pouco se sabe acerca do seu papel 
no lisossoma, em particular no que diz respeito às implicações biofísicas que a sua acumulação 
representa para a membrana lisossomal. Com a compreensão das interações da esfingosina 
com outros lípidos das membranas biológicas e do seu efeito no estado físico de membranas 
modelo, poderão surgir novas pistas sobre os mecanismos que estão na base do seu papel 
biológico. Existem na literatura alguns estudos referentes ao impacto da esfingosína nas 
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propriedades biofísicas de membranas (na grande maioria dos casos membranas artificiais) e 
foi inclusive sugerido que alterações biofísicas induzidas pela esfingosina e outros lípidos 
poderão explicar, em parte, o seu mecanismo de ação nas células.  
No presente trabalho de dissertação, as propriedades biofísicas da esfingosina foram 
exploradas no contexto de membranas modelo com complexidade crescente e também em 
membranas de células vivas. Pretende-se com este estudo responder às seguintes questões: i) 
Quais os efeitos da esfingosina em membranas fluídas constituídas por POPC?; ii) Como é que a 
esfingosina afeta as propriedades de membranas com composição típica de jangada lipídica?; 
iii) Diferenças de pH como as observadas em diferentes localizações celulares podem afetar o 
papel da esfingosina nas células?; iv) Qual a importância do desenvolvimento de novos sistemas 
modelo de membrana que mais se assemelham às situações fisiológicas ocorridas na célula?; v) 
Qual o impacto da esfingosina em membranas biológicas? Neste contexto, e para dar resposta 
a estas perguntas estabeleceu-se uma abordagem experimental baseada em técnicas 
complementares, nomeadamente: espectroscopia e microscopia de fluorescência e ainda 
técnicas de dispersão dinâmica e electroforética da luz. Utilizaram-se maioritariamente 
sistemas modelo de membrana, em particular, vesículas unilamelares com cerca de 100 nm, 
que devido à sua estabilidade, tamanho controlado e natureza unilamelar, se tornam bastante 
úteis em experiências como as de permeabilidade em que é necessário realizar o 
encapsulamento de moléculas fluorescentes no interior das vesículas. Foram ainda utilizados 
tampões com pH distintos na preparação das vesículas, de modo a avaliar o efeito do pH nas 
propriedades biofísicas das membranas. 
  Os resultados demonstraram que a adição de concentrações crescentes de esfingosina 
pode levar à formação de domínios gel, em modelos de membrana constituídos por POPC ou 
por POPC/esfingomielina/colesterol (modelo de jangada lipídica). A formação desses domínios 
depende não só da concentração de esfingosina como também da restante composição lipídica 
da membrana e do pH do meio envolvente. Estes domínios são mais facilmente formados em 
modelos de membrana a pH neutro (7.4), que mimetizam o ambiente da membrana 
plasmática, quando comparado com o ambiente acídico (pH 5.0) do lisossoma, no qual maiores 
concentrações de esfingosina são necessárias. Foi ainda demonstrado que a pH neutro, os 
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modelos de jangadas lipídicas contendo esfingosina (5 ou 10 mol%) apresentam a carga da 
membrana maioritariamente neutra, enquanto nos mesmos modelos a pH ácido a carga da 
membrana é positiva. Neste caso, a carga positiva da esfingosina gera repulsão eletrostática, 
reduzindo a sua capacidade para formar domínios gel. Os dados sugerem, deste modo, que a 
formação de domínios ricos em esfingosina, em membranas celulares, pode ser regulada pela 
carga desta base esfingóide.  
Neste trabalho de doutoramento, foi desenvolvido um novo modelo designado de 
“lysosome-mimicking vesicles – LMVs”, que mais se assemelha ao lisossoma por possuir pH 
acídico no interior e pH neutro no ambiente externo (gradiente de pH). Este modelo foi 
utilizado para avaliar os efeitos da acumulação anormal de esfingosina nos compartimentos 
acídicos da célula. Para avaliar as vantagens da utilização das LMVs, foi estudado o efeito da 
acumulação de esfingosina nas proriedades biofísicas e estruturais da membrana de lipossomas 
padrão (sem gradiente de pH) e LMVs constituídos por diferentes composições lipídicas, de 
modo a mimetizar lisossomas em condições fisiológicas normais e lisossomas com alterações do 
tipo NPC. Verificou-se um maior efeito da adição da esfingosina nas propriedaes biofísicas e 
permeabilidade de membrana das LMVs. Este efeito foi também mais evidente nas vesículas 
que contêm maior concentração de colesterol e esfingomielina, mimetizando as membranas 
lisossomais NPC. A caracterização das LMVs demonstrou a importância de se desenvolverem 
sistemas modelo com características o mais semelhantes possível aos sistemas biológicos em 
estudo, de forma a garantir uma melhor extrapolação dos resultados obtidos em sistemas 
artificais para o contexto biológico. 
O impacto biofísico da acumulação de múltiplas espécies lipídicas em células NPC foi 
também avaliado, verificando-se alterações na fluidez da membrana, que são complexas e 
dependentes da linha celular. Observou-se ainda, tal como se tinha observado em sistemas 
modelo, que a esfingosina tem um efeito importante nas propriedades biofísicas da membrana, 
neste caso, quando externamente adicionada a células saudáveis. Este efeito, que é quase 
imediato, é traduzido na diminuição da fluidez da membrana, e aponta para o possível 
envolvimento da esfingosina na formação/estabilização de domínios especializados na 
membrana.  
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No geral, os resultados sugerem que a esfingosina quando anormalmente acumulada nas 
células pode alterar a fluidez da membrana e consequentemente afetar processos celulares a 
ela associados. Na doença NPC, a integridade da membrana lisossomal pode ficar 
comprometida com a acumulação de esfingosina e afetar o normal funcionamento do sistema 
endocítico. Estes dados, dão suporte biofísico ao papel biológico da esfingosina e podem ser 
tidos em consideração, aquando do desenvolvimento de novas abordagens terapêuticas para 
pacientes NPC.  
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AIMS AND OUTLINE 
The work presented in this dissertation is focused on the characterization of the impact of 
Sph in the biophysical properties of model and cell membranes. With this study new insights on 
Sph biological actions are expected, especially with regard to its involvement in the 
pathophysiology of NPC.  
Through the combination of different techniques, such as fluorescence spectroscopy and 
microscopy, DLS and ELS, this work was conducted in order to characterize: 
i) Binary lipid mixtures containing Sph and POPC, a common membrane 
phospholipid (Chapter II) 
ii) Quaternary mixtures with a composition mimicking the most studied lipid 
domains - raft domains  (POPC, Chol and SM) and Sph (Chapters II and III) 
iii) The effect of pH changes, using an environment that mimics the plasma and 
lysosomal membranes (pH 7.4 and pH 5.0, respectively) (Chapters II and III) 
iv) Sph-induced effect in membrane permeability (Chapter III) 
v) Membrane biophysical properties of NPC cell models (Chapter IV) 
vi) The biophysical impact of Sph externall addition to heathy cells (Chapter IV) 
 
Most of the data obtained during the execution of this work has already been published 
in peer review scientific journals, hence a great part of this thesis comprises a compilation of 
the published work. 
 
This dissertation is divided into 6 chapters. Chapter I comprises an overview of the 
thematic that contextualize the present thesis. In a first approach both the biological role and 
the evolution of the concept of biomembranes are introduced. The importance of the structural 
components of biomembranes is also addressed with a special focus in membrane lipids. A 
description of relevant concepts/systems used for membrane biophysics analysis is presented. 
Moreover, information regarding the techniques employed in the framework of this 
dissertation, for the analysis of membrane biophysical properties, is presented. Review articles 
were published with information regarding sphingolipids/Sph biophysics, from which 
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information was used in the writing of this chapter. After the introduction of the sphingolipids 
category, the metabolism, physico-chemical properties, phase behavior and biological role of 
Sph, the main lipid under study, are described, as well as its involvement in human disease.  
Chapters II, III and IV describe the main results obtained in the studies leading to this 
dissertation. Chapter II, describes the effect of Sph in the biophysical properties of model 
membranes (Large Unilamellar Vesicles - LUVs) composed by POPC/Sph and POPC/SM/Chol 
/Sph. The experiments were performed both at neutral (pH 7.4) and acidic (pH 5.0) pH, in order 
to evaluate the influence of pH changes in the biophysical properties of Sph enriched 
membranes. To address these questions, complementary techniques including fluorescence 
spectroscopy, DLS and ELS were used.  Chapter III addresses the development of a new 
synthetic system that more closely resembles the lysososme – the lysosome-mimicking vesicles 
(LMVs). The effect of Sph accumulation in membrane structure/permeability and biophysical 
properties was assessed in standard liposomes (no pH gradient) and in LMVs representing 
physiological (lower SM, Chol content) and NPC-like conditions (higher SM, Chol content). The 
studies were performed using fluorescence spectroscopy, DLS and ELS. Chapter IV is focused on 
the biophysical impact of lipid abnormal accumulation in NPC. The outcome of: null or down 
expression of NPC1 locus, the pharmacological induction of the NPC phenotype with U18666A 
treatment and the externall addition of Sph to healty cells was evaluated in Chinese Hamster 
Ovary cells (CHO-K1 and CHO-M12) and neuroblastoma cells (SH-SY5Y and their mutant 
counterpart down-expressing the NPC1 locus). The studies were performed using fluorescence 
spectroscopy and microscopy. 
The overall conclusions resulting from this PhD work are presented in Chapter V. Briefly it 
is suggest that model membranes are, in fact, a valuable system to predict cell membrane 
properties. The need to develop model systems that more closely resemble the biological 
systems under study is highlighted. The impact of Sph in the biophysical properties of biological 
membranes, coincident with the model membrane data, further emphasizes the importance of 
such systems. However, when considering the more complex biological systems, other features 
should be taken into account, such as the changes in membrane components (e.g. lipid profile) 
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during differentiation and cell aging. Finally, to conclude this manuscript, future work 
perspectives are presented in Chapter VI. 
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CHAPTER 1 – INTRODUCTION 
 
1. The biological role of biomembranes   
Biomembranes are crucial components of all cells, responsible for the physical separation 
between the inside and outside of each cell. Contrary to prokaryotic cells, where only a single 
extracellular membrane exists, eukaryotic cells present in addition to an outer plasma 
membrane (PM), various internal membranes surrounding different compartments, such as 
nucleous, mitochondria, endoplasmic reticulum (ER), Golgi complex, endosomes and 
lysosomes1,2. Biological membranes are therefore responsible for cell compartmentalization, 
but also for all the communication established between the separated internal and external 
spaces1,3,4. The structural principle of all biomembranes is fundamentally the same: 
biomembranes are composed by lipids, proteins and carbohydrates, as it will be described in 
section 3, however, they are incredibly dynamic structures with a remarkable diversity. This is 
the reason why they are involved in several cellular processes. They regulate the transport of 
ions and molecules into and out of the cell due to their selective permeability5,6. Membranes 
are also involved in cellular energy production due to the creation of ion gradients across 
them7. Moreover, membranes are able to control the flow of messages between cells through 
electrical and chemical signals, being involved in cell to cell communication8–11. In addition, 
biomembranes can present different morphologies that are associated with specific functions12. 
An example of this, are the tight junctions that provide the continuous intercellular space 
between epithelial cells, required for the separation of tissues13. Another important feature to 
consider is the membrane compartmentalization into specialized lipid domains, which will be 
discussed in the next section (section 2). Duo to all the aforementioned properties, biological 
membranes are crucial contributors for the maintenance of cellular homeostasis.  
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2. The evolution of the concept of biomembrane 
The evidence for an osmotic barrier separating the inner and outer face of cells appeared 
in the second half of the 19th century14. Almost in the end of the 19th century, Charles Overton 
discovered by studying the osmotic properties of cells that the partition coefficient of 
molecules between water and oil determines its permeation through membranes14,15. Pursuant 
to such studies it was suggested that the cellular membranes present properties of oil14,15. In 
1917, it was proposed by Langmuir that in a monolayer of lipids formed at the air-water 
interface, the polar head groups interact with the water whereas the hydrophobic backbones 
avoid the liquid phase, pointing to the air phase16. A great contribution to cell biology was made 
in the early 20th century. After preparing a lipid extract from human erythrocyte, a lipid 
monolayer was formed in an air-water interface. By comparing the area occupied by the lipid 
extract with the surface area of the erythrocyte, Gorter and Grendel noticed that the area of 
the extracted lipids was the double of the cell surface. Through these very simple experiments, 
they proposed that the structural basis of the PM is a lipid bilayer17.    
In 1935, Danielli and Davson introduced a new model of biological membrane where it 
was considered that proteins are adsorbed to the surface of the lipid layers18 and during the 
following 30 years, this static structural model prevailed. In 1959, with the progress in 
electronic microscopy, the model of the lipid bilayer was confirmed and this concept was 
extended to all organelle membranes19. The essential distinction between integral and 
peripheral proteins, only appeared in 1972, when Singer and Nicolson proposed the “fluid 
mosaic” model20: the membrane is considered a bidimensional solution in which, the proteins 
are completely or partially inserted in the lipidic bilayer, freely diffusing in it. The word 
“mosaic” refers to the random appearance of the lipid-protein composition (Fig. 1A). The “fluid 
mosaic” model is still the main concept of biomembrane, but with the development of new 
techniques that provided higher structural resolution it is nowadays recognized that the cell 
membrane presents different structural organization in terms of thickness, patchiness and 
protein/lipid composition21,22. It has been proposed that biological membranes are actually 
more mosaic than fluid22, and that the lipid-lipid, protein-protein, lipid-protein and protein-
cytoskeleton interactions are responsible for membrane organization. It is now widely accepted 
  
Chapter I 
3 
 
that membrane components are not randomly distributed in the bilayer. Studies from Kusumi 
group propose that the binding of transmembrane proteins to actin-based membrane skeleton 
can temporarily confine or corral the transmembrane proteins in the membrane skeleton mesh 
– “membrane skeleton fence” model. The “anchored transmembrane protein picket” model in 
other hand explains the hop diffusion of phospholipids (PLs) - various transmembrane proteins 
are aligned and anchored along the membrane skeleton, acting as rows of pickets that hampers 
the free diffusion of PLs23–25. There is also the concept of specialized membrane lipid domains, 
the most extensively studied being known as lipid rafts. This concept appeared for the first time 
to explain the formation of glycolipid-rich apical membrane of epithelial cells26. The concept 
was then generalized as a principle of membrane subcompartmentalization, where specialized 
membrane regions would be responsible for the segregation of proteins and involved in crucial 
biological processes, such as, signal transduction and trafficking27–31. A clear definition of lipid 
rafts only appeared in 2006: rafts were defined as “small (10–200 nm), heterogeneous, highly 
dynamic, sterol- and sphingolipid-enriched domains that compartmentalize cellular processes. 
Small rafts can sometimes be stabilized to form larger platforms through protein-protein and 
protein-lipid interactions”32. It is thought that lipids present in these domains are enriched in 
saturated and longer hydrocarbon chain and ceramide backbones, contributing to the less fluid 
nature of these domains33–35. This more ordered lipid environment, presented both in the inner 
and the outer leaflets of an asymmetric cell membrane can presumably be linked across 
leaflets36,37, creating transient, functional and more stable platforms that would cause the 
entrapment of signaling molecules, thus creating the conditions to activate signaling events33,34. 
The concept of membrane raft is still being developed and it was proposed that for a full 
understanding of these domains, it is crucial to consider the following raft features: i) different 
properties before and after stimulation; ii) variation of sizes, lifetimes and molecular 
constituents25. It should however be mentioned that the presence of these domains in live cells 
remains a question of debate duo to lack of suitable techniques to detect these small and short-
lived domais38–40. Nonetheless, the crucial role of membrane lateral heterogeneity in cellular 
function is widely recognized41 and efforts have been made to better characterize such 
membrane heterogeneity42,43. 
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Kusumi and coworkers25 proposed that the PM can be considered as a hierarchical three-
tiered cooperative meso domain, in which the first tier corresponds to the actin membrane-
skeleton-induced compartments – PM partitioning into domains with 40-300 nm in diameter 
due to its interaction with the actin based membrane skeleton and transmembrane proteins 
anchored to the membrane skeleton fence;  the second tier corresponds to the raft domains, 
generally much smaller (2-20 nm) than membrane-skeleton-induced compartments and the 
third tier refers to dynamic, oligomeric integral protein complex domains that usually present 3 
to 10 nm in diameter and that may or may not be linked to the cytoskeleton. In addition, an 
update “fuid mosaic” model has been proposed based on the new data that also covers 
concepts of membrane curvature44 related to the geometrical and mechanical properties of 
lipids and proteins, lipid phases and deviations from equilibrium45,46 (Fig. 1B). Briefly, the actual 
concept of biomembrane include: i) membrane associated cytoskeletal fences; ii) the formation 
of specialized membrane domains, such as lipid rafts and dynamic protein/glycoprotein 
complexes; and iii) extracellular matrix structures45. This additional information contributes to a 
better description of the structure, dynamics and functions of cellular membranes. In the 
crowded membrane plane, the specialized membrane domains and the transmembrane protein 
fences along with other membrane-associated cytoskeletal and extracellular structures 
contribute to the non-random mosaic macro-organization of biomembranes, while the smaller 
nano or sub-micro sized domains such as membrane lipid rafts and protein complexes form 
dynamic specialized regions in the membrane. This description/model will undoubtedly become 
more and more complex in the future with additional answers concerning not only 
composition, function and dynamics but also thermodynamic and physical explanations 
regarding the functional and structural activities of membrane components45. 
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Figure 1 - (A) The “fluid mosaic” model proposed by Singer and Nicolson20. (B) Updated version of the 
“fluid mosaic” model, containing information regarding membrane domain structures and membrane-
associated cytoskeletal and extracellular structures. The different colours represent different lipids, 
proteins, glycoproteins and oligosaccharides. Adapted from Singer and Nicolson (1972)20 and Nicolson 
(2014)45. 
 
3. Membrane structural components  
Biological membranes are composed by lipids, proteins and carbohydrates (Fig. 2). As 
previously referred, its structure consists of a double sheet of lipid molecules, also known as 
lipid bilayer. In addition to the vast repertoire of lipids that constitute biological membranes, 
there are also various types of membrane proteins and carbohydrates that are crucial 
components of the bilayer structure47.  
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Figure 2 – Structural components of the biological membranes. Adapted from Sezgin et al. (2017)34. 
 
Lipidomics is a relatively recent scientific field dedicated to the analysis of the lipid 
world48. After more than a decade of evolution, many methods have been developed for 
lipidomics analysis. Among other techniques, mass spectrometry (MS) and nuclear magnetic 
resonance (NMR) are very useful approaches for lipid characterization49. Lipidomic studies 
enabled the identification of a wide variety of lipids50–52. In an eukaryotic cell, thousands of 
different lipid species can be present due to variation of the headgroups and aliphatic 
chains48,53. The lipid organization in the membrane allows different protein arrangements. In 
addition, lipids enable cells to fuse, fissure and tubulate, features that are needed for cell 
division and reproduction53. Some lipids are also recognized by their ability to act as first and 
second messengers in important signaling cascades53–55. The great diversity of lipids in cell 
membranes can be divided in eight categories based on their chemical and biochemical 
principles: fatty acyls, glycerolipids, glycerophospholipids, sphingolipids, sterol lipids, prenol 
lipids, saccharolipids and polyketides. These categories are then divided in classes that have 
diverse structural and chemical properties56. In the framework of this dissertation focus will be 
given to glycerophospholipids, sphingolipids and sterol lipids, major lipid categories used in the 
present study (Fig. 3). Glycerophospholipids are the main structural lipids in eukaryotic 
membranes, representing about 65 mol% of lipids in mammalian cells57. These lipids are 
derivatives of glycerol phosphate and in most of them the phosphate is at the sn-3 position of 
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the glycerol. Different classes of glycerophospholipids can be distinguished considering the 
group that is linked to the phosphate. Some examples are Phosphatidylcholine (PC), that 
accounts for more than 50% of the PLs in most eukaryotic membranes53, Phosphatidic acid (PA), 
Phosphatidylethanolamine (PE), Phosphatidylserine (PS), Phosphatidylglycerol (PG) and 
Phosphatidylinositol (PI)53,54,58. 2) Sphingolipids (SLs), differ from the glycerophospholipids in 
the hydrophobic group that is ceramide. This group represents about 10 mol% of lipids in 
mammalian cells55,57. The backbone of a sphingolipid is constituted by a sphingoid base that 
after acylation gives rise to ceramide, which in turn can be glycosylated or linked through 
phosphodiester bridges to various headgroups59, as will be described in section 6. 
Glycosphingolipids (GSLs) are included in this category of lipids and can vary from simple 
cerebrosides, GSLs containing a single carbohydrate residue – glucosylceramide (GlcCer) or 
galactosylceramide (GalCer) - to more complex molecules, such as glangliosides, that are 
constituted by an oligoside containing sialic acid linked to ceramide60. 3) Sterols, constitute the 
major class of non-polar lipids in biomembranes53. Structurally, these lipids are characterized by 
the presence of a steroid hydrophobic core that presents 4 rings linked to an –OH hydrophilic 
group. In mammalians, Chol is the predominant sterol. This lipid is highly abundant in the PM 
(ap. 40%)61 and was identified as an important determinant of membrane fluidity and lateral 
organization. It influences the organization of other lipids62,63, such as in the case of the 
membrane lipid rafts64 and lipid-anchored membrane proteins65. 
The lipid distribution along the cell and within each membrane is strongly differentiated. 
The distribution of lipid molecules is distinct between the two membrane leaflets - internal and 
external. For instance, SLs are mainly found in the PM leaflet facing the external medium, while 
the aminophopholipids PS and PE are essentially located in the cytosolic leaflet57. The lipid 
distribution is also different among the distinct cellular membranes57. As an example, the PM is 
enriched in SLs and Chol66, the inner mitochondrial membrane is enriched in cardiolipin67 and 
the internal membranes of the acidic compartments are enriched in the negatively charged 
bis(monoacylglycero)phosphate (BMP)68. The distinct lipid distribution is fundamental for 
membrane organization into functionaly distinct areas, and thus for the compartmentalization 
of distinct cellular processes in different sub cellular spaces. Accordinaly, Chol is commonly 
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linked to the formation of membrane lipid rafts34, while cardiolipin is associated with the 
mitochondrial bioenergetics, particularly it is found in membranes designed to generate an 
electrochemical gradient used in the production of adenosine tri-phosphate (ATP)67. The BMP 
on the other hand, is thought to play a role in GSLs degradation and Chol transport69. 
The ER and the Golgi complex are the major sites of lipid biogenesis70,71, but there are 
other organelles involved in phospholipid synthesis, such as mitochondria72 and perosixomes72.    
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3 – Examples of lipid categories of eukaryotes and representative structures. Adapted from Saliba 
et al. (2015)73. 
 
In addition to the lipid bilayer, all biological membranes contain proteins and 
carbohydrates. Membrane proteins are fundamental for cellular function, serving as specific 
receptors, enzymes, transport proteins, and so on. The ratio between proteins and 
phospholipid molecules will depend on membrane function. Typically, a ratio of 1 protein per 
25 phospholipid molecules is present in the PM, but in the mitochondrial internal membrane - 
specialized in energy processing, there are in average 1 protein for every 15 lipids. On the other 
hand, the membrane of myelin that encloses the nerve cells, uses the properties of lipids as 
electrical insulators and has 1 protein for 70 lipid molecules2. Membrane proteins are 
Species Core structure 
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distributed either in the surface (peripheral) or immersed (integral) in the membrane 
bilayer34,74. Integral proteins are usually attached to the lipid bilayer through hydrophobic and 
electrostatic interactions but some of them can also covalently attach to fatty acids or other 
lipid groups2. These proteins are folded in a way that its nonpolar hydrophobic surface interacts 
with the nonpolar region of the lipid bilayer, while the polar region interacts with the lipid 
headgroups at the membrane surface. Some of these proteins completely cross the lipid bilayer 
- transmembrane proteins, while others only partially integrate it (Fig. 2). Contrary to integral 
proteins, pheripheral proteins, do not penetrate the hydrophobic core of the lipid bilayer. They 
are weakly bound to the membrane surface, through electrostatic interactions with either lipid 
headgroups or other proteins74. Glycosylphosphatidylinositol (GPI)-anchored proteins are 
attached to the membrane through a GPI moiety, hence their designation. They are also 
present in membrane lipid rafts34 but they become water soluble proteins if the lipid anchor is 
hydrolyzed. In eukaryotic cells, the synthesis of membrane proteins starts on the cytosolic 
ribosomes. In a first step, a short segment of protein is synthesized and the ribosome, mRNA 
and nascent protein chain associate with the ER, where the protein synthesis is finalized and 
simultaneously inserted into the membrane47.  
Membrane carbohydrates occur almost invariably chemically attached to either 
membranes lipids (glycolipids) or membrane proteins (glycoproteins) (Fig. 2). These membrane 
carbohydrates are synthetized in the ER and are modified in the Golgi complex, by the addition 
of many new monomers, to form more complex molecules12. These molecules are mostly 
located in the outer monolayer of the PM, facing the extracellular area, although some of them 
can also be associated to intracellular membranes. The whole group of membrane 
carbohydrates is known as glycocalyx. This is a dynamic structure, generically composed by 
glycoproteins and proteoglycans that insert their amino acid chain among the lipid fatty 
acids75,76. The composition and thickness of the glycocalyx is continuously changing in a 
dynamic equilibrium between the soluble components and the flowing blood75. This structure 
plays an important role in different cellular processes, being involved for instance in cell 
adhesion77,78 and cellular recognition79.  
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4. Membrane lipids and lyotropic phase structures 
Due to their amphipathic nature, lipids form aggregates when in contact with water, 
protecting the hydrophobic moiety from the aqueous phase. These molecules are invariably 
polymorphic and, depending not only on the structure of the lipid molecule itself, but also on 
other parameters such as  water content or degree of hydration, temperature, ionic strength, 
pH environment and pressure (see reference80 and the references therein), two types of 
aggregates can be distinguished: the lamellar phases (L), where the lipids are organized in a 
bilayer, and the non-lamellar phases, where the lipids acquire hexagonal (H) or cubic (C) 
structures (Fig. 4)81. At neutral pH and physiological ionic strength most of the lipids prefer the 
lamellar phase, while others (e.g. PE) may prefer the inverted hexagonal (HII) phase, depending 
on temperature and acyl chain composition80,82. This non-lamellar phase is usually related to 
transient events in the membrane (e.g. fusion, pore formation)53. Different types of hexagonal 
and cubic phases have been identified83,84. Among the cubic phases two classes can be 
distinguished: i) inverted micellar, in which spherical aggregates of lipids pack together in a 
cubic array; ii) bicontinuous, in which the lipid phase and the water channels are in continuous 
space85. In the hexagonal phase, hollow cylinders of lipids are formed, being the most frequent 
the HII phase. The lipid headgroups face the cylinder interior, which is filled with water, and the 
acyl chains form the exterior. Each cylinder is surrounded by other six cylinders - hexagonal 
structure85.      
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Figure 4 – The different lattice types resulting from lipid polymorphism. Lipids with a small polar head, 
such as PE have a molecular shape that resembles a truncated cone. They may induce a negative 
curvature strain and favor the organization of membranes into inverted micelles or tubular (HII phases) 
or even cubic (bicontinuous) structures. Lipids with a bulky polar head, such as, gangliosides and only 
one acyl chain, such as lysoPC have a molecular shape similar to an inverted cone and induce a positive 
curvature strain in membranes. They favor the formation of tubular (HI) or spheric micelles. Lipids that 
have similar cross-sectional areas for the polar head and hydrophobic region, such as PC assume 
cylindrical structures. They form lamellar phases, with no curvature. Adapted from Jouhet (2013)81. 
 
Lamellar phases are ubiquitous in cellular compartments and can phase-separate upon 
mixing lipids in different liquid-crystalline states86. The most relevant lamellar phases are: i) 
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fluid or liquid disordered (Lα or ld), ii) gel or solid ordered (Lβ or so), and iii) liquid ordered (lo) 
(Fig. 5). 
 
 
 
 
 
 
Figure 5 - Different lipid lamellar phases. Schematic representation of (A) liquid disordered (ld), (B) gel or 
solid ordered (so) and (C) liquid ordered (lo) phase. Adapted from van Meer et al., 200853. 
 
Lipids with long and saturated hydrocarbon chains (e.g. SM) are frequent in more ordered 
phases, while lipids with unsaturated hydrocarbon chains (as most glycerophospholipids) tend 
to incorporate more fluid phases53. 
According to the “fluid mosaic” model, the fluid phase is considered the one that better 
represents the biological membrane. In this phase, in comparison to the other lamellar phases, 
the water content is higher, there is a larger interfacial area and the bilayer thickness is smaller. 
The lateral diffusion is increased concomitant with the appearance of fast rotation motions of 
the acyl chains. The lipids are not in a true liquid state, they are able to move with significant 
freedom in a parallel plane to the membrane surface, but not so extensively in a perpendicular 
direction46,53. Considering the conformational freedom of the lipids within the fluid phases, two 
phases can be distinguished: i) liquid-disordered (ld) and ii) liquid-ordered (lo), if Chol is present 
in the membrane53. 
In the lo phase, the lipids are in extended conformations and tightly packed, although not 
as much as in the gel phase, diffusing laterally in the perpendicular axis of the bilayer, but 
slower when compared to the ld phase53. The lipid raft domains mentioned previously, 
characterized by the tight packing of the lipid saturated acyl chains and Chol are thought to be 
in the lo phase, coexisting with the disordered surrounding lipids (ld phase)87,88. Due to the 
favorable packing with saturated lipids, the presence of Chol seems to stimulate this type of  
phase separation88. 
A B C 
  
Chapter I 
13 
 
Even though the water content in the gel phase is usually very low, it depends on the lipid 
headgroup size, polarity and charge. A slow rotation along the long-axis occurs due the 
organization of the hydrocarbon chains in an all-trans conformation53,89,90. In this phase, the 
cross-sectional area is minimal and the bilayer thickness is maximal, which results in closely 
packed headgroups and hydrocarbon chains91. In order to enhance the packing, the acyl chains 
are perpendicular to the bilayer surface for lipids with small headgroups (e.g. ceramide)92 (gel 
phase, Lβ) and tilted for lipids with larger headgroups84 (gel phase, Lβ´), such as in the case of 
DPPC93 and 1,2-distearoyl-sn-glycero-3-phosphatidylcholine91.  
The occurrence of fluid and gel phases as previously referred do not depend solely on the 
structure of the lipid molecules, but also other factors, such as  temperature. For each bilayer-
forming lipid, there is a specific temperature, known as main transition temperature (Tm), at 
which 50% of the thermotropic transition between gel and fluid phases occurs94,95. At that 
temperature the two phases coexist and some packing defects appear at the interface between 
the two phases88. In addition to a transition between a gel and fluid phase, some lipids present 
a pre-transition, at temperatures below the Tm, characterized by the formation of periodic 
ripples (Pβ, rippled gel) in the membrane96. The Lβ to Lα chain-melting phase transition has been 
the most intensively studied lipid phase transition80, considering that most membrane lipids 
exist in the lamellar fluid phase under physiologically relevant conditions53,97, but sometimes 
also in the lamellar gel phase98. 
When studying the lipid-lipid interplay, the phase transitions can be schematically 
represented by phase diagrams (Fig. 6)95. The higher the number of lipids included in the 
mixture, more complex is the phase behavior and usually there is a broad range of 
temperatures where two or more phases can coexist. To define the boundaries of a phase 
diagram, different techniques can be used in order to detect the lipid phase changes. These 
include differential scanning calorimetry (DSC), fluorescence spectroscopy and NMR99–101.  
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Figure 6 – Example of a ternary phase diagram determined for POPC/PSM/Chol mixtures at 24 °C. The 
black line corresponds to the tie line that contains the 1:1:1 POPC/PSM/Chol mixture. The grey shades 
represent regions of different sized raft domains. Legend: ld, liquid disordered; lo, liquid ordered; so, solid 
ordered. Adapted from Silva et al. (2007)102. 
5. Strategies to study lipid-lipid interactions and membrane properties 
The biophysical properties of a membrane are determined by its composition, specifically 
by the lipid-lipid, lipid-protein and protein-protein interactions. The large number of different 
lipids and proteins, their distinct interactions and the changes that occur in the membrane due 
to these interactions, underlie biomembrane complexity. Due to their different structures, 
regarding both headgroups and chain structures, lipids are able to influence the thickness and 
packing of the membrane95,103, and its dynamic organization. In addition, lipid net charge might 
influence the spatial location of proteins, for instance, through the electrostatic interactions 
between negatively charged lipids and cationic moieties of the proteins104. As previously 
referred, lateral heterogeneities in the membrane set different domains with distinct physical 
properties and functions from the neighboring regions90, which might determine the regulation 
of conformational state and sorting of membrane proteins. Well-known examples of these 
specialized domains are the lipid rafts33,105,106 and the ceramide-platforms107,108. A better 
understanding of the interdependence between the changes that occur in the different 
membrane domains is needed. However, due to the complex nature of biomembranes it is 
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difficult to study the biophysical properties of biological membranes and characterize the 
features of the different phases in vivo. Accordingly, different types of membrane model 
systems have been developed (see sub-section 5.1) and several studies (e.g.109–112) have been 
performed using these membrane models to better understand the interplay between different 
lipids in the more complex biological membranes, as well as to predict how membrane 
properties will change when alterations in lipid composition occur.   
 
5.1. Model membranes  
Different types of artificial systems can be used, and their composition and complexity 
can be manipulated according to the specific goals of the study. They can be constituted by one 
or more lipids, and include or not proteins113,114. Liposomes have been the most common 
model systems used in the characterization of membrane properties and the related biological 
processes114 but they also have important applications in the pharmaceutical115 and food 
industry116. This kind of vesicles can present different sizes and lamellar organization (Figure 
7)117. For instance, multilamellar vesicles (MLV) present different overlapping layers and are 
spontaneously formed when bilayer-forming lipids contact with water, being very easily 
prepared118,119. Due to its high cooperativity in phase transition, this system is the most suitable 
to study the thermotropic properties of the membrane120. However, some disadvantages are 
also associated with these model membranes, for instance, the size and number of layers are 
not homogeneous, which can be responsible for an increase in light scattering, affecting 
photophysical studies121. Among other techniques119, large unilamellar vesicles (LUV) can be 
obtained after the repeated extrusion of MLV through polycarbonate filters with specific pore-
size122,123. The lipid amount is about the same in both monolayers124 and the size of these 
vesicles can range from 100 nm to 1 µm. Due to their easy formation, high reproducibility, 
stability, controlled size and unilamellar nature, they are very useful in different types of 
studies, such as the trapping of solutes and drug delivery115,125–127, being therefore a widely 
used model membrane system.  
Small unilamellar vesicles (SUV) are smaller than 100 nm and they can be obtained mostly 
through MLV or LUV disruption, using sonication methods118,128,129. In SUV the great majority of 
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the lipids are located in the outside surface and the aqueous space is small. The smaller the size 
of the vesicle, the higher propensity for the occurrence of fusion events, in order to reduce the 
tension130. This system presents high membrane curvature that hampers the lipid packing131, 
and causes low cooperativity in phase transition132. These vesicles can be useful in the 
preparation of supported lipid bilayers133 or in membrane fusion studies134. 
Giant Unilamellar vesicles (GUVs) have diameters superior to 1 µm, being in terms of size 
the best cell-mimicking approach. Among other preparation methods119, these vesicles are 
commonly obtained through electroformation135. Due to their large size, these systems are very 
suitable for microscopy studies and useful in the analysis of the biophysical properties of 
membranes, such as the observation of phase separation and membrane domains. This can be 
achieved through the use of fluorescent probes which have different partitions towards the 
phases present in the membrane136. 
 
 
 
Figure 7 - Schematic representation of the most commonly applied liposomes. The drawings are not to 
scale. Adapted from Li et al. (2017)117. 
  
5.2. Membrane characterization 
There are several techniques available to characterize the biophysical properties of model 
and cell membranes. Due to their complementarity, they are usually employed in a combined 
way in order to allow a more comprehensive characterization of the systems under 
investigation. Some examples are DSC, fluorescence spectroscopy and microscopic techniques 
(e.g. confocal microscopy and atomic force microscopy).  
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In this section, the principles of the main characterization techniques used in this work 
will be briefly described.  
5.2.1. Fluorescence Spectroscopy  
Fluorescence spectroscopy comprises a set of techniques often employed in biophysics. 
The photophysical properties of fluorophores incorporated in the membrane are evaluated, 
through steady-state and/or time-resolved fluorescence methodologies, giving information 
about the physical properties of a specific lipid environment, such as fluidity, pH, or water 
content137.  
Before fluorescence emission occurs, a fluorophore must enter in an excited state after 
light absorption, which is represented by a transition from the fundamental electronic state (S0) 
to a singlet electronic state of higher energy (e.g. S1 or S2). Upon excitation, the energy 
absorbed by the fluorophore, can then be released through different processes, some of them 
represented in the Jablonski diagram (Fig. 8). The release of energy to the lowest exited-state 
energy level (S1) generally occurs through non-radiative processes. However, this internal 
conversion process may also give place to a radiative process, through the emission of photons. 
Fluorescence, for instance, corresponds to the radiative relaxation from S1 to S0138,139. 
 
 
 
 
 
 
 
 
 
Figure 8 – One form of Jablonski diagram. The singlet electronic states are denoted as S0, S1, S2 and one 
triplet state is represented by T1. Adapted from Lakowicz (2006)138. 
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Fluorescence Emission and excitation spectra  
When a fluorophore is excited at a fixed wavelength and the fluorescence intensity is 
collected for a range of higher wavelengths, an emission spectrum is obtained. In order to 
obtain an excitation spectrum, the inverse process is carried out, i.e., the fluorophore is excited 
at various wavelengths and the fluorescence intensity is collected at a fixed wavelength138.  
Fluorescence spectra are sensitive to changes in the medium and for that reason might be 
useful to study changes in the environment in which a fluorophore is inserted138. The polarity of 
the solvent, for example, has a large effect on the spectral properties of some fluorophores. As 
already mentioned, upon excitation, the fluorophore rapidly losses the excess of vibrational 
energy and relaxes to level S1, from where the emission occurs. This process, in which the 
maximum of fluorescence emission occurs at less energetic wavelengths, i.e. longer 
wavelengths, than that of absorption, leads to an energy gap between the absorption and the 
emission spectrum, termed the Stokes´shift139. The effect of solvent polarity displaces emission 
for even lower energy levels due to stabilization of the fluorophore in the exited state, lowering 
the energy of S1 level (solvent relaxation). When returning to the ground state, the dipole 
alignment will no longer be optimal, which means that the energy in S0 is now higher than the 
initial state (before excitation). This results in a lower energy gap between S1 and S0 manifested 
by emission in longer wavelengths (red shift in emission)138,139. However, excitation spectra are 
usually less suitable because no solvent relaxation takes place during extremely fast absorption 
process.  
 
Steady-state fluorescence anisotropy 
When a fluorophore is continuously illuminated with a lamp emitting a constant flow of 
photons, the concentration of excited fluorophore remains constant, which means it is in a 
steady-state. Steady-state fluorescence anisotropy is regularly used in membrane biophysics 
studies, since it can sense the environment in which the fluorophore is inserted. This 
methodology consists in the measurement of depolarization of emitted light. Upon excitation 
with polarized light, the fluorophores with a parallel transition dipole with the electric vector of 
excitation will absorb the photons more efficiently. Then the emitted photons are measured  
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after passing through a linear filter light (polarizer) that is positioned in either a parallel or a 
perpendicular direction of the polarized light excitation139. The anisotropy can be calculated 
using the intensities of the emitted light, through equation 1: 
 
 
 
where the different intensities (I), are the vertical and horizontal components of fluorescence 
emission in steady-state with vertical (IVV and IVH, respectively) and horizontal (IHV and IHH, 
respectively) excitation relatively to the emission axis. G factor can be determined by the IHV/IHH 
ratio and is used to correct the different sensitivity of the detector for the vertical and 
horizontal polarization138. 
 
Fluorescence anisotropy (<r>) measurements are performed in a spectrofluorometer 
equipped with polarizers, as exemplified in figure 9. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9 – Schematic representation for the measurment of fluorescence anisotropy. Adapted from 
Lakowicz (2006)138. 
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As previously referred fluorescence anisotropy might be used in order to sense the 
environment in which the fluorophore is inserted. In this way, if the fluorophore is located in a 
rigid environment its rotational movement will be hindered and the depolarization of light is 
inefficient. In this case the polarization of emitted light will be intimately related with the 
polarization of the excitation light. On the other hand, if the fluorophore is located in a more 
fluid environment, its rotation is facilitated and there is no preferential polarization orientation 
for the emitted light138.  
In the absence of depolarization processes, a fundamental anisotropy value will vary 
depending on the angle between the absorption and emission transition moments. A variation 
from a maximum of 0.4, in a collinear situation (0°) to negative values of -0.2 for an angle of 90° 
can occur138. Considering a practical application of this concept, if we consider a fluorophore 
with an angle of 0° inserted in a rigid region of the membrane, like a gel phase, it will exhibit a 
high anisotropy value that is usually superior to 0.3. When the same fluorophore, with the same 
angle is located in a more fluid region of the membrane the anisotropy value decreases. 
 
Fluorescence Lifetime of the Intensity Decay 
The average time that a molecule remains in the excited state is given by its fluorescence 
lifetime139. A fluorescence intensity decay is obtained after an excitation pulse infinitely short, 
with enough energy for a given number of molecules to pass into the excited state. Some 
molecules promptly emit a photon just after being excited, however other molecules take 
longer times for the photon emission. This is the reason way the lifetime corresponds to a 
statistical average. Through the time distribution of the emitted photons, an intensity decay is 
obtained138. 
Fluorescence decays can be described by only one exponential (simple decays) or by a 
sum of exponentials (complex decays). Equation 2 describes a single exponential decay that is 
directly obtained from the time-dependent intensity, while equation 3 describes a multi-
exponential decay with n components: 
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where I0 corresponds to the intensity at time 0, and the lifetime is the inverse of total decay 
rate. 
 
 
 
where i and i are the normalized amplitude and lifetime of the component i, respectively 
 
The mean fluorescence lifetime of a fluorophore can be defined by equation 4: 
 
 
 
The time-correlated single-photon counting method, also known as single-photon timing 
is the most popular technique for lifetime determination. The principle of this technique is 
based on the fact that the probability of detecting a single photon at time t, after an excitation 
pulse, is proportional to the fluorescence intensity at that time138. The time between the 
excitation pulse and the emission of the photon is represented as a histogram (Fig. 10). 
 
 
 
 
 
 
Figure 10 – Histogram representing the photon counting over time in order to obtain the average 
fluorescence lifetime of a fluorophore. Adapted from Lakowicz (2006)138. 
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As for fluorescence anisotropy, the fluorescence lifetime is also dependent on different 
environmental factors (e.g. temperature and polarity) and it can be used as a complementary 
methodology in membrane biophysics. In general, fluorophores displaying longer lifetimes are 
usually partitioned into more rigid membrane regions, while the incorporation into more fluid 
areas is reflected by shorter lifetimes. 
5.2.2. Fluorophores 
There are a number of different fluorophores available for the study of membrane 
biophysical properties. The selection of those probes will depend on the specific purpose of the 
study. Some probes are used for labelling specific lipid molecules, others are sensitive to the 
hydration of the surrounding environment and there are also some probes that selectively 
partition into distinct membrane phases, being very useful for the study of membrane 
organization40,140,141. An example of these probes is trans-Parinaric Acid (t-PnA) which was 
specifically selected for this work, with the aim of studying the Sph interplay with other 
membrane lipids. t-PnA presents a preferential partion for tightly packed domains (gel phase), 
where it presents a high quantum yield142. The t-PnA intensity decay is usually described by a 
sum of 3 or 4 exponentials and the longest lifetime component that reflects the order of the 
highly packed domains is often used as a fingerprint for the gel phase detection (values > 30 
ns)102.  
The probe 1,6-diphenyl-1,3,5-hexatriene (DPH), was also used in this work and contratry 
to t-PnA, displays an equal partition among the different membrane lipid phases (ld, lo and 
gel)140 (Fig. 11). DPH is a very sensitive probe to evaluate membrane fluidity143. It presents 
almost no fluorescence in water, but when inserted in the membrane bilayer its fluorescence 
increases significantly. Despite its non-preferential partition to distinct lipid phases, this probe 
shows a higher anisotropy and lifetime values in lo and gel phases, compared to the ld phase.  
TMA-DPH, the trimethylammonium derivative of DPH, has a more shallow location in the 
membrane compared to the hydrophobic DPH143 and it was punctually used in this work, in an 
attempt to acquire additional information regarding the interaction of Sph with cell 
membranes. 
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Figure 11 – Predicted location of fluorescent probes used in this work. The polar headgroups of 
sphingolipids are represented in purple and green) (types A and B), and that of phospholipids in blue. 
Sterols that are involved in the formation of lo phases are represented by a ring system. DPH reports the 
global order of the membrane in the hydrophobic core; t-PnA reports acyl chain packing and has 
preferential partition for gel phases (red t-PnA), but can also be found in lo and ld phases where it 
presents a lower quantum yield (black t-PnA); TMA-DPH, similar to DPH, reports the global order of the 
membrane, but is anchored at the membrane surface by the TMA group and is more sensitive to 
hydration. Adapted from Marquês et al. (2015)144. 
5.2.3. Electrophoretic and dynamic light scattering measurements 
Dynamic Light Scattering (DLS) 
Particle size can be determined by measuring the random changes in the intensity of light 
scattered from a suspension or solution. This technique is known as DLS and it takes in account 
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that the random motion of molecules, known as Brownian motion, at room temperature, 
occurs at a velocity that depends on the size of the vesicles145–147.  
Through the use of a laser beam focused in a small area of the sample, it is possible to 
perform the measurement of the intensity fluctuations resulting from the light that is scattered 
by the particles, in this case the vesicles, crossing the focused area (Fig. 12A). The vesicles 
scatter the light in a way dependent of its hydrodynamic diameter. Moreover, the velocity of 
the Brownian motion is defined by a property known as translational diffusion coefficient. 
Through this coefficient, the size of the vesicles can be calculated using the Stokes-Einstein 
equation: 
 
 
 
where d(H) is the hydrodynamic diameter, D is the translational diffusion coefficient, k is the 
Boltzmann constant, T is the absolute temperature and η corresponds to the medium 
viscosity145. 
 
The scattered light provides a correlation function from which vesicle size distribution can 
be obtained (Fig. 12B). This value is accompanied by a polydispersity index (PDI), which 
provides information about the homogeneity of the size distribution of the sample. The PDI 
varies between 0 and 1, where values close to zero indicate nearly homogeneous monodisperse 
solutions and values close to 1 represent heterogeneous populations with a broad distribution 
of macromolecular sizes, for example, vesicles with different sizes or vesicle aggregation145,146. 
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Figure 12 – Dynamic light scattering. (A) Schematic representation of DLS instrumentation. (B) Example 
of a size distribution plot. Adapted from Bhattacharjee (2016)147 and Malvern Instruments (2013)145. 
 
Electrophoretic light scattering (ELS) 
The net charge at the vesicle surface affects the distribution of the ions in the surrounding 
medium. An increased concentration of counter ions occurs in the surface interfacial region and 
the liquid surrounding the vesicle can be divided into two parts: the Stern layer, an inner region, 
where the ions are strongly bound and an outer region where the ions are attached less firmly. 
This means that around each vesicle an electrical double layer exists. In the outer, more diffuse 
layer, there is a boundary (slipping plane) inside which a stable group of ions is formed. The 
ions inside this boundary will follow the vesicle movement, contrary to the ones that are 
located beyond it. The potential that exists at this boundary is known as ζ-potential (Fig. 
13)145,147. 
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Figure 13 – Representation of the potentials found in a particle in suspension. Adapted from 
Bhattacharjee (2016)147. 
 
The technique used to determine the ζ-potential, consists in a micro electrophoresis. An 
electric field is applied across an electrolyte and the charged vesicles in suspension will be 
attracted and move towards the electrode of the opposite charge (Fig. 13)147. The velocity at 
which the vesicles move will depend on the strength of the electric field, the dielectric constant 
of the medium, the viscosity of the medium and the ζ-potential. By applying the Henry equation 
it is possible to obtain the ζ-potential: 
 
 
 
where ζ is the ζ-potential, U is the electrophoretic mobility, ε is the dielectric constant, η is the 
viscosity of the medium and f (KRs) is the Henry´s function145. 
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5.2.4. Permeability studies 
In order to evaluate the Sph-induced alterations in membrane permeability, leakage 
experiments were performed. This methodology is based on the encapsulation of fluorescent 
probes inside the vesicles. In this work, a well-known fluorophore 8-Aminonaphthalene-1,3,6-
Trisulfonic Acid Disodium Salt (ANTS) and its quencher p-xylene-bis-pyridinium bromide (DPX) 
were used148. Both these molecules are entrapped inside the vesicles. If membrane 
permeabilization occurs after exposing the vesicles to the molecule under study, ANTS and DPX 
become diluted into the external medium and they hardly interact, which can be reflected by 
an increase in ANTS fluorescence intensity (Fig. 14). 
 
 
 
 
 
 
 
 
 
 
 
Figure 14 – Schematic representation of an ANTS/DPX leakage assay. The ANTS maximum fluorescence 
intensity (100% leakage) is obtained after the addition of Triton X-100 in the end of the experiment. 
5.2.5. Fluorescence microscopy 
Fluorescence microscopy, represents a powerful tool in cell and molecular biology. This 
technique allows the detection of the fluorescence from a sample itself (auto-fluorescence) or 
more commonly from fluorophores that are used to detect specific targets. These fluorescent 
labels can be attached to the molecules/structures of interest with high specificity, providing a 
strong intensity contrast in the microscopic image of the sample149.  There are a myriad of 
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fluorophore molecules150,151 and fluorophore bioconjugates152 available in the market and the 
use of fluorescent proteins153,154 is also wide-spread.  
Different variants of fluorescence microscopy techniques can be used, from the basic 
widefield microscopy, to confocal laser scanning microscopy (CLSM)  and the super-resolution 
techniques155 that revealed to be very useful in the study of structures with sizes comprised 
under the diffraction limit of conventional fluorescent microscopes, such as viruses156. These 
techniques allowed the breaking of the diffraction limit while maintaining the advantages of the 
fluorescence readout such as non-invasive live-cell imaging and labelling specificity. With such a 
big diversity of fluorescence microscopy approaches157 different biological processes can be 
studied, including cell signaling158, endocytic trafficking159, spatial location of 
proteins/receptors160, lipid phase separation140,161 and membrane domains38,161–163. A 
fluorescence microscope is used to separate the emitted light from excitation light as it can be 
observed in figure 15. Briefly, a dichroic mirror (DM) that is located in an excitation filter cube 
directs the excitation light that commonly is provided by mercury, xenon, halogen, arc lamps or 
single-wavelength light emitting diodes (LEDs)164,165 to the sample or specimen and passes the 
emitted fluorescence to the emission cube, where it will be separated. To prevent the 
excitation light from reaching the detectors, a filter barrier is used (marked with the letter B in 
the image). A second DM is used to separate the emitted fluorescence into two beams and the 
emission filters (Em 1 and Em 2) block unwanted light. For the detection of fluorescence, 
cameras in the case of widefield microscopy or photomultiplier tubes in the case of CLSM are 
used (Fig. 15A). In the CLSM, the DM and the objective lens reflects and focus the laser light in 
the specimen. Then the laser excites the fluorescence throughout the specimen, which will pass 
the DM and be focused onto the image plane. Only the light from the confocal plane of the 
specimen will reach the photomultiplier tube, through the use of a pinhole (Fig. 15B). In CLSM 
only a small point of the specimen is illuminated and the laser beam needs to scan across it to 
create an image. In widefield microscopy, the whole specimen is illuminated simultaneously by 
a parallel beam of light to excite the fluorophore(s). The simplicity of this technique conjugated 
with diffraction limited optics and the projection of out of focus light onto the single image 
plane of the camera, can result in images with low spatial resolution and low contrast166. 
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However, widefield microscopy is still commonly used and the success of its use depends 
mainly in the selection of the sample. The selection of thin samples, such as a monolayer of 
cells, or macroscopic structures such as organelles are preferable in  order to reduce the 
material outside the focus plane166. To consider the sample thickness the use of confocal 
microscopy can be more suitable, since it is able to reject the out of focus light from the image 
using a pinhole as previously referred, which may result in images with higher resolution167.  
Multiphoton microscopy can also be used to observe far deeper into a thick sample. This 
technique resort to the use of fentosencond pulsed laser and the simultaneous absorption of 
two long wavelengths photons in a single event168,169. The advantage is that, while maintaining 
the three-dimensional resolution of an ideal confocal microscope, a higher level of penetration 
in the sample is achieved with a lower level of photobleaching and photodamage (no 
absorption and fluorescence above and below the plane of focus), which is fundamental for the 
visualization of living cells and tissues169. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 15 – Fluorescence microscopy principle. A) The basic light paths of a fluorescence microscope and 
B) operation of a laser scanning confocal microscope. Adapted from Sanderson (2014)166. 
 
In the present work widefield, LSCM and two-photon microscopy were used for the 
observation of cellular phenotypes associated with lipid abnormal accumulation. 
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6. Sphingolipids: Diversity, metabolism and biological role 
From a lipidomic analysis, it is estimated that more than thousands of SLs can exist. All of 
them are encompassed in the LIPID MAPS Structure Database170, which is regularly updated. 
The complexity of SLs (Fig. 16) is based on the diversity of the 3 structural components, namely 
the headgroup, the fatty acyl chain and the sphingoid base.  
 
 
 
 
 
 
 
 
 
Figure 16 – Representative structures of sphingolipids. Adapted from Futerman and Hannun (2004)171.  
 
In mammalians, sphingoid basis with a chain length of 18 carbons, such as Sph (2S,3R-D-
erythro-2-amino-1,3-octadec-4E-ene-diol, also known as trans-4-sphingenine) (Fig. 17), 
sphinganine (2S,3R-D-erythro-2-amino-1,3-octadecane diol) and phytosphingosine (2S,3S,4R-
erythro-2-amino-1,3,4-octadecane triol, also known as 4-hydroxysphinganine), are the most 
prevalent backbones of SLs, but a number of other sphingoid bases exists and evidence points 
to more than 60 variants172,173. Sphingoid bases with alkyl chain lengths varying from 12 to 26 
carbon atoms have been reported174,175 but variation in the number and position of double 
bonds and hydroxyl groups also occur173. 
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Figure 17 – Examples of sphingoid bases found in mammalian tissues. Adapated from Pruett et 
al. (2008)173. 
 
The sphingoid base simplified nomenclature created by analogy with fatty acids, considers 
3 aspects in the lipid backbone173:  
i) the number of hydroxyl groups (e.g. “d” for 2 and “t” for 3 hydroxyl groups) 
ii) the number of carbon atoms (after hydroxyl groups) 
iii) the number of double bonds (including location and configuration; as a prefix or 
suffix)   
Long chain bases with 20 carbon atoms can be found in brain gangliosides and a fine 
regulation of these molecules must be maintained in order to avoid detrimental effects in the 
nervous tissues176. In human skin, 6-hydroxy-sphingosine is one of the possible sphingoid 
backbone of ceramide, in addition to Sph and phytosphingosine177. The unusual sphingoid 
bases 3-ethoxy-d15:0, 3-ethoxy-d17:0 and 9-methyl-3-ethoxy-d15:0, can be found in milk 
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gangliosides178 and the uncommon 5-hydroxy,3E-sphingosine is obtained through the acid 
hydrolization of brain extracts179. Deoxy-sphinganine (deox-dhSph) and deoxymethyl-
sphinganine (deoxmeth-dhSph) belong to a class of 1-deoxy-sphingolipids that lack the C1-OH 
group of the normal sphingoid bases180,181. This results from the ability of serine 
palmitoyltransferase (SPT) to metabolize different amino acids (Fig. 18). While the conjugation 
of alanine forms deox-dhSph, the conjugation of glycine forms deoxmeth-dhSph. 1-
deoxysphingoid bases can be metabolised to deoxy-ceramides, but neither converted to 
complex SLs nor degraded by the canonical catabolic pathway due to the missing C1-OH 
group182,183. The accumulation of these atypical SLs is reflected by cytotoxic effects and the 
development of pathological situations, reason why they are considered important biomarkers 
for different diseases, such as diabetes182,184,185, hereditary sensory and autonomic neuropathy 
186. 
The concentration of free sphingoid bases in cells is low187,188 due to its rapid 
metabolization into other lipid species. SL metabolism is an extremely complex and organized 
system involving several enzymes and isoenzymes which has been extensively described181. The 
central molecule of SL metabolism is ceramide (Fig. 18). Ceramide is a very simple molecule 
(Fig. 16), but very important in terms of cellular function. The intervention of ceramide as 
second-signal effector molecule in diverse biological processes, such as apoptosis189,190, 
proliferation190 and senescence191, have been demonstrated. In mammalians, the generation of 
ceramide, can occur in the ER through the de novo pathway (Fig. 18). In a first step SPT 
catalyzes the condensation of palmitoyl-coenzyme A (CoA) with serine, forming 3-keto-
sphinganine. Then, the formation of the sphingoid base sphinganine, is followed by the 
attachment of a fatty acid to generate dihydroceramide, catalyzed by ceramide synthase (CerS). 
The final step corresponds to the insertion of a 4,5-trans double bound, by the enzyme 
dihydroceramide desaturase (DES)192. Different CerS isoforms with differential preferences for 
acyl-CoA and acyl chains, reside in the ER and contribute for the generation of ceramides with 
distinct acyl chains lengths193,194, with different impacts in the biophysical properties of 
membranes 195–197. After ceramide generation in the ER, this lipid can be transported by either 
vesicular transport or the action of ceramide transfer protein to the Golgi complex where the 
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formation of more complex SLs will occur198–200. SM is formed through the transfer of a 
phosphorylcholine headgroup from PC to the C-1 of ceramide (Fig. 18) in the trans Golgi 
nertwork201. This is the most common sphingolipid in mammalian PM, where it interacts with 
Chol forming, the lipid raft domains (section 2). SM can be hydrolyzed to ceramide and 
phosphocholine (sphingomyelinase pathway, Fig. 18) through the action of different 
sphingomyelinases, with different subcellular locations202.  
Another way to obtain ceramide is through the salvage pathway (Fig. 18). Sph coming 
from the sub-cellular acidic compartments (LE and lysosomes), where most SLs are cleaved into 
their building blocks203 can be converted into ceramide and its derivatives204, or be 
phosphorylated by sphingosine kinases (SK) to form sphingosine-1-phosphate (S1P) (Fig. 18) an 
highly bioactive lipid205–209. Similarly to Sph, ceramide can also be phosphorylated through the 
action of ceramide kinase to yield ceramide-1-phosphate (C1P)210, another important signaling 
molecule209,211. The de-phosphorylation of S1P and C1P by S1P and C1P phosphatase generates 
Sph and ceramide, respectively.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Chapter I 
34 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 18 – Simplified schematic representation of the SL metabolism. Ceramide synthesis can be 
achieved through the de novo pathway, sphingomyelinase pathway, salvage pathway and the 
exogenous recycling of ceramide. Ceramide is a central molecule in the SLs metabolism and it can be 
used for the synthesis of more complex SLs, such as SM and GSLs or be degraded to form Sph. The 
formation of the atypical sphingoid bases, 1-deoxy-sphinganine and 1-deoxymethyl-sphinganine is 
possible through the conjugation of palmitoyl-CoA with alanine and glycine, respectively. Abbreviations: 
aβGluase, acid β-glucosidase; aCDase, acid ceramidase; aSMase, acid sphingomyelinase; C1PP, 
ceramide-1-phosphate phosphatase; CDase, ceramidase; CerS, ceramide synthase; CK, ceramide kinase; 
DAG, Diacylglycerol; DES, dihydroceramide desaturase; ER, endoplasmic reticulum; GCase, 
glucosylceramidase; GCS, glucosylceramide synthase; KDS, ketosphinganine reductase; LE, Late 
endosomes; Lys, Lysosomes; PC, Phosphatidylcholine; SK, sphingosine kinase; SMase, sphingomyelinase; 
SMS, sphingomyelin synthase; SPPase, sphingosine phosphate phosphatase; SPT, serine 
palmitoyltransferase. 
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As previously reffered GSLs are formed by a ceramide backbone covalently linked to a 
glycan moiety (section 3). The simpler molecules belonging to this group of SLs are the 
cerebrosides that are formed upon the addition of a glucose or a galactose to the ceramide 
backbone, forming GlcCer and GalCer, respectively. While GalCer is formed in the ER and then 
transported to the Golgi complex212, GlcCer is synthesized in the cis-Golgi network213. Sulfatides 
are derived from GalCer via esterification of a sulfate group to the 3-hydroxyl of the galactose 
moiety212 and are important acidic glycolipids with relevant roles in the nervous system, 
immune system, insulin secretion and virus infection, among others214. The addition of 
galactose to a GlcCer gives origin to lactosylceramide, the structural unit of gangliosides and 
globosides215. The classification of the vast majority of GSLs structures is based on seven 
common tetrasacharide neutral sugar cores. The ones sharing the same neutral core belong to 
the same “series”: ganglio, lacto, neolacto, globo, isoglobo, mollu or arthro. The most 
representative “series” in the vertebrates are the ganglio (Fig. 19), globo, and neolacto 
series216. The GSLs are further sub-classified as neutral, if no charged sugars or ionic groups are 
present; sialylated (gangliosides), if one or more sialic acid residues are present or sulfated.  
The official nomenclature of GSLs can be complex217 and for that reason simplified 
nomenclature is also used. This is the case of  Svennerholm218 abbreviations for brain 
gangliosides. In the case of the ganglioside Galβ1-3GalNAcβ1-4(Neu5Acα2-3)Galβ1-4GlcβCer, 
also known as GM1, the first letter “G” corresponds to the serie ganglio, the second letter “M” 
refers the number of sialic acid residues (M=1)  and the number refers to the order of migration 
of the compound in thin layer chromatography60,216.  
Several enzymes are involved in the synthesis of GSLs in the Golgi complex216. After their 
synthesis, these molecules are transported by vesicular transport to the PM219, where they play 
different biological roles, acting as membrane receptors or modulators of other membrane 
components in order to change signal transduction220. GSLs can then undergo endocytosis and 
be recycled back from the early endosomes; sorted from the endosomes to the Golgi complex 
for re-glycosylation or they can be totally or partially degraded in the lysosomes221. 
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Figure 19 – Biosynthetic pathways of ganglio series drived GSLs. Adapted from Schnaar and Kinoshita 
(2015)216. The abbreviations are given according to the recommendations of the International Union of 
Pure and Applied Chemistry – International Union of Biochemistry Joint Commission on Biochemical 
Nomenclature of Glycolipids217. 
 
SLs in general play a fundamental role in withstand the eukaryotic life. GSLs, in 
particularly are crucial for the development of complex multicellular organisms222. Their 
importance was noticed when a knock-out of glucosylceramide synthase, that catalyze the 
GlcCer synthesis, proved to be embryonic lethal223.  A correlation between GSLs expression and 
the cellular events that lead to the development of the vertebrate nervous system has been 
reported224–226. GSLs can interact with growth factor receptors, having a role in growth, 
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differentiation and modulation of signal transduction213. GSLs are also important for cell 
adhesion and motility227. The involvement of some GSLs in membrane  organization112,161,228,229 
and formation of specialized membrane domains34,230 has also been demonstrated. 
 
It is known that alterations in SL metabolism can be related with different 
pathologies231,232 and in order to preserve normal cell function it becomes clear that the cellular 
levels of SLs must be finely balanced. As previously referred, these bioactive lipids can be 
involved in the regulation of different cellular processes, such as proliferation233, 
differentiation234, inflammation235,236, apoptosis237 and autophagy238. Some SLs, including S1P, 
C1P and GlcCer are important regulators of cell proliferation and survival, while Sph and 
ceramide have an antagonistic effect contributing to growth suppression and apoptosis239. 
Recent evidence suggested that the enzymes of the SL rheostat do not function merely by 
directly changing the cell fate through the balance between pro-apoptotic ceramide and pro-
survival S1P, as initially conceived in the rheostat model240, but also by the differential 
activation of a myriad, often opposing, signaling pathways241. Thus, a new rheostat model was 
proposed241 considering the local production, secretion and the signaling mediated by these 
metabolites. The SL rheostat is therefore a fundamental control system that has a profound 
effect in cellular function241.    
 
7. Sphingosine 
 As previously referred, Sph is the most abundant sphingoid base in mammals. It was first 
described by J. L. W. Thudichum in 1884 and structurally characterized as 2S,3R,4E-2-
aminooctadec-4-ene-1,3-diol242.  
7.1. Metabolism 
Sph is formed by deacylation of ceramide through the action of different ceramidases 
(CDase) that act in different subcellular locations, being classified by the optimum pH of activity 
(reviewed in Gault et al. (2010)202). Briefly, in the acidic environment of the lysosome, acid 
ceramidase (aCDase) is responsible for the deacylation of ceramides that result from the 
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degradation of PM SLs202. At neutral pH, the most active CDase is neutral ceramidase (nCDase), 
a soluble protein that can peripherally associate with the outer leaflet of PM, participating in 
the regulation of Sph and S1P synthesis in that subcellular location202,243. There is also a family 
of CDase that presents optimum activity at alkaline pH. This family of alkaline ceramidases 
(ACERs) is constituted by three different members (ACERs 1, 2, 3) with different subcellular 
positions and substrate specificities. ACER1, with several putative transmembrane domains is 
located in the ER244. It is highly expressed in the epidermis245 and has a manifest substrate 
specificity for very long chain ceramide species, especially C24 and C24:1246. ACER2 presents 
also several putative transmembrane domains, but is located in the Golgi complex202,247. It is 
highly expressed in the placenta, but most of the tissues have a lower expression of this 
enzyme202. Compared to ACER1, ACER2 have a less limited substrate specificity, being able to 
metabolize other long chain ceramides (e.g. C16, C18, C20)202. Finally, ACER3 is located both in 
ER and Golgi complex and curiously it has a higher substrate preference for phytoceramide 
species and unsaturated fatty acid ceramides (≤C20)202,248. Similarly, to ACER2, it is broadly 
expressed in different tissues, with a higher level of expression in placenta202. 
As referred in the previous section, Sph can be recycled in the salvage pathway (Fig. 18) 
where a number of enzymes are involved (e.g. sphingomyelinases, cerebrosidases, CDase, and 
CerS), and it can be phosphorylated through the action of two SKs, cytosolic enzymes that 
peripherally associate with membranes. These enzymes, similarly to CDase, have different 
subcellular locations and substrate specificities202. The irreversibly degradation of Sph to 
hexadecenal and phosphoethanolamine by S1P lyase can occur in the ER202. 
7.2. Physico-chemical properties 
In the last two decades, different groups performed studies on the physico-chemical 
properties of the most abundant sphingoid base, Sph249–252. Due to its amphipatic nature, Sph is 
able to form micelles when dispersed in aqueous solutions. However, a large disparity on the 
critical micelle concentration (CMC) values of Sph has been reported109,251,253. For instance, 
CMC values obtained by studies based on fluorescence measurements range from 18 μM to 
112 μM109,251. These differences were attributed to the non-ideal mixing of the fluorophore 
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with sphingoid base and the possible disruption of the micelle. Lower CMC values (0.99 ± 0.12 
μM252) were reported in studies performed by DLS at neutral pH. Such differences may also be 
inherent to the techniques used and the specific conditions in which the measurements were 
performed, particularly pH and ionic strength, which may influence dramatically the ionization 
state and hydrogen bonding ability252. Indeed, Sasaki et al252 showed that alterations in pH 
strongly affected the aggregation behavior of Sph, for instance, by driving an increase in the 
CMC of the protonated Sph due to changes in the ionic and hydrogen-bonding states. In 
addition, it is known that free Sph is found in the micromolar range in the body fluids. In the 
blood, for instance, it is possible to have both Sph and its phosphorylated form in 
concentrations ranging from 0.1 to 1 μM59. This points for the possible existence of Sph micelles 
under physiological conditions.  
The pKa value of Sph is also controversial. The amino group of the sphingoid base should 
be the major determinant of Sph pKa. A simple alkylamine has a pKa between 7 and 8 in both 
Triton X-100 and octyl-β-D-glucopyranoside micelles250, a value considerably lower to that 
determined in water250. For more complex amines, it is likely that the pKa is even more 
dependent on the environment. Accordingly, pKa values ranging from ∼ 6 to ∼ 9 have been 
reported for Sph, under different experimental conditions. NMR and DSC were used to 
determine Sph pKa in mixtures with 1,2-dihexadecanoyl-sn-glycero-3-phosphoserine (DPPS). An 
apparent pKa of 9.1 was reported254. However, DPPS is anionic in the pH range of reported pKa 
values for Sph, and therefore it is expected to stabilize the protonated form of the sphingoid 
base. On the other hand, pKa values of 6.7250 and 8.5249 were determined for Sph in Triton X-
100 micelles. The former value is in the same range as the one determined for Sph aggregates 
in the absence of detergents or other lipids (6.61 ± 0.03)252. This latter value would be 
consistent with an uncharged Sph under physiological conditions in the PM250,252, becoming 
charged when in acidic cell compartments. However, when mixed with POPC, a lipid that 
contains a zwitterionic headgroup, over a wide pH range255, Sph provides a positively charged 
surface both at neutral (pH 7.4) and acidic conditions (pH 5.0)256. Moreover, in quaternary 
POPC/SM/Chol/Sph vesicles at pH 7.4, increase in Sph concentration (10 mol%) gradually 
causes a shift in membrane surface charge into positive values (close to neutrality)256. Once the 
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differences in hydration and/or hydrogen bonding affect the pK of the amino group254 it is not 
surprising that very different pKa values have been reported for Sph in solution, micelles and 
membranes. Accordingly, it was reported that changes in pH from an acidic to a neutral 
environment promotes alterations in the hydrogen-bonding network of Sph aggregates, from 
intramolecular to intermolecular252.  
DSC studies revealed that Sph displays a single phase transition centered at 39 oC251. 
However, studies using fluorescence spectroscopy, suggest that the gel to fluid phase transition 
of Sph occurred at ap. 53 °C under neutral conditions (pH 7.4), being reduced to ap. 48 °C under 
acidic conditions (pH 5.0)256. These results although distinct, probably due to the differences in 
the experimental conditions (e.g. techniques, Sph concentration) suggest that Sph potentially 
exists in the gel phase at physiological temperature. Therefore, Sph is a good candidate to 
induce changes in membrane fluidity and to participate in the formation of ordered lipid 
domains.  
 
7.3. Phase behavior in model membranes 
There are a few studies suggesting that Sph interacts directly to cellular proteins257,258. 
However, there are also increasing evidence that it might exert its biological actions through 
the modulation of the physical state of cell membranes109,111. Indeed, several studies have 
addressed the effect of Sph in bilayer membranes and its ability to change membrane 
biophysical properties, by promoting changes in fluidity109,111,251,254,259,260, formation of 
domains111,261 or by changing membrane permeability109,260,262.  
Studies in model membranes performed using an array of methodologies, such as 
DSC251,254,259,263, NMR254,259, Fourier-transform infrared spectroscopy263, fluorescence 
spectroscopy109,260 and fluorescence microscopy111 point towards a Sph-induced rigidifying 
effect in membranes. This effect has been observed in model membranes containing saturated 
PLs, such as DPPS, 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC), 1,2-dimyristoyl-sn-
glycero-3-phosphocholine (DMPC)251,254,259, and unsaturated PLs, namely PC111, but also in more 
complex mixtures containing Chol and SM109,111,260 as will be discussed below.  
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The effects of Sph on membrane properties are complex and depend on membrane lipid 
composition, the protonation state of Sph and its concentration. For instance, protonated Sph 
(pH 6.0) is able to increase the Tm of DPPC259. The same observation was made for DPPC/Sph 
mixtures at pH 7.4, supporting the ability of Sph to stabilize DPPC gel domains251. According to 
the authors, hydrogen bonding between Sph hydroxyls and the lipid phosphate, changes in 
membrane hydration due to Sph and electrostatic interactions between the lipid phosphate 
and the at least partially protonated amino group of Sph are possible explanations251. For 
instance, interaction with Sph could promote the reorientation of the PC headgroups which 
would decrease the lipid cross-sectional area and promote tighter intermolecular packing in the 
mixtures251,259. Indeed, it was suggested that Sph-induced condensation of POPC monolayers 
might originate among other factors from a reorientation of the P- - N+ dipole of the POPC 
headgroup from a parallel to a more vertical orientation in relation to the membrane plane264. 
This phenomenon might resemble to a certain extent what has been already hypothesized for 
Chol265 and for ceramide266, where the reduction of the steric repulsion between the bulky 
headgroups of the co-lipids, tends to maximize chain-chain interactions and bring the lipids 
closer together. It is therefore interesting to hypothesize that in biological membranes Sph 
might be able to intercalate between other membrane lipids and concomitantly increasing the 
packing of the membrane,  maybe enhancing the formation of ordered lipid domains, such as 
the widely described lipid rafts33. However, the concentration dependent effect of Sph on 
membrane packing251,259, suggests that Sph might have multiple effects on membrane 
properties depending on its local concentration.  
Sph-induced increase in the Tm was also reported for artificial membranes, composed of 
DMPC and the diether lipid 1,2-dihexadecyl-sn-glycero-3-phosphocholine (DHPC)251 
Interestingly, Sph was shown to abolish the pre-transition of DMPC and DHPC, having a 
different impact on the stability of the gel phase formed by both lipids. While for DHPC a 
decrease in the pre-transition temperature was observed, suggesting that Sph does not favor 
the formation of the interdigitated gel phase formed by DHPC, for DMPC the pre-transition 
temperature increased until merging with the Tm, estabilizing the DMPC Lβ phase251. An 
increase in the transition temperature was also shown for DPPC/Chol, SM/Chol and SM/Chol/PE 
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mixtures containing Sph109, which was associated to a global rigidifying effect of Sph. This Sph 
rigidifying effect has also been noticed in other lipid mixtures. For instance, when mixing Sph 
with egg PC261 POPC256 and POPC/SM/Chol256,267. In contrast, Sph promotes a decrease in the Tm 
of 1,2-dielaidoyl-sn-glycero-3-phosphoethanolamine (DEPE)259. This suggests that mixtures 
formed by protonated Sph and DEPE are essentially non-ideal. In addition, in mixtures 
containing high Sph concentration, the abolishment of the Lα to HII transition of DEPE was 
observed, resulting in a direct transition to what is thought to be an isotropic phase in the 31P-
NMR spectra259. This means that Sph could have a detergent-like action, leading to the 
formation of very small, highly curved vesicles, or even mixed micelles of Sph/DEPE. Whether a 
similar situation occurs in biological membranes is to date unknown. However, such structural 
features would be compatible with cellular events that involve vesicle formation and 
membrane sorting, such as the endo-lysosomal pathway and exosome formation. It should be 
stressed that these effects are again dependent on Sph concentration: the lamellar to 
hexagonal phase transition is not affected by low Sph molar fractions259, whereas at high Sph 
content, the formation of the hexagonal phase may be impeded by the opposite curvature 
between the PE and the protonated sphingoid base259.  
Protonated Sph was also shown to affect the thermotropic behavior of acidic PLs251,254. In 
the low Sph concentration range, mixtures of DPPS/Sph form laterally homogeneous bilayers 
characterized by higher phase transition temperatures than the pure lipid components251,254. 
This thermal stabilization of the membrane derives from a tighter packing promoted by 
increased hydrogen bonding and/or electrostatic interactions between the negatively charged 
PLs and the cationic Sph. This effect is, however, abolished in mixtures containing high Sph 
concentration, resulting in a reduction of DPPS Tm251,254, likely due to the formation of 
DPPS/Sph lamellar phases that coexist with an isotropic component (31P-NMR spectra)254. 
Another remarkable effect of Sph in these DPPS membranes is on the deprotonation of the 
carboxyl group of DPPS, which results on the shift of DPPS apparent pKa to lower values due to 
the electrostatic interactions established between the two lipids263. These interactions also 
contribute to an overall electrostatic charge neutralization preventing the binding between the 
positively charged Ca2+ and the negatively charged headgroup263, suggesting that positively 
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charged Sph might prevent the binding of proteins to membranes in a cellular context. Similar 
changes in the thermotropic behavior of mixtures composed by Sph and the acidic PLs 
dimyristoylphosphatidic acid and egg PA, were noticied251. Moreover, it was shown that the 
interaction between Sph and PA lead to transient non-lamellar structures, namely cubic phases, 
which can underline Sph induced membrane permeability260. In studies aiming to develop 
stable and efficient delivery systems for nucleic acid particles, it was also suggested that, after 
endocytosis, the cationic lipids (e.g. 1,2-dilinoleyloxy-3-dimethylaminopropane) used in 
formulations interact with the naturally occurring anionic lipids present in the endosomal 
membrane, forming ion pars that facilitate the membrane disruption through the formation of 
nonbilayer structures268. This effect, if perpetrated by positively charged Sph can be of major 
biological relevance  considering that certain biological membranes, such as the inner leaflet of 
the PM57 and the intralysosomal membranes68, are enriched in negatively charged lipids. Sph 
also has remarkable structural effects on membrane curvature. This lipid tends to favor the 
positive curvature of the membrane, and when in interaction with lipids that have an opposite 
effect, e.g. Chol, it can compensate the negative curvature, stabilizing regions of the membrane 
that are already more organized, i.e., the lo and the gel phases109. This might be due to the 
interplay between the positively charged Sph and Chol, as suggested by studies performed in 
monolayers269. Indeed, Garmy and coworkers269, suggested that Sph and Chol can form 
pairwise condensed complexes that interact by hydrogen bonds formed between the 
protonated Sph amino group and the Chol hydroxyl group. From a structural perspective, this 
agrees with an opposite cone-shape for these two molecules, the sterol having only a hydroxyl 
group as the polar part, and a bulky four ring structure for the hydrophobic one. In such a 
situation, the formation of these complexes in a cellular context would greatly depend on the 
sub-cellular location of these lipids becoming particularly favorable in acidic compartments 
where Sph is likely to exist in its protonated state. Thus could be extremely relevant in the 
context of NPC disease, where lysosomal accumulation of both Sph and Chol occurs270. Despite 
their strong interaction, Sph/Chol interplay cannot solely dictate the formation of the lo phase, 
being SM or saturated PLs also required. This might be correlated with the lack of the 
phosphocholine head group in Sph, which seems to be essential for the formation of the 
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SM/Chol-enriched lo phase111. In mixtures containing SM (SM/Chol and SM/Chol/PE), Sph 
enables the formation of more rigid domains109. In fact, it was shown that Sph can have a 
stabilizing effect in lipid domain formation, particularly in the sterol/SM-enriched lo 
domains111,271. Both Sph and sphinganine contribute to a higher melting temperature of 
Chol/SM-containing mixtures and to the formation of more rigid and stable domains271. 
Additionally, it seems that when SM is present in the membrane, it can compete with Sph for 
the interaction with Chol. The Sph-SM and Sph-Chol interactions, might favor the gel phase 
formation or increase the Sph solubility in the lo phase, respectively109,111. Altogether this 
evidence supports the hypothesis that Sph is a good candidate to participate in the formation 
of ordered lipid raft domains. 
 
7.4. Structural and morphological alterations induced by sphingosine 
Membrane domains are maintained through strong van der Waals interactions between 
the saturated hydrocarbon chains of the SLs and electrostatic repulsions between the lipid 
charges272. The latter are particularly important for SLs with net charge, such as, the positively-
charged Sph and the negatively-charged gangliosides and sulfatides111,273,274. 
The shapes and the sizes of SL-enriched domains are defined by a conjugation of different 
factors, including the balance between the domain line tension and dipole-dipole repulsion. If 
the dipole-dipole repulsion is stronger than the line tension, flower-shape domains are formed; 
if the opposite occurs, round-shaped domains are predominant275. The balance between these 
factors is dependent on the type of phases forming the interface of the domains. Accordingly, 
flower-shape domains (Fig. 20A) are typically observed when gel-fluid phases coexist276,277, as in 
mixtures of PLs with Sph111,261. Round-shape domains (Fig. 20B) result from fluid-fluid (ld/lo) 
phase separation277, such as observed in complex mixtures containing Chol, SM and Sph 
(POPC/SM/Chol/Sph)111. In addition to formation of membrane domains, Sph and other SLs, 
such as ceramide can also promote structural changes on the membrane, which might alter 
their permeability properties. An increase in membrane permeability in model and cell 
membranes containing Sph260 and ceramide278 has been related to the formation of 
nonlamellar inverted structures. The reinforcement of the membrane rigid domains was also 
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pointed as a key phenomenon for Sph-induced membrane permeability109. In addition, the 
formation of membrane pores was also pointed as a possible mechanism underlying the Sph 
and ceramide permeabilizing effect262.  
The molecular mechanisms underlying these alterations are yet not fully resolved and one 
of the goals of thesis is to further address this issue. 
 
                              
 
 
 
 
 
 
Figure 20 – Morphological aspect of different phase separation in GUVs. (A) Gel/ld phase separation in 
egg-yolk PC/Sph (80/20 mol%). (B) lo/ld phase separation in a egg-yolk PC/Sph/egg-yolk SM/Chol 
(30/20/30/20 mol%). Bar 20 µm. Adapted from Georgieva et al. (2010)111. 
 
7.5. Biological actions 
Most studies on the biological function of Sph have been developed by Hannun279 and 
Merrill187,280,281. Protein kinase C (PKC) was the first direct target of Sph to be identified in a 
study showing that Sph has the ability to inhibit PKC activity and phorbol dibutyrate binding279. 
PKC is a main regulatory enzyme that responds to numerous hormones, growth and 
differentiation factors and also tumor promoters281, therefore having an important role in cell 
response, with an important role in cell growth regulation. For instance, Weiss et al. (1991)282 
have shown that Sph has the ability to reverse growth inhibition in vascular smooth muscle cells 
caused by the activation of PKC, through the interference that it causes in the binding of 
phorbol esters or other activators to this enzyme. Another study suggests that the 
accumulation of endogenous Sph in NPC fibroblasts is directly related to the inhibition of PKC, 
since the specific binding of [20-3H] phorbol 12,13-dibutyrate to the regulatory domain of the 
enzyme was significantly reduced in fibroblasts from NPC patients compared to control 
A B 
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fibroblasts. It was suggested that when in high concentrations (> 5-fold increase in relation to 
healthy control patients) Sph could act through a competitive inhibitory process, in contrast to 
what happens when present in lower concentrations. In this later case, Sph might directly 
interact with other membrane lipids, possibly with PS that is negatively charged, or inhibit the 
release of PKC activators, such as Ca2+ 283. In fact, shortly after the discovery of the impact of 
Sph in PKC activity, it was hypothesized that inhibition of PKC by Sph could arise from 
electrostatic neutralization of the negatively charged PS required for the activation of the 
enzyme284. Furthermore, it was suggested that Sph can be involved in the regulation of PKC-
dependent phosphorylation in the nucleus by modulating the association of membrane PLs to 
PKC, or its substrates285. Also, considering studies from Zeidan and Hannun (2007)286 it seems 
that PKC inhibition by Sph may in turn regulate the phosphorylation of acid sphingomyelinase 
(aSMase) within lysosomes. This would alter aSMase activity and adjust the flux of SM being 
broken down into Sph, which might in turn regulate the salvage pathway and also lysosomal 
stability.  
Sph has also been implicated in the modulation of the activity of other protein kinases287–
289. Sph was shown to inhibit calmodulin-dependent kinase and insulin receptor tyrosine 
kinase288, but also to enhance diacylglycerol (DAG), and casein kinase II activities279,289. Sph is 
further known for being a strong activator of Sph-dependent protein kinases, which 
phosphorylate a variety of cellular proteins, like 14-3-3 proteins290, chaperones, glucose-
regulated protein and heat shock proteins291. It has been suggested that Sph effect on these 
kinases might occur via changing the electrostatic interactions between the enzymes and 
membrane lipids284,288,289. Apart from its effect on the activity of protein kinases, Sph can 
reduce the activity of phosphatidate phosphohydrolases that have a role in the synthesis of 
triacylglycerols and the formation of DAG292. Sph can also stimulate the hydrolysis of PC into PA 
in a dose dependent manner, suggesting the activation of phospholipase D293. In addition, Sph 
is capable of interfering with the cellular calcium homeostasis, through the inhibition of Ca2+ 
channels, particularly the PM Ca2+-ATPase294, and also decreasing the amount of Ca2+ stored in 
the cellular acidic compartments, contributing to disease states, such as NPC1270,295, as 
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discussed below. Moreover, it was recently suggested that Sph and SK1 have crucial roles in the 
regulation of endocytic membrane trafficking296. 
Sph also mediates cell growth arrest, apoptosis and response to chemotherapy297,298. 
Some studies have pointed to an active role of Sph in the induction of cell dead297. In U937 
human monoblastic leukemia cells, Sph activates Jun amino-terminal kinases and inhibits 
extracellular signal-regulated kinases leading to apoptosis299. In human neutrophils treated with 
tumor necrosis factor-α, the concentration of ceramide and Sph increases. While ceramide did 
not cause apoptosis, Sph induced morphological changes characteristic of apoptotic cells and 
DNA fragmentation. It was proposed that the apoptotic effect of Sph could be related with the 
inhibition of PKC300. In human hepatoma cells, Sph increases caspase-3 activity, inducing 
apoptosis301. Another study revealed that caspase-7 and -8 are also involved in Sph triggered 
apoptosis, in human hepatoma cells302. Suzuki et al. proposed that Sph-dependent apoptosis is 
based on multiple mechanisms that operate in a concerted manner303. 
Sph can also be a positive modulator of cell growth. In concentrations ranging between 
0.2 and 10 µM, Sph induces the proliferation of quiescent Swiss 3T3 fibroblasts, by stimulating 
DNA synthesis and potentiating the mitogenic response of growth factors304. 
7.6. Sphingosine involvement in human disease 
SLs are important players not only in cell physiology but also in pathophysiology. When 
the normal sphingolipid metabolism is altered, some of the intervenient molecules can 
accumulate in the lysosomes, leading to the development of lysosomal storage diseases (LSD). 
By identifying the sphingolipid that abnormally accumulates in the cell, it is possible to 
distinguish different diseases.  Some examples are Fabry, Farber and Gaucher, which are 
characterized by the primary accumulation of globotriaosylceramide, ceramide, and GlcCer, 
respectively305. NPC, is also included in this group of storage diseases, being associated with the 
primary accumulation of Sph and a secondary storage of multiple lipid species (e.g. Chol, SM, 
GSLs)270. Sphingolipidoses are inherited rare diseases, but with high mortality rates. It is 
expected that a better understanding of the biology of SLs that are in the basis of these 
diseases can lead to the development of new  therapeutic strategies172,306.  
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7.6.1. Niemann-Pick type C1 disease 
 Studies from Platt’s group showed that Sph storage might be an initiating factor in 
neurodegenerative NPC1 disease270,307. This disease is a rare - incidence at conception of 
1.12:100 000308 - inherited atypical LSD, characterized by mutations in one of two genes,  NPC1 
in approximately 95% of the cases or NPC2309. Both proteins have been related with Chol 
transport in the endo-lysosomal system310,311. NPC1, a transmembrane protein, is also involved 
in the lysosomal efflux of the ebola virus312. In addition, this protein was suggested to be 
responsible for mediating the lysosomal efflux of Sph, a necessary process considering the 
protonated state of Sph at acid pH and the potentially lysosomotropic effects of Sph upon the 
lysosomal membrane270,307. Being involved in lysosomal efflux of Sph, NPC1 would be a key 
component of the SL salvage pathway and a regulator of S1P generation, however, further 
work is necessary to confirm this hypothesis. 
 The phenotype of NPC deficient cells is characterized by intra-lysosomal accumulation of 
Sph as well as Chol, GSLs and SM313. Interestingly, NPC1 is the only human disease associated 
with elevated levels of lysosomal Sph. Moreover, defective NPC1 function at the cellular level 
not only affects the storage of lipids, but also reduces the levels of lysosomal Ca2+ and causes 
unique endocytic transport and fusion defects270. There are evidence showing that NPC1 cells 
have normal ER and mitochondrial Ca2+ but lower Ca2+ in the acidic compartments270. A 
reduction of approximatly 69% in NPC1 mutant cell nicotinic acid adenine dinucleotide 
phosphate (NAADP)-induced Ca2+ release was observed. These lysosomal Ca2+ signaling defects 
were shown to cause defects in endocytic transport which in turn leads to the secondary 
accumulation of Chol, SM and GSLs in NPC1 cells. It was proposed that the cause of the Ca2+ 
defect in NPC1 was the primary accumulation of Sph. Furthermore, exogenous addition of Sph 
to normal cells induces the appearance of all NPC1 cellular phenotypes270, and reduction in Sph 
levels in NPC1 cells using the SPT inhibitor myriocin reversed all the NPC1 cellular 
phenotypes270. An atypical feature of NPC, relative to other LSD, is the high complexity of 
storage material. Sph is an unusual lipid because it is stored in all NPC1 disease tissues, but not 
in any other LSD283,314,315. Although the total Sph storage levels in brain and peripheral tissues 
are low, Sph displays the greatest fold elevation compared to the other lipids that are stored in 
  
Chapter I 
49 
 
this disease307, in addition, it is a more potent signaling lipid at far lower concentrations 
compared to the other lipids stored in NPC1 disease. It was suggested that the defect in 
lysosomal Ca2+ storage filling caused by Sph abnormal storage,  may be related with its 
inhibitory effect against  PKC, calcium ATPases and Na+/Ca2+ exchangers or similar 
mechanisms270,316. A further study317 has indicated that inhibition of PKC mediated by Sph could 
be responsible for the defects in Rab9 trafficking observed in NPC disease via a defect in 
phosphorylation of vimentin, further indicating that the accumulation of Chol, which is 
ameliorated by over-expression of Rab9, is a secondary defect in this disease.  
 A link between NPC disease and tuberculosis was also established318. It was observed that 
the infection of WT murine and human macrophages can induce NPC phenotypes, including 
lipid storage and reduced Ca2+ release. These phenotype changes can also be achieved using 
lipids from mycobacteria cell walls. It was suggested that the NPC1 protein can be involved in 
this lipid-mediated inhibition318. Furthermore, it was shown that mycobacteria are able to 
inhibit the host NPC pathway through the accumulation of Sph, which in turn reduces 
LE/lysosome-mediated Ca2+ release preventing host phagosome-lysosomal fusion, and thereby 
facilitating their intracellular survival318. 
 
 NPC has a variable age of onset, and is clinically characterized by a range of non-specific 
visceral, neurological and psychiatric features that progress at different rates, in different 
stages of the disease309,319. Some stabilizing therapeutic approaches might delay the 
progression of the disease or attenuate clinical symptoms320. For instance, Miglustat is used to 
limit the accumulation of gangliosides through the inhibition of GlcCer synthase, and is able to 
delay neurological manifestations of the disease320. Despite this, currently there is no effective 
therapy for NPC and several studies have been developed in an attempt to find new insights 
into the molecular and cellular mechanisms of the disease. These studies resort to different 
animal models321–323, patients tissues324,325, mutant cells326,327 or even the pharmacological 
induction of the NPC phenotype, for instance with the commonly used cationic steroid 
U18666A328. Structurally U18666A drug is similar to Chol (Fig. 21) and it is able to bind to the 
sterol sensing domain of NPC1 protein interfering with the Chol transport out of lysosomes329. 
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Figure 21 – Structures of (A) cholesterol and (B) U18666A. Adapted from Cenedella et al. (2004)330. 
7.6.2. Other roles in disease and therapeutic potential 
 Sph might be important in the prevention of disease and/or disease related 
complications. There is increasing evidence for the protective antibacterial action of sphingoid 
bases and other lipids in infection331. Sph was shown to be crucial for the host defense against 
Pseudomonas aeruginosa and other lung infections332,333.  Cystic fibrosis (CF) is an autosomal 
recessive disorder caused by mutations in the cystic fibrosis transmembrane conductance 
regulator  gene334. Despite the multisystemic implications of this mutation, the major cause of 
dead relies on chronic pulmonary infections. Different microorganisms are involved in the lung 
infections of CF patients. In particular P. aeruginosa infections are incident in these patients335. 
Due to the long term antibiotics treatments the number of resistant P. aeruginosa strains is 
increasing, which asks for alternative therapeutic approaches. It was shown that ceramide 
levels are elevated in the respiratory tract of CF patients336,337, which in turn is reflected by 
lower Sph levels and a diminished antibacterial response332. Increasing Sph levels either by the  
inhalation of Sph or the Sph analog FTY720 (fingolimod), or by treatment with acid CDase has a 
positive effect in CF mice332,333. It is thus suggested to be a preventive/therapeutic measure to 
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reduce bacterial infections in CF patients332. Although the molecular mechanisms related to the 
protection of Sph against bacterial infection are not still clearly defined, it is known that PKC 
signaling is involved in P. aeruginosa elastase-induced epithelial barrier disruption338, which 
indicates that Sph-induced protection against infection might be related to PKC inhibition338. 
Other hypothesis is that Sph induces bacterial cell wall damage by increasing membrane 
permeability and defects in adherence, similarly to what has been suggested for 
sphinganine331,339. 
Sph, together with sphinganine, has also been related to protection mechanisms against 
cancer. By inhibiting proliferation and inducing apoptosis in different cancer cell lines, these 
molecules assume a special importance acting as tumor suppression mediators300,340–342 
Furthermore, they have also the ability to overcome radio- or chemo-resistance in many types 
of cancer (reviewed in Cuvillier & Levade, 2003340). In fact, the potential capacity of Sph to act 
as a tumor suppressor has led to the development of synthetic Sph derivatives - N,N-
dimethylsphingosine and N,N,N-trimethylsphingosine - that showed promising effects on lung 
metastasis. On the molecular level they inhibit PKC, resulting in antimetastatic effects343–345. 
Sph elevation induces cell death via either Golgi fragmentation or lysosomal rupturing346,347 
indicating a key role in programmed cell death.  In contrast, it has been reported that Sph might 
also function as a positive modulator of cell growth304, as previously referred (section 7.5). 
These contradictory effects might somehow be related with the rapid interconversion of 
ceramide, Sph and S1P in the SL rheostat241.   
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CHAPTER II – BIOPHYSICAL IMPLICATIONS OF SPHINGOSINE ACCUMULATION IN MEMBRANE 
PROPERTIES AT NEUTRAL AND ACIDIC PH 
 
 
1. Abstract 
Sphingosine (Sph) is a simple lipid involved in the regulation of several biological 
processes. When accumulated in the late endosomal/lysosomal compartments, Sph causes 
changes in ion signaling and membrane trafficking, leading to the development of Niemann-
Pick disease type C. Little is known about Sph interaction with other lipids in biological 
membranes; however, understanding the effect of Sph in the physical state of membranes 
might provide insights into its mode of action. Using complementary established fluorescence 
approaches we show that Sph accumulation leads to the formation of Sph-enriched gel 
domains in 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) and POPC/Sphingomyelin 
(SM)/Cholesterol (Chol) model membranes. These domains are more easily formed in 
membrane models mimicking the neutral pH plasma membrane environment (PM) as 
compared to the acidic lysosomal membrane environment (LM), where higher Sph 
concentrations (or lower temperatures) are required. Electrophoretic light scattering 
measurements further revealed that in PM-raft models (POPC/SM/Chol), Sph is mainly neutral, 
whereas in LM models, the positive charge of Sph leads to electrostatic repulsion, reducing the 
Sph ability to form gel domains. Thus, formation of Sph-enriched domains in cellular 
membranes might be strongly regulated by Sph charge.  
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2. Introduction 
Sphingosine ((2S, 3R, 4E)-2-amino-4-octadecen-1,3-diol) is a bioactive metabolite 
resulting from ceramide degradation by aCDase in lysosomes.1,2 It is the most common 
sphingoid base in mammalian sphingolipids and influences a variety of cellular activities, such 
as growth, differentiation and apoptosis.3–5 Sphingosine (Sph) may act directly through enzyme 
binding or indirectly through changes in cell membrane properties6. This lipid is responsible for 
activation and inhibition of various kinases, including PKC.7–10 Some of these enzymes do not 
contain a Sph-binding site, and the direct effect of Sph on their activity can be ruled out. 
Therefore, it is feasible that the impact of Sph on some enzymes, receptors and other cellular 
components could be due to its effect on the physical state of cell membranes.11 
Sph is preferentially partitioned into the membrane12, and despite its biological 
importance, little is known about its effect on the lipid bilayer structure and interaction with 
other lipids. Studies in model and biological membranes have revealed that Sph is able to 
change the permeability and rigidity of the membrane6,11,13,14, which might have impact in 
signalling, sorting of proteins and lipids and membrane trafficking.6  
It has been reported that the protonation state of Sph is altered within the range of 
neutral or acidic pH, values found within different cellular compartments.15–17 When in neutral 
pH, Sph can present a non-protonated form and rapidly move across and between biological 
membranes.18 On the contrary, when released into the lysosomal acidic environment, Sph has 
the particularity of being positively charged15, reducing its ability to pass through membranes. 
Crossing the lysosomal membrane to reach ER, where it is responsible for ceramide and S1P 
generation, is essential but currently there is no known Sph transporter in the lysosomal 
membrane.19 
In the endo-lysosomal pathway, changes from neutral to acidic environment occur, and 
the alteration of Sph protonation state could be relevant, once it is likely to promote changes in 
the electrostatic lipid-lipid and lipid-protein interactions.19 Understanding the effects of Sph on 
membrane organization is important also because it is described that accumulation of Sph in 
the late endosome/lysosomal (LE/Ly) compartments is an early event in the development of 
Niemann-Pick disease type C (NPC). NPC is a rare and usually fatal lysosomal storage disorder, 
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inherited in an autosomal recessive manner20, which is characterized by the accumulation of 
multiple lipid species, including Sph, Chol, GSLs and Sphingomyelin (SM).19 Accumulation of Sph 
in NPC is associated with impaired Ca2+ homeostasis, defective endocytic membrane trafficking 
and secondary storage of lipids.21 Despite this, little is known about Sph role in the lysosome, 
particularly regarding the biophysical implications of Sph accumulation. In this work we 
investigate the interaction of Sph with POPC-containing membranes and with a ternary system 
that was previously characterized, and represents a well-defined raft-model mixture 
constituted by POPC/SM/Chol.22,23 To this end, a multiparameter fluorescence spectroscopy 
approach was used, being the analysis performed at neutral (pH 7.4) and acidic (pH 5.0) pH, in 
order to mimic the plasma (PM) and the lysosomal (LM) membrane environment, respectively. 
The results show that Sph-gel like domains are formed through Sph accumulation in model 
membranes and that the formation of these domains is facilitated at neutral pH compared to 
acidic pH, due to intermolecular electrostatic repulsions of the positively charged Sph 
molecules at acidic pH. 
3. Experimental section 
3.1. Materials 
1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC), Sphingomyelin (SM) (Egg, 
Chicken) and D-erythro-sphingosine (Sph) were obtained from Avanti Polar Lipids, Inc. 
(Alabaster, AL, USA). Chol was obtained from Sigma-Aldrich (St. Louis, MO, USA). DPH (1,6-
diphenyl-1,3,5-hexatriene) and t-PnA (trans-parinaric acid) were from Molecular 
Probes/Invitrogen (Eugene, OR, USA). All spectroscopic solvents were from Fluka (St. Louis, MO, 
USA). 
 
3.2. Liposome preparation 
Multilamellar (MLV) and large unilamellar (LUV) lipid vesicles (both with 0.2 mM total 
lipid concentration) were prepared by standard procedures.24 As suspension medium, Hepes 
buffer (10 mM Hepes with 150 mM NaCl, pH 7.4) and Citrate Phosphate buffer (0.1 M citric acid 
and 0.2M Na2HPO4, pH 5.0) were used. The suspensions were equilibrated by freeze thaw 
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cycles (T> 50 °C) and kept overnight at 4°C protected from light. The probe to lipid (P/L) ratio 
was 1:200 for DPH and 1:500 for t-PnA. Before starting the analysis, the samples were 
incubated for at least 1 h at room temperature and protected from light. The composition of 
the ternary POPC/SM/Chol mixtures was selected to span the tie line containing the 1:1:1 
equimolar mixture taken from the ternary POPC/SM/Chol phase diagram22. The ternary 
mixtures used in this study were 71.6:23.3:5.1; 59.7:26.3:14; 45.1:29.9:25; 34:32.7:33.3 and 
25.4:34.8:39.8 (POPC/SM/Chol). The effect of Sph on these mixtures was studied by adding 5 or 
10 mol% of Sph. 
POPC and SM concentration in stock solutions were confirmed by phosphorus analysis25. 
The concentration of Chol and Sph stock solutions were determined gravimetrically with a high 
precision balance (Mettler Toledo UMT2). Probe concentrations were determined 
spectrophotometrically using ε (t-PnA, 299.4 nm, ethanol) = 89 x 103 M-1 cm-1 26, ε (DPH, 355 
nm, chloroform) = 80.6 x 103 M-1 cm-1.27  
 
3.3. Fluorescence measurements  
The fluorescence measurements were carried out on a Spex Fluorolog 3-22/Tau 3 
spectrofluorometer equipped with double grating monochromators in both excitation and 
emission light paths from Horiba Jobin Yvon.28 Excitation/emission wavelengths (nm) were 
358/430 and 303/404 for DPH and t-PnA, respectively. All measurements were performed in 
1.0 cm x 0.4 cm quartz cuvettes, at room temperature (24°C), with the exception of 
thermotropic studies. For measurements performed at different temperatures, the heating rate 
was always below 0.2°C/min and the temperature was achieved by a Braun 852 circulating 
water bath and controlled with 0.1 °C precision directly inside the cuvette with a PT100. 
The fluorescence intensity decay measurements were obtained by a single photon 
counting technique as previously described.28 For t-PnA the excitation wavelength was 315 nm 
(using a NanoLED source, model: N-320; Horiba Jobin-Yvon), being the emission collected at 
404 nm. To analyze the experimental decays and obtain the fitting curves the TRFA software 
(Scientific Software Technologies Center, Minsk, Belarus) was used. Fluorescence decays were 
described by a sum of exponentials, where αi is the normalized pre-exponential, and τi is the 
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lifetime of the decay component i. The mean fluorescence lifetime <τ> is given by <τ> 
iτi2/ iτi. 
3.4. Dynamic light scattering measurements 
The vesicle sizes were determined by performing DLS analysis on a Zetasizer Nano S 
equipment (Malvern Instruments). Size measurement was made using patented NIBS (Non-
Invasive Back Scatter) technology. Samples were placed in 12 mm square polystyrene 
cuvettes and then in a chamber maintained at 25°C. The data analysis was performed by the 
accompanying software and expressed as Z-Average size or size distribution by intensity. The 
polydispersion index (PDI) for each sample was also calculated using the same software. In each 
experiment the measurements were done in triplicate.  
 
3.5. Electrophoretic light scattering measurements  
The electrophoretic mobilities were analyzed through M3-PALS technology on a ZetaSizer 
Nano Z equipment (Malvern Instruments). Samples were placed in clear disposable zeta cells 
and then in a thermostated sample chamber maintained at 25°C. The data analysis was 
performed by the accompanying software and the measurements were done in triplicate in 
each experiment.  
 
4. Results 
4.1. Phase behavior of POPC/Sph mixtures  
To evaluate the effect of Sph in a fluid membrane, two types of fluorescent probes with 
different phase-related properties were used: t-PnA that has preferential partitioning towards 
the gel phase29,30 and DPH that has a similar partitioning between the gel and the fluid phase.28 
To fully understand the system behavior, the entire composition range from 0 to 100 mol% of 
Sph was spanned. Figure 1A shows the fluorescence anisotropy of t-PnA in POPC/Sph mixtures 
at neutral and acidic pH. At pH 7.4, a pH value resembling the environment of the PM, t-PnA 
anisotropy presents a gradual increase with increasing content of Sph, reaching a plateau for 
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XSph ˃ 40 mol%. In contrast, at pH 5.0 (resembling the lysosomal pH environment), t-PnA 
anisotropy slightly increases with Sph content up to 40 mol% and higher Sph content is required 
to induce a sharp increase in t-PnA anisotropy. Nevertheless, the high anisotropy values suggest 
that Sph is able to form gel domains in the fluid POPC matrix, in a manner dependent on pH 
environment and Sph content. This is further supported by the high mean fluorescence lifetime 
values of t-PnA, (Figure 1B) that are typical of a gel phase.31 Figure 1B shows that Sph ability to 
form gel domains is enhanced at neutral pH compared to acidic pH, as shown by the increase in 
t-PnA mean fluorescence lifetime for lower Sph content in models mimicking the PM 
environment. In addition, the longer fluorescence lifetime suggests a tighter packing of Sph- gel 
phase under a neutral pH environment.  
The probe DPH was also used to further characterize the phase behavior of these binary 
mixtures under neutral and acidic conditions (Figure 1C). DPH anisotropy increases with Sph 
content showing the ability of this lipid to increase the order of the membrane. At neutral pH 
and in mixtures containing higher Sph content, the anisotropy of DPH is higher and typical of a 
gel phase, further supporting the stronger ability of Sph to segregate into gel-domains at pH 7.4 
compared to acidic pH. The differences in the anisotropy of DPH at neutral and acidic pH are 
not as strong as those observed with t-PnA because DPH, in contrast to t-PnA, displays an equal 
partition between the gel and the fluid phases.22,28 
 
Figure 1. Effect of Sph on fluid POPC membranes. (A,C) Steady-state fluorescence anisotropy of (A) t-PnA 
and (C) DPH, and (B) Mean fluorescence lifetime of t-PnA at pH 7.4 (solid symbols) and pH 5.0 (open 
symbols) as a function of Sph molar fraction. Values are means ± SD of at least three independent 
experiments. The lines act merely as guides to the eye. 
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4.2. Thermotropic behavior of POPC/Sph mixtures 
To investigate the thermotropic properties of the binary POPC/Sph mixtures, the steady-
state fluorescence anisotropy of t-PnA and DPH was measured as a function of temperature. 
The thermotropic characterization of Sph is shown in Figure 2A. It can be observed that t-PnA 
anisotropy is high and typical of a gel phase in the low temperature range. Increasing the 
temperature decreases the anisotropy to values typical of a fluid phase. At neutral pH, the 
onset and completion of the gel-to-fluid phase transition occurs at higher temperatures, 
showing that the Tm of Sph is pH dependent (Figure 2A), decreasing from  53 °C at pH 7.4 to  
48 °C at pH 5.0. Differences in the thermotropic behavior with pH environment were also 
observed in POPC/Sph mixtures, particularly for Sph content above 30 mol% (Figure 2B). In 
addition, as shown in Figure 2B, increasing the Sph content in the mixtures leads to an increase 
in the temperature at which the complete melting of gel domains occurs.  Similar results were 
obtained in thermotropic studies using the probe DPH (Figure S1 in the Supporting 
Information). From these results, it is possible to determine the partial binary phase diagram of 
POPC/Sph mixtures in neutral and acidic pH (Figure 2C). To determine the liquidus boundary 
(gel+fluid-to-fluid transition) data from t-PnA anisotropy was used. This is because of the strong 
partition of this probe towards the gel phase which therefore can be detected even when 
present in very small fractions. Accordingly, it is the most suitable probe to determine the 
complete melting of gel phase. To determine the solidus boundary, DPH data was used. The 
equal partition of this probe towards the gel and the fluid phases allows a better estimation of 
the onset of the melting of the gel phase.  
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Figure 2. Thermotropic behavior of POPC/Sph mixtures. Steady-state fluorescence anisotropy <r> of t-
PnA as a function of temperature in MLV composed of (A) pure Sph and (B) POPC/Sph mixtures 
containing 30 (squares) and 70 (circles) mol% of Sph at neutral (solid symbols) and acidic (open symbols) 
pH. (C) Partial binary phase diagram of POPC/Sph mixtures at neutral (solid symbols) and acidic (open 
symbols) pH: the gel+fluid-to-fluid transition (liquidus boundary) was obtained from t-PnA anisotropy; 
the solidus boundary was determined from DPH anisotropy data (see text for further details). The point 
for pure POPC is from Curatolo et al.32 Values are means ± SD of at least three independent experiments.  
 
4.3. Characterization of POPC/Sph vesicles by electrophoretic and dynamic light scattering 
Dynamic and electrophoretic light scattering were used to further evaluate the 
characteristics of POPC/Sph vesicles. Zeta potential values shown in Figure 3A reveal that for 
low Sph content (up to 30 mol % Sph), the vesicles present a higher net positive charge at acidic 
pH. However, for Sph molar fractions above 40%, the surface charge at neutral pH continues to 
increase, whereas at pH 5.0, no further increase in the positive charge is observed. Figure 3B 
shows that POPC/Sph vesicles size is mainly comprised in the 100−150 nm range, but a 
tendency for vesicle aggregation and/or fusion can be noticed for high Sph content. In the 
absence of POPC, an increase in size and polydispersity index (PDI) is observed at both neutral 
and acidic pH, even though a higher instability is observed in the latter, suggesting a different 
organization and/or interaction of the Sph molecules at different pH environments. These 
results are reinforced by the high scattering intensities (I/I0) recorded in the range of 0.5 −10 
μm (Figures 3C,D), in the presence of higher Sph contents (XSph > 50%), especially at pH 5.0. 
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Figure 3 - Characterization of POPC/Sph binary mixtures by electrophoretic and dynamic light scattering 
measurements. (A) -potential and (B) Particle mean size and polydispersity index (PDI, inset) of binary 
POPC/Sph mixtures at neutral (pH 7.4, solid squares) and acidic pH (pH 5.0, open squares). Error bars 
represent SD resulting from at least 3 independent experiments. In the point that represents 100% Sph, 
at pH 5.0, the SD associated to vesicle size is ± 825 nm. (C) and (D) Normalized scattered light intensity 
of binary mixtures as a function of particle size (nm) at pH 7.4 and pH 5.0, respectively. Results shown 
correspond to mixtures containing 0 (line 1), 30 (line 2), 50 (line 3), 70 (line 4) and 100 (line 5) mol% Sph. 
Values are the average  SD (A, B) or the median (C, D) of at least 3 independent experiments. The lines 
act merely as guides to the eye.    
 
4.4. Effect of Sph on the biophysical properties of raft-mimicking mixtures 
In addition to Sph, Chol and SM also accumulate in LE/Ly in NPC disease. Accordingly, it is 
important to understand the interplay between Sph, Chol and SM to gain further insight into 
the biophysical alterations that these lipids might promote on the LE/Ly. The phase behavior of 
POPC/SM/Chol mixtures at room temperature and at different pH environments was evaluated. 
Figure 4A shows the fluorescence anisotropy of t-PnA as a function of lo fraction, X lo, for the 
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ternary mixtures. The anisotropy of t-PnA presents a linear increase with X lo in both pH 
environments. However, slightly lower anisotropy values were obtained at pH 5.0. Similar 
results were obtained with t-PnA mean fluorescence lifetime: an increase in <τ> towards values 
typical of lo phase22 was observed and longer lifetimes were obtained at neutral pH 
environment (Figure 4B). These results suggest that the packing properties of the lo phase are 
affected by changes in pH environment.   
-potential measurements of the POPC/SM/Chol mixtures show that the vesicles present 
a non-zero net charge at both pH 7.4 and 5.0 (Figure 4C). The structures of both POPC and SM 
include the same hydrophilic phosphorylcholine head group, which is zwitterionic over a wide 
range of pH (approximately 3-12).33 At neutral pH the vesicles showed a small negative net 
charge in accordance with other studies reporting that liposomes made from zwitterionic lipids 
carry a negative charge at neutral pH.34,35,36 An increase in the -potential from – 5 mV to + 4 
mV was observed when the pH decreased from 7.4 to 5.0. Regardless of the pH environment, 
changes in -potential with the lipid composition of the ternary mixtures were minimal.  
 
Figure 4. Characterization of POPC/SM/Chol raft-like mixtures in neutral and acidic pH. (A) Fluorescence 
anisotropy and (B) long lifetime component of t-PnA, and (C) -potential in ternary POPC/SM/Chol 
mixtures at pH 7.4 (solid symbols) and pH 5.0 (open symbols).  The values are the mean  SD of at least 
three independent experiments. The lines act merely as guides to the eye. 
 
Figure 5 (A - H) shows the variation of fluorescence anisotropy and of the long lifetime 
component of t-PnA in ternary POPC/SM/Chol mixtures with different Sph contents at both 
neutral and acidic pH. Normally the intracellular Sph levels are very low, but in some situations, 
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like in NPC cells, Sph abnormally accumulate.2,19 Accordingly, it is important to elucidate the 
effect of Sph accumulation in the membrane biophysical properties. To better evaluate the 
impact of Sph on the organization and properties of raft-mimicking membranes, the data was 
represented as a function of X lo. Our studies showed that at pH 7.4 (Figures 5A,B) and for the 
lower lo fraction, the addition of 10 mol% Sph causes a substantial increase in the anisotropy 
(Figure 5A), mean fluorescence lifetime (See Figure S2 in the Supporting Information) and  long 
lifetime component (Figure 5B) of t-PnA, suggesting that under these conditions Sph induces 
the formation of more ordered phases with gel-like properties, as suggested by the very long 
lifetime component of t-PnA fluorescence intensity decay (Figure 5B)30. The extent of gel phase 
formation is, however, low as suggested by the small pre-exponential (i) associated to the long 
component lifetime of t-PnA (See Figure S3 in the Supporting Information). Gel domain 
formation becomes less pronounced as the Chol concentration increases and, for the mixtures 
with the highest lo fraction, the ordering effect of Sph on membrane properties is no longer 
observed. At pH 5.0 the effect of increasing Sph content in the ternary mixtures is not so 
marked (Figures 5C,D), and both the anisotropy values and the long  lifetime component of t-
PnA are lower comparing with pH 7.4, even when in the presence of lower lo fractions and 
higher Sph content (Figures 5E,H). This suggests that when Sph accumulates in acidic vesicles, 
its ability to form gel domains diminishes. 
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Figure 5. Interplay between Sph, Chol, and SM in lipid raft-mimicking mixtures. Panels A-D show the 
variation in t-PnA (A, C) fluorescence anisotropy and (B, D) long lifetime component in ternary 
POPC/SM/Chol mixtures (diamonds) and POPC/SM/Chol mixtures containing 5 (circles) and 10 
(triangles) mol% of Sph at (A, B) pH 7.4 and (C, D) pH 5. Panels E-G show the (E, G) fluorescence 
anisotropy and (F, H) long lifetime component of t-PnA in POPC/SM/Chol mixtures containing (E, F) 5 
and (G, H) 10 mol% of Sph at pH 7.4 (solid symbols) and pH 5.0 (open symbols). The values are the mean 
 SD of at least three independent experiments. The lines act merely as guides to the eye. 
 
4.5. Characterization of POPC/SM/Chol/Sph vesicles by electrophoretic and dynamic light 
scattering 
As above mentioned, the ternary POPC/SM/Chol mixtures have a slightly negative surface 
charge at pH 7.4. With the increase of Sph content this charge gradually reaches positive values 
close to zero at 10 mol% Sph (Figure 6A). In the acidic environment (pH 5.0), the surface charge 
of the ternary mixtures is always positive and the net positive charge increases with increasing 
contents of Sph (Figure 6B), reaching -potencial values close to 20 mV in the presence of 10 
mol% Sph.  Moreover, the presence of Sph in these mixtures leads to a small increase in the -
potential as the lo fraction is increased, particularly at pH 5.0 (Figure 6B). This was not observed 
for the ternary mixtures in the absence of Sph (Figure 4C).  
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Figure 6. Surface charge characterization of POPC/SM/Chol/Sph mixtures. (A) and (B) -potential at 
neutral (7.4) and acidic (5.0) pH, respectively. The symbols represent 0 (diamonds), 5 (circles), and 10 
(triangles) mol% Sph. The values are the mean  SD of at least 3 independent experiments. The lines act 
merely as guides to the eye. 
 
Concerning the particles size (see Figure S4 in the Supporting Information), the model 
membranes tested in the different pH environments have generally sizes that range 100-150 
nm. At pH 7.4, when the mixtures are constituted by higher Chol (higher lo fraction) and Sph 
molar fractions, the PDI is higher and the particles seem to have a tendency to aggregate. 
Considering that at pH 7.4 the -potential of the mixtures is close to neutral even in the 
presence of 10 mol% Sph, it is probable that in this environment the vesicles are not able to 
repel, which could justify their tendency to aggregate. There is also the possibility that the 
increase in the vesicle size is a result of different mechanical properties in vesicles with high 
Chol and Sph content, leading to a less efficient extrusion.37 On the other hand, the net positive 
charge presented by the vesicles at acidic pH is probably responsible by repulsive forces that 
hamper the aggregation. 
5. Discussion 
Despite being a crucial lipid in cell function, little is known about Sph mode of action. In 
particular, the biophysical impact caused by Sph accumulation remains incompletely 
understood. Some studies have addressed the effect of Sph in the biophysical properties of 
model membranes6,11,15,38,39, but information regarding its effect on the fluid POPC, a major 
  
Chapter II 
84 
 
phospholipid membrane component, and an understanding of its interplay with lipids that also 
accumulate in the lysosomes of NPC disease, such as Chol and SM, are currently unavailable. In 
this study, we evaluated the influence of Sph in the biophysical and interfacial electrostatic 
properties of model membranes constituted by (1) POPC (fluid membrane) and (2) 
POPC/SM/Chol (raft model). The behavior of the artificial membranes was analyzed in neutral 
pH (pH 7.4) and acidic pH (pH 5.0) in order to mimic the PM and LM environments, respectively. 
 
5.1. Impact of Sph on the physical state, thermotropic behavior and electrostatic 
properties of a fluid POPC membrane 
Our results showed that Sph accumulation in POPC model membranes promotes the 
formation of Sph gel-like domains, in agreement with previous studies.6,11,15,38,39 However, to 
our best knowledge, this is the first study reporting the phase behavior, thermotropic, and 
interfacial electrical properties of Sph-containing mixtures, in neutral and acidic pH 
environments. Our results demonstrated that the effect of Sph on the membrane is dependent 
on the pH of the hydration medium. Gel domain formation occurred with lower Sph 
concentrations at pH 7.4, compared to pH 5.0, and these differences are reflected in the partial 
binary phase diagrams of the mixtures at both pH. Sphingolipid gel domains are maintained by 
strong van der Waals interactions between the saturated hydrocarbon chains and electrostatic 
repulsive forces due to lipid dipoles.11 In the case of Sph, the net positive charge is probably 
underlying the electrostatic repulsion, which certainly destabilizes domain formation. 
Apparently, this destabilization is higher at acidic pH, as denoted by the lower ability of Sph to 
form gel domains under these conditions. This could be related to differences in the ionic state 
of Sph. It was reported that the apparent pK of Sph might range from 6.740 to 9.115,16 depending 
on the environment (e.g., solution, micelles, bilayers) due to differences in hydration and 
hydrogen-bonding states.16,33,34 Therefore, the assumption that Sph is positively charged at 
neutral pH16,41 might not always be valid. For example, it was demonstrated that when Sph 
forms aggregates at neutral pH, the great majority of molecules presents a neutral net charge.17 
Our results show that increasing Sph concentration at neutral pH increases the net 
positive charge of the mixtures, suggesting that under these conditions, Sph molecules are 
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indeed positively charged. The higher net positive charge increases the repulsive forces and 
prevents strong vesicle aggregation. Because Sph is protonated at acid pH, it would be expected 
that Sph aggregation would also be hampered in these conditions, due to the repulsive forces 
created by the charged groups. Interestingly, when Sph molar fraction exceeds 30%, a pH 
dependent change in the interfacial electrical properties of POPC/Sph vesicles is observed. The 
net surface charge of these vesicles (which is lower at pH 7.4 when Sph <40 mol %) continues to 
increase at neutral pH, although at acidic pH, the value reaches a plateau at +25 mV. Because it 
is not expected to have a decrease in the positive surface charge of the vesicles as the 
concentration of Sph is increased in the mixtures, additional alterations in the electrical and/or 
mechanical properties of the vesicles should account for the observed surface charge 
stabilization at acidic pH. One hypothesis could be the formation of structures that bury the 
positive charge of Sph, such as aggregated vesicles or high curvature regions rich in Sph. This 
would contribute to a decrease in the repulsive forces between the vesicles and increase in 
their aggregation (Figure 3). Alterations in the H-bonding network of Sph from intramolecular at 
pH 5.0 to intermolecular at pH 7.417 could also account for the differences observed in the 
thermotropic behavior of Sph and POPC/Sph mixtures at distinct pH. This would also explain the 
different organization of Sph molecules in the absence of POPC, particularly the larger 
structures formed at acidic pH. 
 
5.2. Effect of pH environment on the biophysical and electrostatic properties of raft-
mimicking mixtures 
Lipid rafts are thought to exist mainly at the PM, and they are virtually absent from 
intracellular membranes, where the content of lipids involved in raft formation is lower.42 A 
typical example is the lysosome, where the total levels of Chol are low.43 However, this is not 
the case of the lysosomes of NPC, where the accumulation of both Chol and SM contribute to 
an increase in the levels of these raft components.44 It has been hypothesized that lipid rafts 
might accumulate in the LE/Ly of NPC (and other lipidoses) and cause the impairment of LE/Ly 
functions.42 However, despite the large amount of studies addressing the biophysical properties 
of raft-mimicking membranes,22,23,45−48 little attention has been given to the effect of pH 
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environment on lipid raft organization and properties. In the present study, we showed that 
upon acidification there is a decrease in the ordering of the membrane, which is independent of 
the composition of the ternary mixtures. This was accompanied by an increase in the net 
surface charge, showing that pH environment affects both the physical and the electrostatic 
properties of the raft-mimicking mixtures. The raft model membranes showed a nonzero net 
charge at both pH values, resulting from the exposure of the membrane to different ions. POPC 
and SM contain phosphate and choline, functional groups whose electric charge distributions is 
determined by the binding of counterion.49−51 At pH 5.0, vesicles have a positive ζ-potential 
pointing to the association of protons with groups at the membrane surface. 
 
5.3. Impact of Sph on the physical state and electrostatic properties of POPC/SM/Chol 
membranes (raft model) 
Our results show that Sph is able to change the physical properties of POPC/SM/Chol 
even when in low concentrations. These effects are more pronounced when the fraction of lo 
phase is low (low Chol and SM content) and at neutral pH, but these effects are also observed 
at acidic pH. Comparing this effect with the effect that Sph had upon the properties of the fluid 
POPC vesicles, we can conclude that the ordering ability of Sph in the ternary mixtures is higher, 
because lower amounts of Sph already induce significant changes in the lipid packing. However, 
Sph-induced changes on the properties of raft-mimicking mixtures are minor when Chol 
content, and thus the lo fraction, is high. This effect resembles that described for ceramide 
interacting with lipid-raft mixtures,45,46 suggesting that Sph ability to increase the ordering of 
the membrane and segregate into Sph gel domains depends on the Chol content. This is 
probably a consequence of the Sph −SM and Sph –Chol interactions, which might facilitate the 
formation of a gel phase or increase the solubility of Sph in the lo phase, respectively, as 
previously shown for ceramide.45,46,52 It was reported that increasing the Chol content in 
ternary POPC/Sph/Chol mixtures favors the miscibility of Sph in the membrane.11 In addition, it 
was suggested that in ternary POPC/SM/Chol mixtures, a competition between Sph and SM 
might occur for the interaction with Chol, and that SM leads to a decrease of Sph miscibility, 
possibly due to the formation of a SM/Sph-enriched gel phase.6,11 These observations support 
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our hypothesis that Sph might induce changes on the biophysical properties of raft-mimicking 
mixtures comparable to ceramide,45,46 (i.e., induce the formation of a gel phase in the low Chol, 
low lo phase fraction range) and it may also become miscible in the lo phase when the Chol 
content and the lo phase fraction is high). However, significant differences regarding the 
interaction of ceramide and Sph with lipid raft mixtures can be highlighted: (i) Sph has a lower 
ability to form gel phase compared to ceramide. For instance, strong alterations in the 
properties of raft mixtures, including gel phase formation, are observed for mixtures containing 
∼4 mol % of ceramide;45 however, higher amounts of Sph are required to promote comparable 
effects. (ii) These observations further suggest a lower synergy between SM and Sph in the 
formation of gel domains, compared to ceramide/SM, where formation of ceramide gel 
domains was enhanced by SM.45 (iii) Moreover, the packing properties of the Sph gel differ 
from the ceramide gel phase. Even though Sph has an ability to form gel phase in the fluid POPC 
and in raft mimicking mixtures, both the extent and the packing of the gel phase is lower in Sph-
containing mixtures compared to ceramide containing mixtures,29,45 as observed by the higher 
content of Sph required to induce gel phase formation and the lower fluorescence lifetime of t-
PnA in Sph-containing mixtures. In addition, information derived from studies using DPH 
showed that ceramide-enriched gel domains were extremely ordered, preventing the 
incorporation of this probe in the ceramide gel phase. This was not observed in mixtures 
containing Sph. In contrast, the increase in DPH anisotropy toward values typical of gel phase 
further supports the ability of Sph to form a less packed gel phase as compared to ceramide. 
The analysis of the vesicles through electrophoretic and dynamic light scattering further 
showed that Sph also changes the interfacial electrical properties of the raft mixtures. Our ζ-
potential measurements indicate that the electrical properties of the POPC/SM/Chol 
membranes are affected by both Sph content and solution pH. Sph increases the surface charge 
at both pH values, but at pH 7.4, the net charge is mainly neutral. However, at pH 5.0, the 
surface charge density is positive. In addition, while the surface electrical properties of the 
ternary lipid vesicles seem not to be significantly affected by their lipid composition, the 
presence of Sph appears to change the interfacial properties in a Chol/SM content-dependent 
manner, particularly at pH 5.0. Indeed, at pH 5.0, the presence of Sph leads to an increase in ζ-
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potential with Chol content. A possible explanation could be a lower segregation of Sph into gel 
domains when the lo phase fraction is higher (Sph is more randomly dispersed in the 
membrane), which contributes to the stabilization of cationic Sph due to lower repulsive forces 
in the absence of neighboring Sph molecules (also positively charged). It is also important to 
notice that we are using mixtures with ld/lo domains which can also contribute to Sph 
stabilization, for example, in the interfaces between the different domains. At pH 7.4, in the 
presence of 100% lo, we can verify a decrease in the surface net charge of the vesicles that can 
be a result of vesicle aggregation or binding of counterions, which also contributes to vesicle 
aggregation. At pH 5.0, the membrane is more disordered and probably the formation of 100% 
lo does not occur, even for the highest Chol/SM mole fraction employed. Even though ζ-
potential measurements in binary POPC/Sph mixtures at neutral pH show a Sph-dependent 
mild increase in the net positive surface charge density, it is possible that not all of the Sph are 
on a protonated form at pH 7.4. This would contribute to a decrease in the repulsive 
electrostatic forces between Sph molecules and would justify the increased ability of Sph to 
segregate into gel domains both in the binary and raft mixtures at neutral pH compared to pH 
5.0. On the other hand, the electrostatic repulsion created by Sph positive charge at pH 5.0 
would hinder molecule aggregation and reduce Sph ability to form gel domains in this 
environment. In Figure 7, where the difference of ζ-potential between pH 5.0 and pH 7.4 can be 
observed, it is clear that Sph changes its protonation state in the different environments and 
that these alterations are dependent on mixture composition. The mixtures are more charged 
at acidic pH and for higher lo fractions. Probably the lipid organization, orientation of the head 
groups (that are also altered by Chol presence), and the alteration of Sph hydrogen-bonding 
states due to pH variation are the cause of the observed behaviors. 
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Figure 7. Difference of -potential in POPC/SM/Chol/Sph mixtures between pH 5.0 and pH 7.4. The 
symbols represent 0 (diamonds), 5 (circles), and 10 (triangles) mol% Sph. The lines act merely as guides 
to the eye.  
6. Conclusions 
In this study, we demonstrate the impact of Sph on fluid and raft-mimicking model 
membranes at neutral pH (7.4) and acidic pH (5.0). Our studies revealed that Sph has an 
ordering effect in the fluid POPC membrane that is more pronounced in higher concentrations 
and at neutral pH. However, in rafts (POPC/SM/Chol membrane), its presence, even in low 
concentrations (5 or 10%), contributes to formation of Sph gel-like domains, in a Chol/SM 
content-dependent manner. These results support the hypothesis that the Sph biological role 
could be exerted through biophysical changes in cellular membranes. 
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9. Supporting Information for: Biophysical Implications of Sphingosine Accumulation in 
Membrane Properties at Neutral and Acidic pH 
 
 
Figure S1. Thermotropic behavior of POPC/Sph mixtures. Steady-state fluorescence anisotropy of 
DPH as a function of temperature in MLV composed of POPC/Sph mixtures containing 30 (squares) 
and 80 (circles) mol% Sph at pH 7.4 (solid symbols), pH 5.0 (open symbols). Values are means ± SD of 
at least three independent experiments. 
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Figure S2. Mean fluorescence lifetime of t-PnA in POPC/SM/Chol/Sph mixtures. Mean fluorescence 
lifetime of t-PnA in ternary mixtures containing 0 (diamonds), 5 (circles), and 10 (triangles) mol% Sph 
at (A) neutral and (B) acidic pH. Mean fluorescence lifetime in mixtures containing (C) 5 and (D) 10 
mol% Sph at pH 7.4 (solid symbols) and pH 5.0 (open symbols). The values are the mean ± SD of at 
least three independent experiments. The lines act merely as guides to the eye. 
 
 
 
 
 
 
 
 
Figure S3. Normalized pre-exponential factors associated to the long component lifetime of t-PnA, in 
POPC/SM/Chol/Sph mixtures. The symbols represent 0 (diamonds), 5 (circles), and 10 (triangles) mol% 
Sph. The lines act merely as guides to the eye. 
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Figure S4. Size of POPC/SM/Chol/Sph mixtures as a function of X lo. (A) and (B) size at neutral (7.4) and 
acidic (5.0) pH, respectively. The symbols represent ternary mixtures containing 0 (diamonds), 5 (circles), 
and 10 (triangles) mol% Sph. Insets: polydispersity index of the same mixtures. The values are the mean 
± SD of at least 3 independent experiments. The lines act merely as guides to the eye.  
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CHAPTER III – DEVELOPMENT OF LYSOSOME-MIMICKING VESICLES TO STUDY THE EFFECT OF 
ABNORMAL ACCUMULATION OF SPHINGOSINE ON MEMBRANE PROPERTIES 
 
 
1. Abstract 
Synthetic systems are widely used to unveil the molecular mechanisms of complex 
cellular events. Artificial membranes are key examples of models employed to address lipid-
lipid and lipid-protein interactions. In this work, we developed a new synthetic system that 
more closely resembles the lysosome – the lysosome-mimicking vesicles (LMVs) – displaying 
stable acid-to-neutral pH gradient across the membrane. To evaluate the advantages of this 
synthetic system, we assessed the distinct effects of sphingosine (Sph) accumulation in 
membrane structure and biophysical properties of standard liposomes (no pH gradient) and in 
LMVs with lipid composition tuned to mimic physiological- or NPC1-like lysosomes. Ternary 1-
palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC)/Sphingomyelin (SM)/Cholesterol (Chol) 
mixtures with, respectively, low and high Chol/SM levels were prepared. The effect of Sph on 
membrane permeability and biophysical properties was evaluated by fluorescence 
spectroscopy, electrophoretic and dynamic light scattering. The results showed that overall Sph 
has the ability to cause a shift in vesicle surface charge, increase membrane order and promote 
a rapid increase in membrane permeability. These effects are enhanced in NPC1 - LMVs. The 
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results suggest that lysosomal accumulation of these lipids, as observed under pathological 
conditions, might significantly affect lysosomal membrane structure and integrity, and 
therefore contribute to the impairment of cell function. 
2. Introduction 
Sphingosine (2S,3R-D-erythro-2-amino-1,3-octadec-4E-ene-diol) is one of the most 
abundant sphingoid backbone in mammalian sphingolipids (SLs)1. It results from the 
degradation of ceramide (Cer) by ceramidases in different sub-cellular locations2. In the 
lysosome, Sph is generated through the hydrolysis of Cer by aCDase. The amino group of Sph is 
protonated under acidic conditions and therefore it needs a transporter (currently unknown) to 
facilitate its egress from the acidic compartments3. Free Sph levels are generally maintained 
low, due to its rapid further metabolization into important signaling molecules. This lipid can be 
converted into S1P through the phosphorylation of C1 hydroxyl group or acylated through the 
action of different ceramide synthases to produce ceramide2,4,5.  
Sph is itself a bioactive lipid and it plays an active role in different biological processes, 
such as differentiation6, and apoptosis7,8. Moreover, Sph has been implicated in the regulation 
of the activity of various enzymes, including protein kinases7,9-13. Most of these enzymes do not 
have a bona fide Sph-binding site identified. They are amphitropic proteins, a feature that is 
important for their activity and regulation14. This suggests that the regulatory effect of Sph can 
in part be exerted at the membrane level, namely through physical changes that might affect 
the distribution of lipids and proteins and consequently trigger different cellular events. 
As an important bioactive molecule, Sph has its cellular levels tightly regulated15. 
However, in some situations, like in Niemann Pick Disease type C1 (NPC1), Sph abnormally 
accumulates in the LE and lysosomes of cells, inducing the secondary accumulation of Chol, SM 
and other SLs16. These lipid changes might have important consequences at the level of 
membrane structure, organization and properties, which might influence lysosomal-associated 
events3,17 or even compromise lysosomal integrity18,19. 
In recent years, efforts have been made in order to understand the impact of Sph in 
membrane organization. It was demonstrated that Sph has the ability to change the membrane 
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physical organization, promoting the formation of more ordered domains18,20-26. The order of 
these domains depends not only on the membrane lipid composition but also on the 
surrounding pH environment21,26,27. It is likely that Sph-induced alterations in membrane 
properties are closely related to the physico-chemical changes experienced by this lipid. The 
protonation state23,28 and thus the H-bonding network of Sph29 are susceptible to pH changes 
occurring within the range of  different physiological pH environments, suggesting that Sph 
might have a different behavior depending on its sub-cellular location. For instance, the fact 
that Sph might become more positively charged in the acidic conditions of the lysosome may 
strongly affect its interaction with the surrounding lipids and interfere with the formation and 
maintenance of Sph domains. It was recently shown that by interacting with negatively charged 
lipids, commonly found in biological membranes, including lysosomal membranes, Sph 
contributes to the formation of transient non-lamellar phases, which affect membrane 
permeability18. This might be of biological relevance, especially when considering disorders, 
such as NPC1, where Sph, which is a positive regulator of calcium release from the acidic stores, 
abnormally accumulates in acidic compartments16,30. Other mechanisms have been suggested 
in order to explain this Sph-induced permeability, including the formation of structural defects 
at the interfaces between biophysically distinct lipid domains20, and the formation of pores31. 
Despite this, the molecular mechanisms underlying this phenomenon are not yet completely 
understood. In addition, most of the model systems used to address the physico-chemical 
impact of Sph in the membranes fail to mimic the biological properties of one of the most 
important subcellular locations of Sph – the lysosome – not only in terms of lipid composition, 
but especially concerning the pH gradient across the lysosomal membrane. Therefore, in the 
present work, we developed and characterized a synthetic membrane system - the LMVs - in 
which Sph encounters two different pH environments: an internal acidic pH (pH 5.0), mimicking 
the lysosomal lumen, and an external neutral pH (7.4), mimicking the lysosomal outer leaflet, 
i.e., pH 5.0in/7.4out (Fig. 1). The LMVs were then used to address the biological relevant question 
of how Sph accumulation in the lysosome, as observed in NPC116, changes lysosomal 
membrane properties, both in dynamic and in thermodynamic equilibrium conditions (Fig. 1). 
The lipid composition of the vesicles has been manipulated in order to compare the effects of 
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Sph on membrane permeability and biophysical properties under situations that more closely 
resemble the physiological conditions, i.e., low Chol content32,33, and NPC1-like pathological 
conditions, i.e., high levels of Chol and SLs3,16. Our results showed that Sph has a more dramatic 
impact on membrane organization and permeability in NPC1-mimicking conditions, compared 
to physiological-like situations. Moreover, our data further showed significant differences in the 
effects caused by Sph in LMVs and standard vesicles (with no pH gradient, Fig. 1), further 
supporting the notion that adequate synthetic systems should be used to address lipid-lipid 
interactions in conditions that better mimic the biological context. 
 
3. Methods 
3.1. Materials 
Sph, POPC and SM from Egg, Chicken were obtained from Avanti Polar Lipids, Inc. 
(Alabaster, AL, USA). Chol and TX-100 were obtained from Sigma-Aldrich (St. Louis, MO, USA). 
trans-parinaric acid (t-PnA) and pyranine were purchased from Molecular Probes/Invitrogen 
(Eugene, OR, USA). 8-Aminonaphthalene-1,3,6-Trisulfonic Acid, Disodium Salt (ANTS) and p-
xylene-bis-pyridinium bromide (DPX) were supplied by Life Technologies (Carlsbad, CA, USA). 
The organic solvents were obtained from Fluka (St. Louis, MO, USA).  
The concentration of the lipid and of the probes stock solutions were determined as 
previously described26. 
 
3.2. Liposome preparation  
The lipids were dissolved in chloroform or absolute ethanol (in the case of Sph) and mixed 
in the required proportions. The following ternary mixtures have been used: 71.6:23.3:5.1; 
59.7:26.3:14; 45.1:29.9:25; 34:32.7:33.3 and 25.4:34.8:39.8 (POPC/SM/Chol). These mixtures 
span the tie line containing the 1:1:1 equimolar mixture of the ternary POPC/SM/Chol phase 
diagram34. For simplicity, data are represented as a function of the lo phase fraction of the 
mixtures: 0; 0.26; 0.58; 0.83 and 1, respectively. To evaluate the effect of Sph on membrane 
properties, 5 and 10 mol% Sph were also used in the preparation of some samples. Vesicles in 
thermodynamic equilibrium with pre-incorporated Sph and the dynamic interaction of Sph 
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(external addition) with POPC/SM/Chol vesicles were studied. The solvent was evaporated 
under a stream of nitrogen and the samples were left under vacuum overnight in order to 
remove traces of solvent. As suspension medium, Hepes buffer (10 mM Hepes and 150 mM 
NaCl, pH 7.4) and Citrate Phosphate buffer (0.1 M citric acid and 0.2M Na2HPO4, pH 5.0) were 
used. The lipid suspensions were equilibrated by freeze thaw cycles (T > 50 °C) before LUVs 
preparation. LUVs (0.2 or 3 mM total lipid concentration, depending on the experiment) were 
then prepared by standard procedures47 e.g. using Nuclepore polycarbonate filters of 0.1 μm 
pore diameter, at a temperature above the transition temperature of all the individual lipids 
present in the mixtures (T > 50 °C). 
 
3.3. Preparation of lysosome-mimicking vesicles 
To obtain the LMVs, LUVs with a total lipid concentration of 3 mM were prepared with 
Citrate Phosphate buffer (pH 5.0). To change the external pH environment, LUVs were 
separated through a Sephadex G-25 gel filtration column (GE Healthcare, Little Chalfont, UK) 
using Hepes buffer (pH 7.4) as elution buffer. To prevent vesicle burst during gel filtration 
chromatography, the osmolarity of the buffers was measured using an osmometer (Knauer, 
Berlin), and when necessary sucrose was added to the elution buffer in order to have identical 
internal and external buffer osmolarity. Liposomes with pH 5.0 in the internal medium and pH 
7.4 in the external medium were recovered mainly in fractions 3 and 4 (1 mL each), as 
confirmed by absorption, fluorescence and dynamic light scattering measurements (data not 
shown). The liposomes were then diluted to approximately 0.2 mM lipid concentration.  
 
3.4. Determination of the partition coefficient of t-PnA between aqueous and lipidic 
phases at different pH conditions 
POPC and POPC/SM/Chol (26% lo) vesicles were prepared with different total lipid 
concentrations (0.001; 0.003; 0.005; 0.01; 0.025; 0.05; 0.1; 0.15; 0.2; 0.25; 0.3; 0.4; 0.5; 1; 2 and 
3 mM). The samples were placed in 96 well opaque plates and fluorescence intensity 
measurements of t-PnA (0.4 µM) were performed at 24 °C, in a microplate reader (Spectramax 
Gemini EM), using 303 and 404 nm as the excitation and emission wavelengths, respectively. 
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The data analysis software GraFit (Erithacus Software) was used to perform the non linear 
fitting of equation 1 to the experimental data. 
 
                    Eq. 1 
 
In this equation, ∆I = I – I0, stands for the difference between the steady-state 
fluorescence intensity of the probe measured in the presence (I) and in the absence of lipid 
vesicles (Io). Imax is the limiting value of I measured upon increasing the lipid concentration, [L], 
of the solution, and [W] corresponds to the molar concentration of water at 24 °C 
(approximately 55.5 M)35. 
 
3.5. Characterization of membrane biophysical properties  
To characterize the biophysical properties of the membranes, steady-state and time 
resolved fluorescence spectroscopy measurements of t-PnA were performed. Lipid vesicles 
were incubated with t-PnA (probe to lipid ratio of 1:500) at 24 ºC for at least 1h. 
Fluorescence measurements were carried out in a Spex Fluorolog 3-22/Tau 3 
spectrofluorometer equipped with double grating monochromators in both excitation and 
emission light paths from Horiba Jobin Yvon. The t-PnA excitation/emission wavelengths (nm) 
were 303/404. The fluorescence anisotropy (<r>) was calculated as previously described48.  
The fluorescence intensity decay measurements were obtained by the single photon 
counting technique, as previously described48. The excitation wavelength was 315 nm (using a 
NanoLED source, model N-320; Horiba Jobin-Yvon), and the emission was collected at 404 nm. 
To analyze the experimental decays and obtain the fitting curves, the TRFA software (Scientific 
Software Technologies Center, Minsk, Belarus) was used. Fluorescence decays were described 
by a sum of exponentials, where αi is the normalized pre-exponential, and τi is the lifetime of 
the decay component i. The mean fluorescence lifetime <τ> is given by: 
  Eq. 2 
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All measurements were performed in 1.0 cm × 0.4 cm quartz cuvettes, at 24 °C. Constant 
temperature was maintained using a Braun 852 circulating water bath. 
 
3.6. Leakage studies 
LUVs with 3 mM total lipid concentration were prepared (as above described) using 
Hepes or Citrate Phosphate buffer: (pH 7.4 or pH 5.0, respectively) containing 12.5 mM of ANTS 
and 45 mM of DPX (leakage buffers)49. The non-encapsulated fluorescent probe was separated 
from the vesicle suspension using a Sephadex G-25 gel filtration column. Buffers with the same 
osmolarity (adjusted with sucrose as described above) of the leakage buffer but without 
ANTS/DPX was used as eluent. Liposomes encapsulating ANTS/DPX were recovered mainly in 
fractions 3 and 4 (1 mL each), as confirmed by absorption, fluorescence and dynamic light 
scattering measurements (data not shown). Liposome final concentration was determined by 
lipid phosphorous analysis50, for the samples prepared in Hepes buffer. The liposomes were 
then diluted to approximately 0.2 mM lipid concentration and fluorescence measurements 
were performed at 24 °C, in 1 cm x 0.4 cm quartz cuvettes under continuous stirring. To 
evaluate the effect of Sph on membrane permeability, 5 and 10 mol% of Sph, dissolved in a 
small volume of absolute ethanol (ethanol was kept below to 1% v/v to prevent vesicle 
destabilization) were added to lipid vesicle suspensions that were in continuous stirring. The 
same volume of ethanol, without Sph was used as a control. At this ethanol concentration, the 
permeability change was negligible. Membrane leakage was evaluated by following the 
increase in the fluorescence intensity of ANTS upon its release from the liposome. To this end, 
ANTS fluorescence intensity was recorded over time using the same set up described in 3.4, 
using 355/520 nm as the excitation/emission wavelengths. The fluorescence intensity 
corresponding to full leakage was obtained by adding 0.1 % (v/v) of Triton X-100 to the samples 
at the end of the experiment, i.e., approximately 30 minutes after Sph addition.  
The extent of leakage was determined as: % release = (Ft - F0)/(F100 - F0) x 100, where Ft is 
the  value of fluorescence intensity at time t, F0 is the initial fluorescence of the vesicle 
suspension, and F100 is the fluorescence intensity value after the addition of Triton X-100.  
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3.7. Studies with pyranine 
Pyranine is a pH sensitive probe that was used in this work to test the stability of the pH 
gradient in LMVs. The maximum absorption wavelengths for the acid (protonated) and the base 
(unprotonated) forms of pyranine are 405 nm and 450 nm, respectively51. The fluorescence 
intensity of pyranine excited at 450 nm is high at pH 7-8 but near background at acidic pH, 
while the inverse is true for the fluorescence produced by 405 nm excitation52. Ratiometric 
measurements using an excitation ratio of 450/405 nm are for that reason frequently used to 
provide information about the pH of a determined solution. This is an advantageous method 
since it not depends on pyranine concentration and is directly related with pyranine ionization 
degree. 
LMVs/LUVs with 3 mM total lipid concentration were prepared using Hepes or Citrate 
Phosphate buffer (pH 7.4 or pH 5.0, respectively), as above described. These vesicles contained 
0.5 mM pyranine encapsulated35. The following (POPC/SM/Chol ternary mixtures were used: 
59.7:26.3:14 (Xlo = 26) and 34:32.7:33.3 (Xlo = 0.83). Liposomes encapsulating pyranine were 
recovered (after separation through a Sephadex G-25 column) mainly in fractions 3 and 4 (1 mL 
each). Liposome final concentration was determined by lipid phosphorous analysis50, for the 
samples prepared in Hepes buffer. The liposomes were then diluted to approximately 0.2 mM 
lipid concentration in 96 well opaque plates and fluorescence measurements were performed 
at 24 °C, in a microplate reader (Spectramax Gemini EM), using 405 and 450 nm as the 
excitation wavelengths and 510 nm as emission wavelength. The auto mix option of the 
microplate reader was selected to mix the samples 5 seconds before the first read and 3 
seconds between reads. To evaluate the stability of the pH gradient in LMVs, the fluorescence 
measurements were performed during ap. 5 hours. After this time, triton X-100 (0.1% (v/v)) 
was added to the samples in order to obtain the fluorescence intensity induced by an 
immediate burst of the vesicles. Some of the wells with LMVs (without the addition of triton X-
100) were left overnight and measurements were also performed next day, to observe if the pH 
gradient remained stable. No significant changes were observed (data not shown). Samples 
with acidic and neutral pH both inside and outside the vesicles were prepared to obtain the 
fluorescence intensity of pyranine at only acidic and neutral conditions (control samples). The 
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stability of the LMVs was evaluated in the absence and presence of Sph (pre-incorporation of 
10 mol% Sph and external addition of 10 mol% Sph). In the external addition studies, Sph was 
dissolved in a small volume of absolute ethanol (ethanol was kept below to 1% v/v to prevent 
vesicle destabilization) and added to lipid vesicle suspensions (the auto mix option of the 
microplate reader was selected to mix the samples 5 seconds before the first read and 3 
seconds between reads). Control experiments were also performed by adding the same volume 
of ethanol, without Sph. 
  
3.8. Electrophoretic and Dynamic Light Scattering Measurements 
The electrophoretic mobilities were analyzed through M3-PALS technology on a ZetaSizer 
Nano Z equipment (Malvern Instruments, UK). Samples were placed in clear disposable zeta 
cells and then in sample chamber maintained at 24 °C. Data analysis was performed using the 
accompanying software, and the measurements were done in triplicate in each experiment. 
Vesicle sizes were determined by performing dynamic light scattering analysis on a 
Zetasizer Nano S equipment (Malvern Instruments, UK). Size measurements were performed 
using patented non-invasive back scatter (NIBS) technology. Samples were placed in 12 mm 
square polystyrene cuvettes and then in a chamber maintained at 24 °C. Data analysis was 
performed using the accompanying software and expressed as Z average size or size 
distribution by intensity. The PDI for each sample was also calculated using the same software. 
For each sample, the measurements were done in triplicate. 
 
3.9. Statistical analysis  
The statistical analysis was performed using Student´s t-test. Mean values were 
considered significantly different for p values below 0.05. 
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4. Results 
4.1. Rationale 
The present study aimed at developing synthetic systems that more closely resembled the 
lysosome, to more accurately address the impact of lipid changes on the biophysical properties 
of lysosomal membranes in physiological and pathological (NPC1-like) situations. Therefore, to 
mimic the lysosomal compartment, we developed a model bilayer – the LMVs (Fig. 1) - where 
the pH environment is acid for the inner membrane leaflet and neutral for the outer membrane 
leaflet, i.e., pH 5.0in/7.4out. In addition, we took advantage of the well-characterized 
POPC/SM/Chol ternary mixtures34 in order to evaluate the effect of Sph on the properties of 
membranes containing low (physiological-like) or high (NPC1-like) levels of Chol and SLs (Fig. 1 
and supplementary table S1). Studies were performed to address the effects of Sph when in 
conditions of thermodynamic equilibrium (i.e., pre-incorporated in the membrane prior to 
vesicle preparation, Fig. 1a.2,b.2,c.2) and upon dynamic interaction with the membrane (i.e., 
externally added to pre-formed vesicles, Fig. 1a.3,b.3,c.3). In addition, to further show the 
importance of developing adequate synthetic systems to address lipid-lipid interactions, 
comparison with standard vesicles (without pH gradient across the membrane) prepared under 
neutral, i.e., pH 7.4in/7.4out, and acidic, pH 5.0in/5.0out, conditions, was performed (Fig. 1), based 
both on new as well as available literature data26. 
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Figure 1 – See legend in the next page. 
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Figure 1 – Schematic representation of the synthetic systems used in this study.  Artificial membrane 
systems composed by POPC/SM/Chol were prepared at different pH conditions. (a) A new synthetic 
system that more closely resembles the lysosome – the lysosome-mimicking vesicles (LMVs), displaying 
internal acidic pH and external neutral pH (pH5.0in/7.4out) was prepared through buffer exchange by gel 
filtration and compared with data from simpler systems prepared at (b) pH7.4in/7.4out and (c) 
pH5.0in/5.0out. To address the effects of Sph in the membrane, studies were performed in equilibrated 
sample conditions (a.2, b.2, c.2) (i.e., pre-incorporated in the membrane prior to vesicle preparation) 
and (a.3, b.3, c.3) upon dynamic interaction with the membrane (i.e., externally added to pre-formed 
POPC/SM/Chol vesicles. In addition, vesicles with different lipid compositions were prepared in order 
to evaluate the effect of Sph on the properties of membranes containing low (physiological-like) or 
high (NPC1-like) levels of Chol and SLs. The higher the levels of Chol and SM of the mixtures the higher 
the lo phase fraction (Xlo) (see methods section and supplementary table S1 for further details).  
 
4.2. Preparation and characterization of lysosome-like models (LMVs) 
The preparation of LMVs (pH 5.0in/7.4out) (Fig. 1a) is complex involving size exclusion 
chromatography to create a pH gradient across the bilayer. To test whether this experimental 
set up would compromise the stability of the vesicles altering its size, and to evaluate if the 
expected changes in surface charge were taking place upon changing the outer membrane pH 
from an acidic to a neutral environment26, analysis of vesicle size and surface charge was 
performed before and after separating the vesicles through the chromatographic column (Fig. 
2) The ζ-potential of the ternary POPC/SM/Chol mixtures before size exclusion 
chromatography (i.e., when displaying pH 5.0in/5.0out) was slightly positive, as expected since 
these lipid mixtures are at pH of 5.026. A change in ζ-potential towards slightly negative values 
was observed upon creation of the pH gradient across the bilayer (Fig. 2a), reflecting the 
charge behavior of these mixtures at pH 7.426. Changes in the surface charge of the LMVs (Fig. 
2a) upon creation of the pH gradient were accompanied by only a slight increase in the size of 
the vesicles (Fig. 2b), showing that LMVs are stable and not prone to aggregation.  
To demonstrate the pH gradient stability of the LMVs (pH 5.0in/7.4out) we took 
advantage of the fluorescence properties of the pH-sensitive dye pyranine35. The pH gradient 
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in POPC/SM/Chol LMVs was stable over several hours, as shown by the constant ratio of the 
fluorescence intensity of pyranine (Fig. 2c,d).  
To characterize the biophysical properties of the LMVs, fluorescence spectroscopy 
measurements of t-PnA were performed. The partition coefficient (Kp) of t-PnA to POPC and 
POPC/SM/Chol vesicles at pH 5.0in/5.0out  and  pH 7.4in/7.4out was determined as described in 
Methods section and no significant differences were noticed, regarding both lipid composition 
and pH environment (See supplementary table S2), showing that probe interaction with the 
membrane is independent of these parameters. The results of the steady-state and time-
resolved fluorescence spectroscopy measurements of t-PnA are represented in Fig. 2 (panels 
(e) and (f)). An increase in the fluorescence anisotropy (Fig. 2e) and mean fluorescence 
lifetime (Fig. 2f) of t-PnA was observed in LMVs containing higher lo phase fraction (Xlo), 
reflecting an increase in the order of the membrane as the levels of Chol and SM in the 
mixtures are increased. Moreover, t-PnA anisotropy (Fig. 2e) and mean fluorescence lifetime 
(Fig. 2f) in LMVs (pH 5.0in/7.4out), are in general slightly higher compared to the same mixtures 
where the internal/external pH was either pH 7.4in/7.4out or pH 5.0in/5.0out26 (e.g. the 
fluorescence anisotropy values for ternary mixtures with no lo phase are 0.164 at pH 
5.0in/5.0out; 0.179 at pH 7.4in/7.4out and 0.187 at pH 5.0in/7.4out; Supplementary Fig. S1)26, 
showing that the creation of the pH gradient across the membrane changes lipid-lipid 
interactions. Therefore, the overall membrane order and organization of the mixtures change 
with possible consequences for the phase boundaries of the POPC/SM/Chol ternary phase 
diagram34. 
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Figure 2 – Characterization of POPC/SM/Chol LMVs (pH 5.0in /7.4out). (a) Surface charge and (b) size 
characterization of POPC/SM/Chol vesicles, containing increasing fractions of lo phase (see 
Supplementary table S1). The open circles in (a) and (b) represent the samples before chromatography 
(pH 5.0in/5.0out), the solid symbols represent the same samples after chromatography (pH 5.0in/7.4out). 
The light grey symbols represent the external addition of 10 mol% Sph to POPC/SM/Chol LMVs. (c) and 
(d) pH gradient stability of LMVs (pH 5.0in/7.4out) composed by (c) Xlo = 0.26 and (d) Xlo = 0.83 was 
evaluated overtime through ratiometric measurements of pyranine excited at 450 and 405 nm 
(450/405). After approximately 300 minutes, triton X-100 (0.1% (v/v)) was added to samples. The light 
grey line represents LMVs (pH 5.0in/7.4out) (Fig. 1a.1), while the black and grey lines represent control 
vesicles prepared with pH 5.0in/pH 5.0out (Fig. 1c.1) and pH 7.4in/pH 7.4out (Fig. 1b.1), respectively. The 
vesicles contained 0.5 mM encapsulated pyranine. These experiments were repeated at least three 
independent times and the values are median representative curves of those experiments. Panels (e) 
and (f) show the variation in (e) steady-state fluorescence anisotropy and (f) mean fluorescence 
lifetime of t-PnA in ternary POPC/SM/Chol LMVs. In (a,b,e,f) the values are the mean ± SD of at least 
three independent experiments. The lines act merely as guides to the eye. 
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4.3. Effect of Sph on membrane properties under thermodynamic equilibrium 
To investigate the effects of Sph in membrane properties under thermodynamic 
equilibrium conditions, 5 or 10 mol% of Sph was pre-incorporated in the lipid mixtures prior to 
vesicle preparation (see Fig. 1 and Methods for further details). Pre-incorporation of Sph into 
the LMVs does not significantly change the fluorescence anisotropy or mean fluorescence 
lifetime of t-PnA compared to LMVs without Sph (See supplementary Fig. S2). This is in 
contrast to what has been previously reported for identical mixtures characterized either at 
pH 7.4in/7.4out or pH 5.0in/5.0out, where a significant increase in membrane order was observed 
upon pre-incorporation of Sph, particularly in mixtures containing low Chol and SM content26. 
This suggests that under pH conditions mimicking the lysosome, pre-incorporation of Sph at 
those small molar ratios has no significant effect on the overall membrane order. However, 
pre-incorporated Sph increases the packing of the ordered phase of the LMVs, as observed by 
the increase in the long lifetime component of t-PnA fluorescence intensity decay (Fig. 3a). 
The effect is more pronounced in mixtures containing higher levels of Chol/SM. For these 
mixtures, the fluorescence lifetime of t-PnA is very long and typical of gel phase36. These 
results differ from our previous observations performed in standard vesicles with no pH 
gradient (i.e., pH 5.0in/5.0out and pH 7.4in/7.4out), where it was concluded that Sph-ability to 
form gel domains was higher in mixtures displaying lower lo fraction, thus less Chol/SM26. This 
observation further shows that Sph-induced changes on membrane organization are highly 
dependent on pH. 
Surface charge analysis showed that the ζ-potential of the Sph-containing vesicles before 
size exclusion chromatography, i.e., pH 5.0in/5.0out, is positive (Fig. 3b) and similar to what we 
have previously reported26. Upon creation of the pH gradient (pH 5.0in/7.4out) the ζ-potential 
decreases towards values close to neutrality, which are only slightly lower compared to those 
previously obtained for Sph pre-incorporated in vesicles prepared at pH 7.426. The creation of 
the pH gradient also resulted in a shift in the population size towards larger vesicles (Fig. 3c), 
which was accompanied by a significant PDI increase (from < 0.1 to >1.5) (data not shown), 
especially for the mixtures with higher Chol/SM concentration (higher lo fraction). This is 
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probably due to increased propensity for vesicle fusion and/or aggregation, as suggested by 
the scattering intensities (I/I0) recorded in the 1-10 µm range (Fig. 3d). The presence of pre-
incorporated Sph in LMVs (Fig. 1a.2) might cause transient membrane instability due to 
changes in the surface charge and/or redistribution of Sph molecules upon creation of the pH 
gradient. Nonetheless, pre-incorporation of Sph into LMVs does not affect the pH gradient 
stability, as shown by the constant ratio of the fluorescence intensity of pyranine (Fig. 3 e,f).  
 
 
Figure 3 – Characterization of POPC/SM/Chol/Sph LMVs (pH 5.0in /7.4out). Panel (a) show the variation 
in long lifetime component of t-PnA in ternary POPC/SM/Chol LMVs (black circles) and POPC/SM/Chol 
LMVs containing 5 (grey triangles) and 10 (black triangles) mol% of Sph (pre-incorporated in the 
vesicles) (Fig. 1a.2). (b) Surface charge and (c) size characterization of POPC/SM/Chol/Sph (10 mol%, 
pre-incorporation) vesicles. The open symbols represent the samples before chromatography (pH 
5.0in/5.0out) and the solid symbols represent the same samples after chromatography (pH 5.0in/7.4out). 
Panel (d) represent the normalized scattered light intensity of POPC/SM/Chol/Sph (10 mol%, pre-
incorporation) (Fig. 1a.2) vesicles containing Xlo = 0.26 (black lines) and Xlo = 0.83 (light grey lines) as a 
function of particle size (nm). The measurements were also made before (solid lines) and after (dash 
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lines) size exclusion chromatography. In panels (a) to (c) data are represented as a function of the lo 
phase fraction (Xlo): the higher the Xlo the higher the levels of Chol and SM of the mixtures (see 
methods and supplementary table S1 for further details). The values are the mean ± SD of at least 
three independent experiments. The lines act merely as guides to the eye. In panels (e) and (f) the pH 
gradient stability of POPC/SM/Chol/Sph (10 mol% pre-incorporated) LMVs (pH 5.0in/7.4out) (Fig. 1a.2) 
composed by (e) Xlo = 0.26 and (f) Xlo = 0.83 was evaluated overtime through ratiometric 
measurements of pyranine excited at 450 and 405 nm (450/405). After approximately 300 minutes, 
triton X-100 (0.1% (v/v)) was added to samples.  The light grey line represents LMVs (pH 5.0in/7.4out) 
(Fig. 1a.2), while the black and grey lines represent control vesicles prepared with pH 5.0in/5.0out (Fig. 
1c.2) and pH 7.4in/7.4out (Fig. 1b.2), respectively. The vesicles contained 0.5 mM encapsulated pyranine. 
These experiments were repeated at least three independent times and the values are median 
representative curves of those experiments. 
 
4.4. Dynamic interaction of Sph with LMVs and POPC/SM/Chol vesicles with no pH 
gradient 
To evaluate the dynamic interaction of Sph with the membrane and consequent 
alterations in membrane properties, Sph was externally added to the already formed lipid 
vesicles (see Fig. 1 and Methods for further details). To address the importance of adequate 
model systems in the study of lipid-lipid interactions, studies were performed both in LMVs 
(i.e., pH 5.0in/7.4out) (Fig. 1a.3) and in standard liposomes display identical internal/external pH 
(i.e., pH 7.4in/7.4out (Fig. 1b.3) and pH 5.0in/5.0out (Fig. 1c.3). 
 
Surface charge  
Incorporation of Sph in the lipid bilayer upon its addition to the vesicles is expected to 
cause a change in their surface charge properties, due to the positive nature of Sph. 
Therefore, from these experiments it is also possible to evaluate the ability of Sph to 
incorporate the different type of mixtures. 
Addition of Sph to LMVs caused a change in vesicle surface charge towards positive 
values (Fig. 2a). The ζ-potential values obtained under these conditions are in general 
comparable to those previously obtained at pH 7.4in/7.4out for identical mixtures where the 
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same amount of Sph has been initially incorporated in the lipid bilayer prior to liposome 
preparation26. This charge variation reflects the increase in positively charged lipids in the 
bilayer as a result of Sph incorporation.   
The effect of adding Sph to standard liposomes prepared under neutral (pH 7.4in/7.4out, 
Fig 4a) and acidic (pH 5.0in/5.0out, Fig. 4d) conditions, was also evaluated. A Sph-concentration 
dependent increase in the surface charge of both types of vesicles was observed upon adding 
Sph, reflecting the incorporation of Sph in the membrane. It should, however, be stressed 
that, while ζ-potential values obtained at pH 5.0in/5.0out (Fig. 4d) are similar to those 
previously reported for POPC/SM/Chol mixtures containing pre-incorporated Sph26, the net 
surface charge of the vesicles at pH 7.4in/7.4out is much higher (Fig. 4a) and comparable to the 
one measured at pH 5.0in/5.0out (Fig. 4d). This difference could be due to a preferential 
accumulation of Sph in the outer membrane leaflet and/or slow transbilayer movement to the 
inner membrane leaflet, due to the different protocols used. This would be a valid explanation 
if the increase of ζ-potential in the presence of Sph was ca. half for pre-incorporation of what 
was measured for the external addition. However, the ζ-potential increase observed upon 
external addition is ≈ 3-fold larger for external addition than for pre-incorporation. This can 
only be explained if Sph is mostly charged when externally added, and not when pre-
incorporated. This can be rationalized considering that when the pre-incorporation protocol is 
used, Sph in the dry lipid - i.e. not ionized - is hydrated together with the other lipids and 
therefore it is never found in a bulk aqueous environment. In the less polar lipid environment 
the pKa can shift several units, because the charged form is not being stabilized by the strong 
ionic character of water37. 
 
Vesicle size 
The external addition of 10 mol% Sph to LMVs led to an increase in vesicle size, 
especially in mixtures containing higher lo content (Fig. 2b). The relatively high PDI (ap. 0.2, 
data not shown) and the scattering intensities (I/I0) showing a population of particles in the 1-
10 µm range (See supplementary Fig. S3) indicate that these vesicles are prone to fusion 
and/or aggregation similarly to the observed for LMVs with pre-incorporated Sph (Fig. 3c,d). A 
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similar behavior was observed after the external addition of Sph to POPC/SM/Chol vesicles 
prepared at pH 7.4in/7.4out  (Fig. 4b,c) but not for the vesicles prepared at pH 5.0in/5.0out (Fig. 
4e,f). At pH 5.0 the surface charge of the membranes is slightly positive, becoming more 
positive upon adding Sph. Therefore, adding Sph will increase repulsion between the 
liposomes. In case of external pH 7.4, whether the internal pH is 5.0 as in LMVs or 7.4, the 
initial incorporation of Sph will create areas of the membrane surface that are positively 
charged, whereas other areas of the membrane still retain the negative surface charge they 
had prior to Sph addition. This will favor electrostatic attraction between vesicles, and 
probably facilitate aggregation/fusion events38. These events will be limited, occurring only 
until the distribution of Sph is equilibrated and all the vesicles acquire a similar charge along 
their surface, and justify the appearance of a population of very large particles in both 
situations where external pH is 7.4.  
 
Figure 4 – Electrophoretic and dynamic light scattering characterization of POPC/SM/Chol vesicles 
with no pH gradient. (a,d) Surface charge and (b,c,e,f) size  characterization of POPC/SM/Chol vesicles 
displaying (upper panels) pH 7.4in/7.4out  (Fig. 1b.1,b.3) and (lower panels) pH 5.0in/5.0out (Fig. 1c.1,c.3). 
(a,b,d,e) The characterization was made before (black) and after the addition of 5 (white) and 10 (light 
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grey) mol% Sph to vesicles containing Xlo = 0 and  Xlo = 0.26. Panels (c,f) represent the normalized 
scattered light intensity as a function of particle size (nm). The measurements were made before (dot 
lines) and after the external addition of 5 (dash lines) and 10 (solid lines) mol% Sph to vesicles 
containing 0 (black lines) and 0.26 (light grey lines) Xlo phase. The values are the mean (± SD) of at least 
three independent experiments. *, p < 0.001 versus 0% Sph; **, p < 0.01 versus 0% Sph; ***p < 0.05 
versus 0% Sph. 
 
pH gradient and membrane permeability 
The external addition of 10 mol% Sph to pre-formed LMVs (Fig. 5a,b) changed 
membrane stability and the pH gradient, showing that Sph addition to the vesicles causes 
membrane permeabilization. This effect was more pronounced for vesicles containing higher 
lo phase fraction (Xlo = 0.83, Fig. 5b), suggesting that Sph-induced changes in membrane 
permeability might depend on the initial membrane lipid composition and biophysical 
properties. 
To further address this issue the well-established ANTS/DPX assay was used18,20. Ternary 
POPC/SM/Chol vesicles were loaded with the fluorescence emitter/quencher pair ANTS/DPX. 
The release of ANTS/DPX into the aqueous medium results in an increase in the fluorescence 
intensity of ANTS due to dissociation of the emitter/quencher complex. Therefore, changes in 
fluorescence intensity are a measure of membrane permeability. The addition of Sph to LMVs, 
i.e., pH 5.0in/7.4out, leads to an initial and rapid increase in membrane permeability (up to 2-3 
minutes), after which no further changes are observed (Fig. 5c,d). The extent of membrane 
permeabilization depends both on Sph concentration (Fig. 5c-f) and membrane lipid 
composition (Fig. 5e,f). Interestingly, and in agreement with the pH gradient stability assays 
(Fig. 5a,b), the effect of Sph is slightly more pronounced for membranes containing higher 
content of Chol and SM (Fig. 5f), i.e., in NPC1-like lysosomes, suggesting that accumulation of 
Sph and Chol in NPC1 lysosomes might lead to higher changes in lysosomal membrane 
permeability. Control experiments showed that membrane permeability did not change 
significantly upon addition of ethanol, confirming that increased membrane permeabilization 
was due to Sph (Fig. 5a-f). 
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Figure 5 – Characterization of POPC/SM/Chol LMVs (pH 5.0in/7.4out) upon dynamic interaction with 
Sph. (a,b) The pH gradient stability of LMVs (pH 5.0in/7.4out) composed by (a)  Xlo = 0.26 and (b) Xlo = 
0.83 was evaluated overtime through ratiometric measurements of pyranine excited at 450 and 405 
nm (450/405), after the external addition of 10 mol% Sph (Fig. 1a.3). After approximately 45 minutes, 
triton X-100 (0.1% (v/v)) was added to samples. The light grey lines correspond to LMVs after the 
addition of ethanol (control samples) and the black lines correspond to LMVs after the external 
addition of 10 mol% Sph (ap. 10 minutes after LMVs preparation). The vesicles contain 0.5 mM 
pyranine encapsulated. These experiments were repeated independently, at least three times and 
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these are median representative curves of those experiments. (c,d) Sph-induced membrane 
permeability was evaluated overtime upon adding 5 (white circles) and 10 (light grey circles) mol% of 
Sph, or ethanol (black circles) to LMVs containing (c) Xlo = 0.26 and (d) Xlo = 0.83. (e) and (f) show the 
extent of Sph-induced leakage (e) 2 and (f) 25 minutes after adding 5 and 10 mol% of Sph, or ethanol 
(control). The symbols are the same used in panels c and d. The values are the mean ± SD of at least 
three independent experiments. The lines act merely as guides to the eye.  
 
To address whether the effect of Sph was influenced by the pH environment of the 
vesicles, studies were also performed in vesicles displaying pH 7.4in/7.4out (Fig. 1b.3) and pH 
5.0in/5.0out (Fig. 1c.3). Fig. 6 shows that Sph-induced permeability depends on Sph 
concentration, membrane lipid composition of the vesicles and pH environment. At pH 7.4 the 
extent of Sph-induced membrane permeabilization is very low, particularly when 5 mol% Sph 
are added to the vesicles (Fig. 6a,b). The addition of 10 mol% Sph to the mixtures resulted in a 
higher leakage, being this effect more pronounced when the lo phase is predominant (Fig. 6b), 
i.e., higher levels of Chol and SM. The extent of leakage induced by Sph under this 
experimental conditions is comparable to that obtained by Contreras et al20, in SM/Chol 
(80/20) mixtures (pH 7.4) after the addition of the same molar proportions of Sph. Similar 
results were obtained at acidic pH (Fig. 6c,d), but the extent of leakage is higher at pH 5.0 
compared to pH 7.4. 
As observed for LMVs (Fig. 5c,d) the effect of Sph addition to vesicles with no gradient is 
immediate, but at pH 7.4 and pH 5.0 a slight increase in leakage is observed overtime (Fig. 
6a,c). However, a similar trend is observed when ethanol is added to the vesicles, suggesting 
that this small variation is only reflecting the overall permeability properties of the vesicles.   
  
Chapter III 
121 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6 – Sph-induced membrane permeability on POPC/SM/Chol vesicles with no pH gradient. (a,c) 
Sph-induced membrane permeability was evaluated upon adding 5 (white circles) and 10 (light grey 
circles) mol% of Sph, or ethanol (control, black circles) to POPC/SM/Chol vesicles displaying (upper 
panels) pH 7.4in/7.4out (Fig. 1b.3) and (lower panels) pH 5.0in/5.0out (Fig. 1c.3) containing Xlo = 0.26. (b,d) 
Show the extent of Sph-induced leakage 25 minutes after adding 5 (white circles) and 10 (light grey 
circles) mol% of Sph, or ethanol (control, black circles). The values are the mean ± SD of at least three 
independent experiments. The lines act merely as guides to the eye. 
 
Further comparison of the effects of Sph on membrane permeability under different pH 
conditions showed that the extent of leakage was in general lower for vesicles with pH 
7.4in/7.4out, and higher for vesicles mimicking the lysosomal compartment (pH 5.0in/7.4out) (Fig. 
7 and Supplementary Fig. S4). The extent of leakage induced by Sph at pH 5.0in/5.0out is 
intermediate between the two other pH conditions, although closer to the situation mimicking 
the lysosomal compartment. This suggests that Sph-induced membrane permeabilization is 
facilitated at acidic conditions. This is further supported by data showing that indeed the initial 
extent of leakage is higher at pH 5.0in/5.0out compared to pH 7.4in/7.4out or pH 5.0in/7.4out, in 
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which Sph first interacts with the membrane exposed to a neutral pH (Fig. 7c and 
Supplementary Fig. S4c). Indeed, data obtained at pH 7.4in/7.4out and pH 5.0in/7.4out are very 
similar (2 minutes after Sph addition; Fig. 7c), which reflects the similar neutral pH conditions 
sensed by Sph upon its addition to the vesicles prepared at 7.4in/7.4out and pH 5.0in/7.4out. 
After this initial slower destabilization, a larger increase in the extent of leakage is observed 
for the LMVs (Fig. 7d and Supplementary Fig. S4d), which is probably due to increased 
destabilization of the membranes that are exposed to the pH gradient. Therefore, there is a 
conjugation of different factors that all together contribute to the observed increase in 
membrane permeabilization upon adding Sph to the LMVs.   
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7 – Comparison of Sph-induced membrane permeability in LMVs and POPC/Chol/SM vesicles 
with no pH gradient. (a,b) Sph-induced membrane permeability was evaluated overtime, at pH 
5.0in/7.4out (white triangles) (Fig. 1a.3), pH 7.4in/7.4out (Fig. 1b.3) (light grey triangles) and pH 5.0 in/5.0out 
(Fig. 1c.3) (black triangles) after the addition of 10 mol% Sph to POPC/SM/Chol vesicles containing (a) 
Xlo = 0.26 and (b) Xlo = 0.83. (c,d) The extent of Sph-induced leakage was determined in POPC/SM/Chol 
vesicles containing increasing fractions of lo phase (c) 2 and (d) 25 minutes after Sph addition. The 
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values are the mean ± SD of at least three independent experiments. The lines act merely as guides to 
the eye. 
 
Sph-induced changes on membrane fluidity and lateral organization  
It has been previously suggested that Sph-induced membrane permeability could be due 
to Sph-pore formation31 or due to increased membrane packing defects as a consequence of 
lipid phase separation18,20. Therefore, to further characterize the biophysical impact of adding 
Sph to LMVs, the fluorescence anisotropy and lifetime of t-PnA was measured and compared 
with the effect of adding Sph to vesicles with no pH gradient (Fig. 8 and Supplementary Fig. 
S5). The studies were performed for mixtures where a high impact of Sph on membrane 
properties was observed previously26, i.e., mixtures containing lower lo phase fraction.  For the 
LMVs, the t-PnA fluorescence anisotropy was measured 30 minutes (Supplementary Fig. S6), 
24h (data not shown) and immediately (approximately 1 minute) after (Fig. 8a and 
Supplementary Fig. S6) Sph addition. No significant differences were observed between the 
different time points, suggesting that the effect of Sph on membrane properties is immediate, 
likely due to a fast interaction/partition to the membrane.  
Addition of Sph to the vesicles caused a Sph-concentration dependent increase in t-PnA 
fluorescence anisotropy (Fig. 8a-c), irrespective of the pH environment. However, the effect 
was more pronounced for higher Sph concentrations, at pH 5.0in/7.4out (Fig. 8a) and pH 
7.4in/7.4out (Fig. 8b), reflecting the higher tendency of Sph to increase membrane order at 
neutral pH26. A similar trend of variation was observed upon measuring t-PnA mean 
fluorescence lifetime (Supplementary Fig. 5a,b), further supporting these conclusions.   
To gain further information on the differences in membrane ordering of the mixtures, 
analysis of the long lifetime component of t-PnA was performed (Fig. 8d-f). Addition of Sph 
caused a significant increase in t-PnA long lifetime component, particularly at pH 5.0in/7.4out 
(Fig. 8d) and pH 7.4in/7.4out (Fig. 8e), in agreement with the observation that Sph-induced 
membrane ordering is facilitated at neutral pH.  
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Figure 8 – Sph-induced alterations in the biophysical properties of LMVs and POPC/SM/Chol vesicles 
with no pH gradient. (a-c) Steady-state fluorescence anisotropy and (d-f) long lifetime component of t-
PnA in ternary POPC/SM/Chol vesicles containing Xlo = 0 and Xlo = 0.26  before (black) and immediately 
after addition of  5 (white) and  10 (light grey) mol % of Sph. (left panels, a,d) pH 5.0in/7.4out (Fig. 1a.3), 
(middle panels, b,e) pH 7.4in/7.4out (Fig. 1b.3) and (right panels, c,f) pH 5.0in/5.0out (Fig. 1c.3). The values 
are the mean ± SD of at least three independent experiments. *, p < 0.001 versus 0% Sph; **, p < 0.01 
versus 0% Sph; ***p < 0.05 versus 0% Sph. 
 
5. Discussion 
5.1. LMVs: novel lysosome-mimicking systems 
To unravel the molecular mechanisms underlying complex cellular events it is often 
necessary to take advantage of more simple systems that can mimic certain cell features. 
Artificial membranes are a key example of synthetic systems widely used to address lipid-lipid 
and lipid-protein interactions, among others39-41. The composition of these membranes can be 
tuned so that specific interactions can be individually studied. The major goal of the present 
study was to develop a synthetic system with features that more closely resemble one of the 
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major organelles responsible for lipid synthesis and recycling – the lysosome. Such synthetic 
system constitutes an ideal tool to study how changes in lipid composition derived from both 
normal and impaired lysosomal lipid metabolism influence membrane structure and 
biophysical properties. Considering that Sph is a lipid mainly formed by degradation of 
ceramide in the lysosome, and implicated in human disease upon its accumulation in the 
lysosome16, we took advantage of the LMVs (pH 5.0in/7.4out) (Fig. 1a) to investigate Sph-
mediated changes in membrane properties. To this end, the lipid composition of the vesicles 
was tuned in order to establish a comparison between the effects of Sph in systems mimicking 
physiological- and NPC1-like conditions.  
The LMVs developed in the present study displayed a stable pH gradient across the 
bilayer, with internal acidic pH (pH 5.0) and external neutral pH (pH 7.4). The surface charge 
characteristics of the system reflect the neutral pH environment of the outer membrane. The 
LMVs were stable and not prone to aggregation as verified by vesicle size analysis. The order 
of the membranes showed differences relative to vesicles with identical lipid composition at 
only neutral (pH 7.4in/7.4out) (Fig. 1b) or acidic (pH 5.0in/5.0out) (Fig. 1c) pH, both in the absence 
or presence of Sph. This might be due to changes in the lipid-lipid and lipid-solvent 
interactions42,43. These observations further support that lipid organization, and consequently 
membrane fluidity, are highly influenced by the surrounding pH environment, and therefore 
suitable systems to address lipid interactions in a specific subcellular location should be 
developed to account for organelle-specific features. This is particularly relevant for Sph, 
where it is already known that this lipid presents different H-bonding states depending on the 
surrounding environment, shifting from intramolecular to intermolecular between pH 6.7 and 
9.929. In addition, it is likely that lipid organization both in the plane of the membrane and 
across membrane leaflets reflect membrane pH gradient, contributing to the differences in 
the overall packing of the lipids in the LMVs.  
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5.2. Application of LMVs to unravel the biophysical impact of abnormal Sph lysosomal 
accumulation 
Our data clearly indicates that the synthetic systems developed herein, with features 
closer to lysosomes, display distinct properties compared to standard vesicles with no pH 
gradient. Therefore, those models should be employed to elucidate specific molecular 
interactions that enable gaining further insight into the biophysical effects derived from Sph 
lysosomal accumulation under pathological conditions. Hence, we addressed both the 
dynamic behavior of Sph and its effects under thermodynamic equilibrium conditions, by 
comparing changes in the ζ-potential, and on the fluorescence properties of the probes. While 
the ζ-potential relates to the surface charge of the vesicles, and therefore is sensitive to the 
changes occurring in the outer leaflet of the vesicles, the fluorescent probes are incorporated 
and distributed within both bilayer leaflets, thus providing biophysical information over the 
entire bilayer.  
The data obtained in the present work pinpoint that the interaction of Sph with the 
membrane, as well as its effects on membrane order and permeability, strongly depend on the 
pH environment, inasmuch, as an initial faster permeabilization was observed at acidic pH (pH 
5.0in/5.0out), but the extent of vesicle permeabilization was higher in LMVs (pH 5.0in/7.4out).  
Moreover, the results suggest that an increased membrane order, as observed in vesicles 
presenting an external neutral pH (i.e., LMVs and pH 7.4in/7.4out vesicles), can be crucial for an 
initial protection against membrane destabilization/permeabilization promoted by addition of 
Sph. Interestingly, data indicate that after the initial minutes upon Sph addition, it seems to 
exist no direct correlation between Sph-induced changes on membrane order and Sph-
induced permeability. Indeed, addition of Sph to the vesicles caused an increase in the overall 
membrane order, being this effect more pronounced in LMVs and pH 7.4in/7.4out vesicles. 
However, Sph-induced membrane permeabilization was almost negligible in pH 7.4in/7.4out 
vesicles, in contrast to the LMVs that showed the highest extent of membrane 
permeabilization. Moreover, smaller changes in membrane order were detected in pH 
5.0in/5.0out vesicles, even though the extent of membrane permeabilization was still 
significant. Therefore, this suggests that the increase in membrane permeability might not be 
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solely due to structural defects that could be formed at the interface between different 
phases upon addition of Sph to the vesicles as suggested by other groups18,20. In addition, the 
hypothesis of permanent pore formation seems to be excluded, since after the initial vesicle 
destabilization promoted by Sph addition, the pH gradient of the vesicles remained practically 
unchanged. The extent of Sph-induced membrane permeability might be related not only with 
membrane order and pH environment, but also to the amount of Sph molecules able to 
incorporate into the membrane as well as with their distribution between the two membrane 
leaflets. Indeed, the amphiphilic nature of Sph determines its partition into the membrane.  
It is expected that several factors determine the equilibrium between Sph molecules in 
the aqueous medium and in the membrane. Sph might exist in water both as monomeric 
species and in the form of micelles, even though the CMC values of Sph were not yet 
ascertained (e.g., CMC values ranging from ca. 1 μM to 112 μM have been reported20,22,29,44. In 
addition, Sph partition into the membrane is likely to be affected by the phase properties of 
the membrane, the electrostatic forces, as well as the properties of the surrounding 
environment (pH, ion composition, etc). Due to the complexity of this equilibrium it is difficult 
to correctly determine the extent of Sph membrane partition. In this way, we rationalized our 
data providing only a qualitative description of the effects of adding Sph to the different 
vesicles. Thus, we only attempted to compare the effects of externally added Sph to the effect 
of the same amount of Sph pre-incorporated in vesicles with the same lipid composition. 
These two scenarios enable comparing the dynamic effects of Sph incorporation on a model of 
lysosomes, to a situation mimicking a lysosomal membrane enriched in Sph. The former would 
therefore represent the situation occurring in cells upon interaction of aqueous (free or 
aggregated) Sph with the lysosomal membrane, which clearly showed that this lipid has the 
ability to change membrane organization, permeability and surface charge. The latter case 
would provide the biophysical properties of the membrane with the maximum retention of 
Sph and with symmetrical distribution of the sphingoid base across the two bilayer leaflets.  
Our data shows that irrespective of the pH environment, Sph-induced permeability 
tends to increase with the extent of lo phase present in the vesicles, which seems to be in 
accordance with the observation made by Contreras et al20, that the presence of lo regions in 
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the membrane makes it a target for Sph-induced permeabilization. This suggests that Sph 
interaction with the membrane is facilitated upon increasing the lo phase fraction of the 
vesicles. This could be due to electrostatic forces created between the positively charged Sph 
and the more electronegative membranes enriched in Chol. Indeed, it has been shown that 
membranes with higher Chol content are more electronegative due to a lower ability of 
cations to interact with Chol hydroxyl (-OH) groups42. However, the ζ-potential remained 
constant in LMVs and vesicles with no pH gradient regardless of the Chol content, which may 
reflect the occurrence of different conformational changes or lipid-lipid interactions26,45,46. 
Nonetheless, the external addition of Sph to these vesicles resulted in a larger ζ-potential 
increase for vesicles with higher Chol content, which suggests a higher incorporation of Sph in 
the membrane when Chol content is higher. These observations suggest that Sph partition to 
the membrane is not solely driven by electrostatic forces but it also depends on the lipid 
composition and membrane biophysical properties.  
Indeed, POPC/SM/Chol vesicles have a more disordered membrane at acidic pH, which 
can favor a faster incorporation of Sph within the membrane, leading to the observed higher 
initial rate of membrane permeabilization. In contrast, the higher membrane order of the 
vesicles exposed to an outer neutral pH (LMVs and pH 7.4in/7.4out vesicles) might decrease the 
rate of Sph membrane incorporation, resulting in a lower initial membrane destabilization 
compared to acidic conditions. In vesicles with no pH gradient across the bilayer, the 
externally added positively charged Sph tends itself to create a gradient across the membrane, 
followed by flip-flop movement, until equilibrium is reached. Conversely, in the LMVs, the pH 
gradient present across the bilayer might decrease the driving force for Sph incorporation. Sph 
is positively charged and it will not readily move against the charge gradient, that is more 
positive (<pH) in the interior of the vesicles compared to the external environment (>pH).  
Thus, the asymmetry between the inner and the outer leaflets created upon the incorporation 
of Sph in the external monolayer contributes to transient membrane stress and instability (Fig. 
9). 
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Figure 9 – Schematic representation of the effects of external addition of Sph to POPC/SM/Chol 
vesicles, at different physiological pH conditions. Sph that might exist in water both as monomeric 
species and in the form of micelles has different patterns of incorporation in the membrane, 
depending on the pH environment. For pH 7.4in/7.4out and pH 5.0in/5.0out vesicles the inexistence of a 
pH gradient across the membrane, favors the creation of a gradient by the positively charged Sph 
molecules inserted in the outer leafleat, promoting their flip-flop movement to the inner leaflet, until 
the gradient is cancelled and the system reaches the equilibrium. In contrast, the pH gradient across 
the LMVs (pH 5.0in/7.4out) bilayer decreases the driving force for Sph incorporation. In this case, the 
distribution of positively charged Sph molecules in the external leaflet of LMVs might generate 
asymmetries and curvature stress at the membrane. Together with the fact that the inner leaflet of the 
LMVs is more disordered than the external leaflet, this could justify the increase in membrane 
permeability. The membrane of the pH 5.0in/5.0out vesicles is indeed more disordered compared with 
the membrane of pH 7.4in/7.4out vesicles. Thus, the higher fluidity of the former can favor a faster 
incorporation of Sph within the membrane and result in an increased rate of membrane 
permeabilization. The more ordered outer membranes exposed to pH 7.4, would on the contrary 
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contribute to a slower rate of Sph incorporation and prevent membrane destabilization, which is 
reflect by a lower membrane permeabilization. Thin vertical black arrows: low membrane 
permeability; thicker black arrows: increased membrane permeability. Curved vertical grey arrows: 
favorable Sph incorporation in the membrane bilayer through flip-flop movement; horizontal curved 
arrows: lower driving force for Sph incorporation in the membrane bilayer/higher initial distribution of 
Sph in the external leaflet. Drawn from left to right: (pH 7.4in/7.4out) vesicles displaying higher 
membrane order in both leaflets; (pH 5.0in/pH5.0out) displaying lower membrane order in both leaflets; 
and LMVs (pH 5.0in/pH7.4out) displaying higher membrane order in the external leaflet compared to the 
inner leaflet. 
 
Besides changes in membrane permeability, Sph incorporation in the membrane also 
caused alterations in membrane biophysical properties, leading to an increase in the overall 
order of the membrane, particularly in the packing of the ordered phase, irrespective of the 
pH environment. However, Sph was unable to drive gel-fluid phase separation, as previously 
observed for identical mixtures containing pre-incorporated Sph26. This might be due to an 
effective smaller number of Sph molecules incorporated in the membrane and therefore not 
enough to induce gel-fluid phase separation. In addition, Sph positive charges can hinder the 
formation of Sph domains due to the repulsive forces between Sph molecules.  According to 
our surface charge analysis, a significant amount of Sph is located in the outer membrane 
leaflet, which might create repulsive electrostatic forces that prevent close association 
between Sph molecules in a gel phase. Sph positive charge might also interfere with the 
orientation of the head groups and curvature of the neighboring lipids24, causing additional 
defects responsible for increased membrane permeability. As an example the interaction of 
positively charged Sph with negatively charged PLs induce membrane permeabilization 
through formation of non-lamellar structures18.  
6. Conclusions 
The results in the present study highlight the importance of the development of 
synthetic systems that closely resemble physiological environments. These systems are helpful 
for better understanding specific molecular interactions that occur in more complex scenarios, 
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namely at the cell level, and even cellular dynamics. Particularly in this study, where systems 
mimicking physiological and NPC1 like conditions were used to address the interaction of Sph 
with the membrane, it was possible to detect significant differences as compared to standard 
vesicles with no pH gradient. Indeed, stronger changes in membrane biophysical properties 
and permeability were observed upon addition of Sph to vesicles that closely resemble the 
lysosomal environment (pH 5.0in/7.4out). This effect was also more pronounced for the vesicles 
containing higher Chol and SM concentrations, thus mimicking NPC1-membranes. Overall, the 
results suggest that the abnormal accumulation of lipids in the acidic compartments of 
diseased cells, might significantly compromise the lysosomal membrane integrity, and 
consequently affect the normal function of the endolysosomal pathway, and support the 
further use of LMVs to understand physiological and pathological processes involving the 
lysosomal membrane. 
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9. Supporting information for: Development of lysosome-mimicking vesicles to study the 
effect of abnormal accumulation of sphingosine on membrane properties 
 
Supplementary table S1 – Lipid composition of the vesicles used in this study. Lipid mixtures with five 
different lipid compositions were prepared. From 1 to 5 the content of both SM and Chol were 
increased, while the levels of POPC were decreased. This change in membrane lipid composition was 
made to evaluate the effect of Sph on the properties of membranes containing low (physiological-like) 
or high (NPC1-like) levels of Chol and SLs. The lipid structures were drawn using Chemdraw software. 
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Supplementary table S2 – Partition coefficient between aqueous and lipidic phases, Kp, and 
fluorescence intensity maximum, Imax, of t-PnA at different pH conditions. 
 
 
Vesicles composition 
 
log Kp at pH 5.0 
Imax (a.u.) at 
pH 5.0 
 
log Kp at pH 7.4 
Imax (a.u.) at 
pH 7.4 
 
POPC 
 
4.74 ± 0.07 
 
482 ± 12 
 
4.30 ± 0.04 
 
509 ± 10 
POPC/SM/Chol (26% lo) 4.60 ± 0.09 804 ± 22 4.43 ± 0.06 1125 ± 23 
 
 
Figure S1 - pH-induced alterations in the biophysical properties of LMVs and POPC/SM/Chol vesicles 
with no pH gradient. The variation of t-PnA fluorescence anisotropy <r> in ternary POPC/SM/Chol 
mixtures at pH 5.0in/5.0out (black circles), pH 7.4in/7.4out (light grey circles) and pH 5.0in/7.4out (white 
circles) is represented as a function of lo fraction. The values are the mean ± SD of at least three 
independent experiments. 
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Figure S2 – Biophysical properties of LMVs (pH 5.0in /7.4out) in the absence and presence of pre-
incorporated Sph. Panels (a,b) show the variation in (a) steady-state fluorescence anisotropy and (b) 
mean fluorescence lifetime of t-PnA in ternary POPC/SM/Chol mixtures (black) and POPC/SM/Chol 
mixtures containing 5 (grey triangles) and 10 (black triangles) mol % of pre-incorporated Sph (Fig. 1a.2). 
Data are represented as a function of the lo phase fraction (Xlo): the higher the Xlo the higher the levels 
of Chol and SM of the mixtures (see methods for further details). The values are the mean ± SD of at 
least three independent experiments. The lines act merely as guides to the eye. 
 
 
 
 
 
 
 
 
Figure S3 - Dynamic light scattering characterization of POPC/SM/Chol LMVs upon dynamic 
interaction with Sph. Panels (a,c) represent the normalized scattered light intensity of  POPC/SM/Chol 
vesicles containing  (a) Xlo = 0.26  and (b) Xlo = 0.83 as a function of particle size (nm). The 
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measurements were made before (black lines) and after (light grey lines) size exclusion 
chromatography, and after the addition of 10 mol% Sph to the LMVs (dark grey lines). The values are 
the mean (± SD) of at least three independent experiments.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S4 –Sph-induced membrane permeability in LMVs and POPC/SM/Chol vesicles with no pH 
gradient. (a,b) Sph-induced membrane permeability was evaluated overtime after the addition of 5 
mol% of Sph to POPC/SM/Chol vesicles prepared at pH 5.0in/7.4out (white triangles), pH 7.4in/7.4out 
(grey triangles) and pH 5.0in/5.0out (black triangles). (a) Xlo = 0.26  and (b) Xlo = 0.83. (c,d) The extent of 
Sph-induced leakage was determined in POPC/SM/Chol vesicles containing increasing fractions of lo 
phase (c) 2 and (d) 25 minutes after Sph addition. The values are the mean ± SD of at least three 
independent experiments. 
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Figure S5 – Sph-induced alterations in the biophysical properties of LMVs and POPC/SM/Chol 
vesicles with no pH gradient. The variation in the mean fluorescence lifetime of t-PnA before (black) 
and after external addition of 5 (white) and 10 (light grey) mol% of Sph to POPC/SM/Chol vesicles is 
represented as a function of lo fraction. (a) pH 5.0in/7.4out, (b) pH 7.4in/7.4out and (c) pH 5.0in/5.0out. The 
values are the mean ± SD of at least three independent experiments. *, p < 0.001 versus 0% Sph; **, p 
< 0.01 versus 0% Sph; ***p < 0.05 versus 0% Sph. 
 
 
 
 
 
 
 
 
 
 
Figure S6 – Sph-induced alterations in the biophysical properties of LMVs. t-PnA fluorescence 
anisotropy was measured before (black), just after (white) and 30 minutes (grey) after the addition of 
(a) 5 and (b) 10 mol% Sph to LMVs containing Xlo = 0 and Xlo = 0.26. The values are the mean ± SD of at 
least three independent experiments.  
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CHAPTER IV – BIOPHYSICAL IMPACT OF LIPID ABNORMAL ACCUMLATION IN NPC1 CELL 
MODELS 
1. Abstract 
Niemann-Pick disease type C (NPC) is a complex and rare pathology, which is mainly 
associated to mutations in the NPC1 gene. This disease is phenotypically characterized by the 
abnormal accumulation of multiple lipid species in the cell acidic compartments. Due to the 
complexity of stored material, a clear molecular mechanism that explains NPC pathophysiology 
is still not established. Sphingosine (Sph) abnormal accumulation was suggested as the primary 
factor involved in the development of NPC disease, being followed by the accumulation of 
other lipid species (e.g. Cholesterol (Chol), Sphingomyelin (SM), Glycosphingolipids (GSLs)). 
With the aim to characterize the impact of the NPC phenotype in the biophysical properties of 
biological membranes, fluorescence spectroscopy studies were performed to evaluate the 
outcome of: null or down expression of NPC1 locus, the pharmacological induction of the NPC 
phenotype (U18666A treatment) and the addition of Sph to healthy cells. Experiments 
performed with Chinese Hamster Ovary (CHO) cell lines (CHO-K1 and CHO-M12) show that the 
abnormal accumulation of multiple lipid species in CHO NPC cells generally results in a decrease 
in membrane fluidity, irrespectively of the tested condition (locus, U18666A or Sph treatment). 
An inverse effect, i.e., an increase in membrane fluidity was observed in a mutant NPC 
neuroblastoma cell line down expressing the NPC locus, suggesting that changes in membrane 
order arising from lipid accumulation in NPC are complex and cell type dependent.  
 
2. Introduction 
NPC disease is a rare autosomal recessive disorder associated with mutations in the NPC1 
or NPC2 genes. The great majority (ap. 95%) of the cases are associated with pathogenic 
variants of NPC1 gene1. This disease is phenotypically characterized by the storage of multiple 
lipid species, such as Sph, Chol, SM and GSLs, in the late endosomes/lysosomes of cells2. Due to 
the complexity of storage material it has been challenging to find a mechanism that clearly 
explains the cell biology of NPC disease. Studies have proposed different theories to explain this 
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unique disease, each suggesting a different NPC metabolite as the key player in the 
development of the NPC associated pathophysiology3–5. In 2008 it was suggested that Sph 
abnormal accumulation was the first crucial event in NPC disease6. It was proposed that after 
Sph accumulation in the acidic compartments, a calcium homeostatic defect characterized by 
low calcium levels occurred in those organelles, being responsible for the secondary 
accumulation of other lipid species, such as Chol and sphingolipids (SLs)6. In addition, it was 
shown that Sph is able to induce the NPC phenotype when added to healthy cells in 
concentrations found in NPC cells, which was not observed for the other lipid species that also 
abnormally accumulate in NPC disease6. Moreover,  Sph was the first lipid to accumulate after 
the pharmacological induction of the NPC phenotype using the class II amphiphile U18666A 
drug that binds to NPC1 protein interfering with its cellular function6,7. 
The cellular levels of free Sph and other sphingoid bases are generally low (e.g. the blood 
is thought to have 0.1 to 1 μM of Sph and S1P)8 due to its rapid metabolization into more 
complex molecules. Deregulation of Sph levels occurs in NPC patient organs at different extents 
as observed for other lipid species2. Despite being a minor storage lipid in NPC brain and 
peripheral tissues in terms of mass, it still presents the greatest fold elevation compared to 
other lipid species that also accumulated in NPC disease2. For example, increase in the levels of 
Sph ranging from 4-fold to 12-fold are observed in the brain and liver, respectively2. In addition, 
Sph is an important bioactive lipid with impact in different cellular processes, such as cell 
proliferation9 and apoptosis10,11. The mechanisms behind its regulatory effect are still not clear. 
Although Sph is able to directly bind to cellular proteins12,13, there are some proteins that do 
not have a known Sph-binding site14,15 and evidence suggests that Sph might exert its 
regulatory function at the membrane level, through biophysical changes that can affect the 
membrane organization and consequently trigger different cellular responses16–19. Moreover, it 
is expectable that the impact of this lipid in the properties of the membranes will depend on its 
subcellular location, since its physico-chemical features, such as, protonation and H-bonding 
states, vary in different physiological pH environments20. In fact, it was shown that Sph has 
different abilities to change the biophysical properties of the membranes, depending on the pH 
of surrounding environment18: at neutral pH Sph tends to decrease membrane fluidity16,17,21–25, 
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while, in acidic conditions that mimic the lysosome environment, Sph has a lower ability to 
decrease membrane fluidity, likely due to repulsive forces generated by the positively charged 
Sph molecules18. Another aspect to consider is the membrane lipid composition, since it was 
shown that Sph ability to decrease membrane fluidity is also dependent on the SM and Chol 
content18,19, lipids that also accumulate in NPC disease. Considering that Sph has a strong 
influence in the biophysical properties of model membranes, it is tempting to hypothesize that 
the pathological accumulation of this lipid might have a strong impact in the properties of 
biological membranes. To test for this hypothesis, fluorescence spectroscopy studies were 
performed to evaluate different situations: cells with the NPC phenotype (null or down 
expressing the NPC1 locus), the pharmacological induction of the NPC phenotype (U18666A 
treatment) and the addition of Sph to healthy cells. Considering that NPC organs/tissues are 
differently affected2, CHO-K1 cells and SH-SY5Y neuroblastoma cell lines were analyzed, 
together with their mutant counterparts, null (CHO-M12 cells)26 or down-expressing (SH NPC 
cells)27 the NPC1 locus. The results show that the effect of lipid abnormal accumulation in the 
biophysical properties of biological membranes are complex and cell type dependent. Sph, in 
particular, revealed to have the ability to change the fluidity of biological membranes, in a 
concentration dependent manner, in accordance to what was observed in model membrane 
studies18,19. After Sph treatment, an almost immediate decrease in membrane fluidity is 
observed both in CHO-K1 and SH-SY5Y cell membranes, suggesting a direct effect of Sph rather 
than a downstream metabolite. For longer incubation periods the membranes become globally 
more fluid, which might be due to Sph internalization, Sph metabolization into other lipid 
species and/or the involvement of other lipid species that also accumulate in NPC. Despite this, 
the present study clearly shows that Sph itself has an impact in membrane organization that is 
likely to be related to its role in the pathophysiology of NPC disease.   
 
 
 
 
 
  
Chapter IV 
 
146 
 
3. Materials and Methods 
3.1. Materials  
D-erythro-sphingosine (Sph) was obtained from Avanti Polar Lipids, Inc. (Alabaster, AL, 
U.S.A.). U18666A was obtained from Sigma-Aldrich (St. Louis, MO, U.S.A.). DPH (1,6-diphenyl-
1,3,5-hexatriene), TMA-DPH (1-(4-(trimethylamino)phenyl)-6-phenylhexa-1,3,5-triene) and t-
PnA (trans-Parinaric Acid) were from Molecular Probes/Invitrogen (Eugene, OR, EUA). All the 
other reagents were of the highest purity available. 
The concentrations of Sph and of the probes were determined as previously described18. 
 
3.2. Methods  
3.2.1. Cell Culture 
In this work different cell lines were used: wild-type (WT) CHO-K1 and SH-SY5Y 
neuroblastoma cells and their mutant counterparts lacking (CHO-M12; a kind gift of Dr. Daniel 
Ory, Washington University, St. Louis, MO) or down expressing (SH-NPC; a kind gift of Dr. Elsa 
Rodrigues, Lisbon University, Lisbon, Portugal) the NPC1 locus.  All this cell lines were grown in 
DMEM Ham F-12 (Sigma-Aldrich, Dorset, UK). The Medium was supplemented with 10% fetal 
bovine serum (Sigma-Aldrich, Dorset, UK), heat inactivated at 60°C for 1 hour, 1% L-glutamine 
(100x) (Life Technologies, California, USA) and 1% pen-strep (VWR, Pennsylvania, USA). The 
cells were grown as monolayers at 37 °C with 5% CO2 in a humidified incubator. 
 
 3.2.2. Microscopy 
Coverslip preparation 
Glass coverslips were washed with nitric acid and kept in 100% ethanol before use. The 
cellular suspensions were counted and seeded onto 13 mm cover slips (VWR, PA, USA) in 24 
well plates (VWR, Pennsylvania, USA). Approximately 10,000 cells were used per coverslip. Cells 
were grown at 37 °C with 5% CO2 in a humidified incubator, till reach 70-80% confluence. 
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Cell fixation with paraformaldehyde 
Cells were washed once with 1 mL of DPBS (Dulbecco's Phosphate Buffered Saline) 
(Sigma-Aldrich, Dorset, UK) and incubated with 300 μL of 0.4% paraformaldehyde (PFA) (VWR, 
Pennsylvania, USA) for 10 minutes at room temperature. PFA was removed and the cells were 
incubated with 1 mL of DMEM Ham F-12 complete medium for 5 minutes and washed twice 
with 1 mL of DPBS (1x). The cells were left in 1 mL of DPBS (1x), at 4 °C until required for 
staining or mounting. 
 
Filipin staining 
To visualize cholesterol in cells, fluorescent filipin that binds specifically to unesterified 
cholesterol was used. The stock solution of filipin was prepared by adding 2 mg of filipin (Sigma-
Aldrich, Dorset, UK) to 100 μL of DMSO (Sigma-Aldrich, Dorset, UK). Filipin working solution was 
made by adding 7.5 μL of filipin stock solution to 1 mL of DMEM Ham F-12 complete medium. 
Cells were stained by adding 500 μL of filipin working solution into each well and left to 
incubate for 30 minutes at room temperature in the dark. After incubation, cells were washed 
once with complete medium and twice with DPBS (1x). The coverslips were mounted on glass 
slides using Mowiol and allowed to dry overnight. Excitation at 380 nm and emission at 405 nm 
were used for imaging. 
 
Lysenin staining 
Lysenin specifically binds to sphingomyelin and for that reason lysenin stain was 
performed to trace the intracellular sphingomyelin distribution. PFA fixed cells were incubated 
with  lysenin toxin (Peptides International, Kentucky, USA) at 1:1500 dilution of a 0.5 µg/mL 
stock solution in blocking solution (1% bovine serum albumin (Sigma-Aldrich, Dorset, UK) and 
0.1% saponin (Sigma-Aldrich, Dorset, UK) in DPBS)) and left overnight at 4 °C. After, lysenin 
toxin was removed by washing the cells three times for 5 minutes with DPBS (1x). Cells were 
incubated with lysenin primary antibody (raised in rabbit) (Peptides International, Kentucky, 
USA) at 1:1000 dilution in blocking solution for 1 hour at room temperature. Cells were then 
washed three times for 5 minutes with  DPBS (1x), and stained with the fluorescent secondary 
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antibody DyLightR 488 Anti-Rabbit (Vector, California, USA) at 1:500 dilution in blocking 
solution for 30 minutes at room temperature. After incubation, cells were washed three times 
for 5 minutes with DPBS (1x). Excitation at 493 nm and emission at 518 nm were used for 
imaging. 
 
Bis(monoacyl)glycerophosphate/lyso-bisphosphatidic acid (p-LBPA) 
LBPA is a lysosome specific lipid. Fixed cells were incubated with anti-LBPA primary 
antibody (Echelon Biosciences, Utah, USA) at 1:1000 dilution in blocking solution (1% bovine 
serum albumin and 0.1% saponin in DPBS) overnight at 4 °C. After incubation, cells were 
washed three times for 5 minutes with DPBS (1x) and stained with the secondary antibody 
(DyLightR 488 Anti-Mouse (Vector, California, USA)) at 1:200 dilution in blocking solution. After 
1 hour incubation at room temperature cells were washed three times for 5 minutes with  DPBS 
(1x). Excitation at 493 nm and emission at 518 nm were used for imaging. 
 
Cholera Toxin B staining 
To trace the intracellular glycosphingolipid (ganglioside GM1) distribution the cholera 
toxin B stain was performed. Alexa Fluor 488 Cholera toxin subunit B (Invitrogen, Paisley, UK) 
protein was solubilized in DMEM Ham F-12 complete medium to make a working solution of 1 
μg/mL. PFA fixed cells were incubated with Alexa Fluor 488 Cholera toxin subunit B working 
solution at 4 °C overnight and protected from light. When the toxin was removed, cells were 
washed three times for 5 minutes with DPBS (1x). Excitation at 493 nm and emission at 518 nm 
were used for imaging.  
 
Nucleus staining 
The counterstain of cell nucleus was performed with Hoechst (Invitrogen, Paisley, UK), a 
fluorescent DNA stain, solubilized in DPBS (1x) at 1:5000 dilution. The Hoechst solution was 
added to each well and left to incubate for 10-20 minutes at room temperature. After 
incubation, cells were washed three times with DPBS (1x). Excitation at 380 nm and emission at 
405 nm were used for imaging. 
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Coverslip mounting 
Stained coverslips were mounted on glass microscope slides (Fisher, Loughborough, UK) 
using 12 μL of Mowiol mounting solution (Calbiochem, Nottingham, UK) and left overnight to 
dry. 
 
Cell visualization 
Cells were visualized using Zeiss Colibri LED fluorescence microscope (Carl Zeiss, 
Oberkochen, Germany) and AxioVission 4.7 software (Carl Zeiss, Oberkochen, Germany) or with 
a Leica TCS SP5 (Leica Mycrosystems CMS GmbH, Mannheim, Germany) inverted microscope 
(DMI6000). 
 
3.2.3. Cell treatments 
U18666A drug28 was used to induce an NPC1 phenotype in the healthy WT cells. A stock 
solution of U18666A (5 mg/mL) was prepared using sterile DMSO, aliquoted and kept frozen at 
-20 °C. For the microscopy studies, cells (ap. 10 000) were transferred onto a glass coverslip and 
for the fluorescence spectroscopy studies, cells (ap. 500 000) were grown in 90 mm petri dishes 
(VWR, Pennsylvania, USA).  To maintain identical concentration of drug per cell number, cells 
were treated with a final concentration of 2μg/mL and 10μg/mL (respectively) of U18666A in 
DMEM Ham F-12 complete medium and grown at 37°C, during 24 hours.   
To evaluate the effects of external addition of Sph, cells were grown in 90 mm petri 
dishes. Sph stock solutions were prepared in ethanol and kept at -20 °C. The cells were treated 
with a final concentration of 1, 2 or 10 µM Sph for different incubation periods: 1, 10, 20, 30, 
240 (4h) or 1440 (24h) minutes. For the shorter incubation periods the Sph addition was 
performed directly in the fluorescence cuvettes containing approximately 1x106 cells/mL and 
for the longer incubation periods (4 and 24h), Sph was directly added to the petri dish 
(containing also approximately 1x106cells) and the cells were harvested only at the end of the 
incubation period, to perform the fluorescence measurements.  
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Control experiments were performed, in which ethanol or DMSO were added to the cells. 
The volume of ethanol and DMSO was  always kept below 1% (v/v) in order to avoid possible 
cytotoxic effects29.  
 
3.2.4. Fluorescence measurements 
After being suspended and counted, cells were centrifuged and re-suspended in PBS with 
calcium and magnesium (Life Technologies, California, USA), to obtain a final concentration of 
1x106cells/mL. The cell suspension was incubated for 5 minutes at 37 °C with the different 
probes (t-PnA, DPH or TMA-DPH, all at a final concentration of 2 µM). The fluorescence  
measurements were carried out  in a Spex Fluorolog 3-22/Tau 3 spectrofluorometer equipped 
with double grating monochromators in both excitation and emission light paths and with a 
thermostated sample holder with magnetic stirring from Horiba Jobin Yvon. The measurements 
were performed in 1 x 0.4 cm quartz cuvettes at 37 °C under continuous stirring. For the steady-
state experiments, the excitation and emission wavelengths were 360 and 430 nm for DPH and 
TMA-DPH, and 320 and 404 nm for t-PnA. The steady-state anisotropy (r) was calculated 
according to Equation 130: 
                    
 
 
in which G is the instrumental correction factor. Subscripts V and H represent the vertical and 
horizontal orientations of the polarizers, and the order of the subscripts corresponds to the 
excitation and emission. An adequate blank (cell suspension without probe) was subtracted 
from each intensity reading. 
The fluorescence intensity decay measurements were obtained by the single photon 
counting technique30. A NanoLED source, model N-320 was used for t-PnA excitation, and the 
emission was collected at 404 nm. For DPH and TMA-DPH excitation, a nanoLED N-370 plus and 
a UGI-370 band pass filter were used, and the emission wavelength was set to 420 nm. To 
analyze the experimental decays and obtain the fitting curves, the TRFA software (Scientific 
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Software Technologies Center, Minsk, Belarus) was used. Ludox® was used as the scatterer to 
obtain the instrumental response function. Fluorescence decays were described by a sum of 
exponentials, where αi is the normalized pre-exponential, and τi is the lifetime of the decay 
component i. The mean fluorescence lifetime <τ> is given by: 
 
 
 
An adequate blank was prepared and measured under the exact same conditions of the 
samples and subtracted from each intensity reading. 
 
3.2.4. Statistical analysis 
The statistical analysis was performed using Student’s t-test. Mean values were 
considered significantly different for p values below 0.05. 
 
4. Results  
The impact of lipid abnormal accumulation in the biophysical properties of living NPC1 
cell models was evaluated.  
 
4.1. Effect of the NPC1 locus deletion  
CHO-M12 is a CHO-K1 mutant cell line with a deletion of the NPC1 locus26. As previously 
referred, the NPC phenotype is associated with the accumulation of different lipid species 
(Chol, SM, GSLs, Sph) in the LE/lysosomes of cells, resulting from mutations in the NPC1 or 
NPC2 genes1,6. CHO-M12 cells were already shown to have a Chol trafficking defect through 
filipin staining26, which is considered to be the gold standard method to establish the diagnosis 
in NPC patients31. In the present work, in addition to filipin staining, lysenin, cholera toxin and 
anti-LBPA stains were also performed, to trace the CHO-K1 and CHO-M12 intracellular levels of 
unesterified Chol, SM, the ganglioside GM1 and LBPA, respectively. Figure 1 shows that, as 
previously observed26, CHO-M12 cells present a filipin-positive stain when compared to the 
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control CHO-K1 cells. In addition, this null NPC1 cell line was also characterized by a rise in the 
cellular levels of the other lipids in study, which can be observed by an increased punctate 
staining, suggesting an accumulation of these lipid species in the endosomal/lysosomal vesicles 
of CHO-M12 cells. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1 – Phenotypic characterization of CHO-K1 and CHO-M12 in terms of lipid content. Chol was 
stained with filipin, GSLs (ganglioside GM1) were stained with cholera toxin subunit B and SM was 
stained with lysenin. LBPA, a lipid that is present in high concentrations in the internal membrane 
network of endosomes and lysosomes, was also stained (anti-LBPA staining). The nucleus was contra 
stained with Hoechst solution (blue) after lysenin, cholera toxin and anti-LBPA stain. Scale bars, 10 µm. 
 
To understand the consequences of this abnormal lipid accumulation in the biophysical 
properties of living cell membranes, fluorescence spectroscopy studies were performed, taking 
advantage of the photophysical properties of two fluorescent probes: t-PnA and DPH. t-PnA 
displays an equal partition among ld and lo phases similarly to DPH32 but has strong partitioning 
and higher quantum yield in the presence of gel domains33,34. For this reason, t-PnA is generally 
used to detect ordered phases in the membrane, such as, a gel phase characterized by a very 
long fluorescence lifetime component32,35 and lo phases36, while DPH, provides more general 
information of the overall fluidity of the membrane. Due to the rapid internalization of both 
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probes37,38, this methodology will report alterations undergone both in the PM and internal 
membranes. It should be noted that the experimentally determined fluorescence parameters 
(anisotropy and lifetime) are weighted averages that will depend on the fraction of each phase 
and the partition coefficient of the probes toward that phases in the different and 
heterogeneous membrane environments.  
Figure 2 shows that t-PnA (Fig. 2A) and DPH (Fig. 2D) fluorescence anisotropy is 
significantly higher in mutant CHO cells, suggesting an overall decrease in membrane fluidity 
compared to control CHO-K1 cells. The same tendency was observed upon measuring the mean 
fluorescence lifetime (Figs. 2B,E) and the long lifetime component (Figs. 2C,F) of the probes, 
although not in the same extent as observed for the anisotropy measurements. Overall the 
results indicate an alteration in the fluidity of the membranes of mutant CHO cells, which is 
compatible with an ordering effect caused by the accumulation of Sph18,19 and other lipid 
species, such as Chol and SM39, in NPC disease. 
 
 
Figure 2 – Characterization of the biophysical properties of living CHO-K1 and CHO-M12 cells.  (A,D) 
Fluorescence anisotropy <r>, (B,E) Mean fluorescence lifetime <τ> and (C,F) Long lifetime component of 
(A-C) t-PnA and (D-F) DPH. Values are means ± SD of three independent experiments.*p < 0.01 versus 
CHO-K1 cells. 
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4.2. Effect of U18666A treatment  
The NPC phenotype can also be pharmacologically induced with the class II amphiphile 
U18666A (referred in this study as U-drug)6, a cationic steroid, containing a diethylaminoethyl 
chain attached to the 3-hydroxyl group. Studies have shown that U-drug can directly bind to the 
sterol-sensing domain of NPC1 protein, blocking the movement of Chol out of the lysosomes7, 
which can affect many pathophysiological events40. In addition, it was demonstrated that Sph is 
the first lipid to be elevated following inactivation of NPC1 in healthy RAW cells6. The elevation 
of Sph concentration (ap. 0.75 µM in U18666A-treated RAW cells) occured few minutes (ap. 10 
minutes) after U-drug treatment and remains elevated for 24h. The secondary accumulation of 
Chol, SM and GSLs occured 4-8h later6. 
As expected, the phenotypic characterization of CHO-K1 cells after U-drug treatment 
revealed an abnormal accumulation of multiple lipid species, which was represented by an 
increased punctate staining (Fig. 3), similarly to what was observed for the mutant NPC CHO 
cells (CHO-M12). 
 
 
 
 
 
 
 
 
 
Figure 3 – Phenotypic characterization of CHO-K1 cells in terms of lipid content before and after U-
drug treatment for 24h. Chol was stained with filipin, GSLs (ganglioside GM1) were stained with cholera 
toxin subunit B and SM was stained with lysenin. LBPA, a lipid that is present in high concentrations in 
the internal membrane network of endosomes and lysosomes, was also stained (anti-LBPA staining). The 
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nucleus was contra stained with Hoechst solution (blue) after lysenin, cholera toxin and anti-LBPA stain. 
Scale bars, 10 µm. 
 
The biophysical impact of the U-drug treatment in the membranes of CHO-K1 cells was 
also evaluated. The results were very similar to the ones obtained for the mutant NPC cells 
(CHO-M12), where it was observed a decrease in membrane fluidity. This effect was 
represented by an increase in the fluorescence anisotropy and mean fluorescence lifetime of t-
PnA (Figs. 4A,B) and DPH (Figs. 4D,E). A slight increase in the long lifetime component was also 
observed (Fig. 4C,F).  
 
 
 
 
 
 
Figure 4 – Characterization of the biophysical properties of living CHO-K1 cells before and after U-drug 
treatment for 24h.  (A,D) Fluorescence anisotropy <r>, (B,E) Mean fluorescence lifetime <τ> and (C,F) 
Long lifetime component of (A-C) t-PnA and (D-F) DPH. Values are means ± SD of three independent 
experiments. *p < 0.01 versus CHO-K1 cells; **p < 0.05 versus CHO-K1 cells. 
 
4.3. Effect of Sph external addition 
When added at the concentration found in NPC cells, Sph seems to be the only lipid from 
all the NPC1 storage lipids that induces an NPC phenotype in normal cells6. To evaluate if the 
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exogenous addition of Sph has a similar effect in the biophysical properties of CHO-K1 
membranes compared with the deleterious mutation of the NPC1 locus and the altered NPC1 
function through the U-drug treatment, three different Sph concentrations were tested: 1 and 2 
µM, concentrations that are able to induce the NPC phenotype in healthy cells6 and 10 µM that 
seems to have a rapid detergent effect in RAW macrophages6 but was recently found to be 
responsible for the formation of multiple dilated intracellular vesicles in different cell lines, with 
an important impact in endocytic membrane trafficking41. The experiments were performed for 
short incubation periods (ap. 1, 10, 20 and 30 minutes), an intermediate period of 4h (for the 
lower Sph concentrations – 1 and 2 µM) and also for a period of 24h incubation with Sph. 
Figure 5 shows that Sph changes the biophysical properties of CHO-K1 cell membranes 
through a decrease in membrane fluidity, similarly to the observed for the mutant CHO cell line 
(CHO-M12) that lacks the NPC1 locus (Fig. 2) and the cells treated with the U-drug (Fig. 4). 
Furthermore Sph-induced alterations in membrane fluidity are time and concentration 
dependent (Fig. 5): while 1 µM Sph did not cause significant variations in the anisotropy of t-
PnA or DPH compared to control cells, higher Sph concentrations (2 and 10 µM) induced an 
immediate decrease in the overall membrane fluidity (ap. 1 min. after Sph addition). This effect 
was reflected by a significant increase in the fluorescence anisotropy of t-PnA (Fig. 5A) and a 
slighter increase in the fluorescence anisotropy of DPH (Fig. 5B), which reflect a lower impact in 
the global properties of the membranes. This could be indicative of the involvement of Sph in 
the formation of specialized ordered lipid domains in the PM where the levels of Chol and SM 
are generally high42, in agreement with data obtained in model membranes in which the Sph 
interplay with Chol and SM was studied18. The significant increase of the fluorescence 
anisotropy of t-PnA, close to the values observed for ceramide gel phases33 in the first minute 
after Sph addition, was not accompanied by a strong increase in the long lifetime component of 
the probe (Fig. 5C), which is considered as a “fingerprint” for the gel phase. These results 
suggest that such phase is not occurring in the membranes of CHO-K1 cells and that Sph is 
probably contributing to an increase in the lo phase fraction without significant impact in the 
packing and order of the acyl chains.  
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Figure 5 – Effect of Sph in the biophysical properties of CHO-K1 cells.  Steady-state fluorescence 
anisotropy of (A) t-PnA and (B) DPH after ap. 1, 10, 20, 30, 240 (4h) and 1440 (24h) minutes of 1 (red 
circles), 2 (blue triangles) and 10 (green triangles) µM external addition of Sph. Control cells without Sph 
addition are represented by black squares. Mean fluorescence lifetime (black diamonds) and long 
lifetime component (black circles) of (C) t-PnA and (D) DPH were obtained after approximately 5 minutes 
incubation with Sph at 37 °C. Values are means ± SD of at least three independent experiments.  The 
lines act merely as guides to the eye. *p < 0.01 versus control CHO-K1 cells; **p < 0.05 versus control 
CHO-K1 cells. 
 
The membrane ordering effect was also observed, in a slightly lower extent, for longer 
incubation periods (4 and 24h) (Figs. 5A,5B), where the accumulation of other lipid species is 
also expected6. Figure 6 shows that irrespectively of the tested condition, i.e., lacking of NPC1 
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locus (CHO-M12), U-drug and Sph treatment, the biophysical impact in the membranes of CHO-
K1 cells is similar and reflected by a decrease in membrane fluidity, especially with regard to 
the parameters obtained with the probe t-PnA. Sph did not have a significant effect on the DPH 
anisotropy (Fig. 6D) and lifetime (Fig. 6 E,F), further suggesting that the effects sensed by t-PnA 
are located into specific membrane domains. 
 
Figure 6 – Comparison between the effect of NPC1 locus deletion, U-drug treatment and Sph external 
addition on the biophysical properties of CHO-K1 cells. (A,D) Fluorescence anisotropy <r>, (B,E) mean 
fluorescence lifetime <τ > and (C,F) long lifetime component of (A,B,C) t-PnA and (D,E,F) DPH, 
respectively. The values are the mean ± SD of at least three independent experiments. Control 
experiments showed that membrane biophysical properties did not change significantly upon addition 
of ethanol (probe solvent; <r> values of 0.247±0.011 for t-PnA and 0.174±0.006 for DPH) or DMSO (U-
drug solvent; <r> values of 0.255±0.007 for t-PnA and 0.174±0.010 for DPH), confirming that the 
observed changes in the biophysical properties of CHO-K1 cells membranes were due to Sph and the U-
drug, respectively. *p < 0.01 versus CHO-K1 cells; **p < 0.05 versus CHO-K1 cells. 
 
Interestingly, and contrary to what was observed for RAW macrophages treated with 2 
µM Sph for 24 h6, CHO-K1 cells treated with 2 µM Sph during the same incubation period, did 
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not result in increased Chol filipin staining (Figure S1). Nevertheless, this concentration revealed 
to have an effect in the membrane biophysical properties of CHO-K1 cells 24h after incubation, 
which suggests that the observed biophysical changes, can in fact be related to a Sph-induced 
effect. Sph metabolism and the involvement of other lipid species cannot, however, be ruled 
out.  
 
4.4. The cell type effect 
Considering the different patterns of lipid accumulation in the visceral organs and in the 
brain in NPC disease2,43, a human neuronal cell model of NPC generated from a SH-SY5Y 
neuroblastoma cell line and down expressing the NPC1 locus27 was also studied. The 
fluorescence anisotropy and lifetime of t-PnA, DPH and TMA-DPH were measured and the 
results are presented in Figure 7.   
 
Figure 7 – Biophysical characterization of WT and NPC mutant SH-SY5Y neuroblastoma cells. (A,D) t-
PnA; (B,E) DPH  and  (C,F) TMA-DPH fluorescence anisotropy <r> (A,B,C) and fluorescence lifetime (D,E,F) 
measured in WT and NPC mutant SH-SY5Y neuroblastoma cells, at 37 °C. In panels D, E and F the light 
grey bars represent the mean fluorescence lifetime, while the dark grey bars correspond to the long 
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lifetime component. Values are means ± SD of three independent experiments. *p < 0.01 versus SH WT 
cells. 
 
Figure 7 shows that t-PnA (Fig. 7A) and DPH (Fig. 7B) fluorescence anisotropy are lower in 
mutant neuroblastoma cells, suggesting an increase in the overall membrane fluidity compared 
to control WT SH-SY5Y neuroblastoma cells. The lifetime of these probes followed a similar 
behavior, but no significant changes occurred between mutant and control cells. These results 
are opposite to those obtained in CHO cells, where decreased fluidity was observed in mutant 
cells (Fig. 2). To further characterize these cells, the DPH trimethylammonium derivative (TMA-
DPH) was used. This probe has a more favorable electrostatic interaction with electronegative 
lipids and a slightly shallower position in the membrane compared to the hydrophobic DPH44 
and a lower rate of internalization45, thus enabling characterizing the properties of the PM. 
Similarly to t-PnA and DPH, TMA-DPH fluorescence anisotropy is lower in mutant SH cells, 
compared to the WT cells (Fig. 7C), further suggesting a slight increase in membrane fluidity in 
mutant cells. Regarding TMA-DPH lifetime, no significant differences were observed between 
mutant and control cells. These results suggest that changes in membrane fluidity arising from 
lipid accumulation in NPC are complex and cell type dependent. This is likely to be due to 
differences in lipid composition of these cell lines, since the WT neuroblastoma cell line 
revealed to have highly ordered domains in the membranes, represented by high anisotropy 
values of t-PnA (0.272±0.014) and TMA-DPH (0.287±0.026)46, compared to CHO-K1 cells that 
present a higher membrane fluidity (t-PnA <r> 0.243±0.010). 
The effect of Sph external addition (2 µM, 1 minute and 24h incubation) and U-drug 
treatment (24 h) in the biophysical properties of WT neuroblastoma cells was also evaluated, 
taking advantage of the photophysical properties of t-PnA. Figure 8 shows that both U-drug and 
Sph treatment resulted in a decrease in membrane fluidity in WT neuroblastoma cells, as 
observed for CHO-K1 cells. Moreover, the effect of 2 µM Sph was also immediate and reflected 
by a significant increase in the fluorescence anisotropy of t-PnA (Fig. 9A), but not by a strong 
increase in the long lifetime component of t-PnA (Fig. 8B), as previously observed for CHO-K1 
cells. This data further suggests that Sph might contribute to an increased fraction of lo phase in 
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biological membranes, rather than the formation of a highly ordered and compact gel phases.  
After 24 h treatment with Sph an increase in membrane fluidity was observed, similarly to what 
was registered for the NPC neuroblastoma cell line (t-PnA anisotropy values are very similar, 
0.262±0.01 for SH NPC (Fig. 7A) and 0.258±0.01 for cells treated with Sph during 24 h (Fig. 8A)), 
suggesting a change in the lipid profile, probably related to metabolization of Sph and  
secondary accumulation of other lipid species, as observed for RAW cells after Sph treatment6.  
 
 
Figure 8 - Comparison between the effect of NPC1 down regulation, U-drug treatment and Sph 
external addition on the biophysical properties of SH-SY5Y cells (SH WT). (A) Fluorescence anisotropy 
<r> and (B) long lifetime component of t-PnA. The values are the mean ± SD of at least three 
independent experiments. *p < 0.01 versus SH WT; **p < 0.05 versus SH WT. 
 
5. Discussion 
NPC disease is a complex LSD genetically associated with mutations in the NPC1 or NPC2 
genes and phenotypically characterized by the abnormal accumulation of different lipid species, 
such as Chol, SM, multiple GSLs and Sph6. Even though a vast number of studies have been 
made to understand the cellular role of each accumulated lipid in the development of this 
disease (reviewed in Lloyd-Evans and Platt (2010)2) little attention has been given to the impact 
of an increased content of these lipids in the biophysical properties of biological membranes. In 
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the present study, the biophysical properties of biological membranes were evaluated in 
different NPC1 cell models: i) cells that are null or down expressing the NPC1 locus, ii) cells that 
were treated with U18666A drug to pharmacologically induce the NPC phenotype and iii) cells 
to which different concentrations of Sph were added. In CHO-K1 cells, it was observed that 
regardless the tested condition, a general decrease in membrane fluidity occurred when 
compared to the control WT cells. This effect was also observed in human NPC fibroblasts and 
mouse SPM-3T3 cells, represented by an increase of approximately 0.03 in the fluorescence 
anisotropy of DPH47, that was similar to the one observed in the present study for the same 
probe (DPH <r>, CHO-K1: 0.18±0.01; CHO-M12: 0.21±0.01). In other lysosomal storage 
disorders, such as Gaucher disease a similar behavior was observed but to a higher extent. 
Gaucher mutant fibroblasts, enriched in GlcCer, seems to have regions of the membrane 
displaying properties of a gel phase48, a behavior that was observed for other SLs, particularly 
ceramides, in living cells46. In the present study, the increase in membrane order was not 
accompanied by a strong increase in the long lifetime component of the fluorescence intensity 
decay of t-PnA (Fig. 2C) suggesting that such phase is not occurring in the membranes of CHO 
mutant cells.  In addition, the data obtained with NPC mutant neuroblastoma cells revealed 
that the membrane biophysical changes arising from lipid abnormal accumulation in NPC cells 
are highly complex, and seem to depend on the specific membrane lipid composition prior to 
lipid accumulation, which is cell type and aging49 dependent. The present results show that the 
NPC mutant neuroblastoma cell line have an increased membrane fluidity when compared to 
WT neuroblastoma cells and the inverse effect was observed in the NPC mutant CHO cells 
(CHO-M12). In fact, the cells tested in the present study have different origins and lipid 
patterns, particularly regarding the SLs levels and profile50–52. Neuronal cells are highly enriched 
in SLs53. In particular, gangliosides are usually abundant in the external leaflet of the PM of 
neuronal cells50. Since the presence of SLs, including gangliosides, in the membranes have been 
related to the formation and stabilization of specific membrane lipid domains with reduced 
fluidity54–56, this could justify the presence of highly ordered domains in the membranes of the 
WT neuroblastoma cell line, compared to CHO-K1 cells. Another aspect to consider is that the 
mutant neuroblastoma cells (down expressing the NPC1 locus) revealed to have a 1.2 fold 
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increase in the ganglioside GM2 and a 2 fold increase in Chol content27. This increase in Chol 
could contribute for the destabilization of the highly ordered membranes, through a 
“fluidifying” effect of Chol57,58, leading to more fluid membranes in the mutant cell line when 
compared to control neuroblastoma cells. 
In this study it was also observed that, independently of the cell line, both the U-drug and 
Sph treatment resulted in changes in the biophysical properties of biological membranes, 
generally by decreasing membrane fluidity. The treatment of healthy cells with U-drug has been 
associated with abnormal accumulation of Chol59–61 but it also interferes with the levels of 
other lipid species, as observed by Lloyd-Evans et al.6 and in the present study.  This cationic 
steroid, was already shown to have a condensing and ordering effect on membrane lipids in 
model membranes62, however, the abnormal accumulation of different lipid species after the 
treatment of healthy cells with this drug point to the possible involvement of those lipids in the 
observed effects. In fact, the changes in membrane fluidity and the differences observed 
among locus deletion, U-drug and Sph treatment might be related with the association of lipid 
molecules prone to form specialized ordered domains, such as SM and Chol63, GSLs64,65 or 
ceramides33,66,67. Studies in model membranes have demonstrated that all the lipid species 
accumulated in NPC disease have the ability to change the membrane fluidity. For instance, 
Chol is associated to an ordering effect in fluid phases58, contributing in association with 
saturated, high-melting phospho- and SLs, such as SM, to the formation of specialized lipid 
domains, known as lipid rafts63. In contrast, and as previously referred, Chol might also 
contribute to the destabilization of highly ordered membranes57,58. Moreover, our previous 
studies regarding the impact of Sph in the biophysical properties of model membranes18,19, 
show that similarly to other SLs, such as GlcCer48 and ceramide35, an increased content of Sph 
results in a membrane ordering effect, either due to the formation of a Sph-enriched gel phase 
or stabilization of the lo phase, depending on the lipid composition of the artificial membranes.  
In the present study, it was possible to assess the effect of Sph in a more complex 
environment, i.e., in the membranes of living cells. The results showed that Sph induces a 
concentration and time dependent ordering effect in the membranes of CHO-K1 cells. These 
results are in accordance with model membrane data that, as previously reffered, predict an 
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increase in the packing  of membranes upon increasing Sph levels18,19. Nonetheless, it should be 
considered that Sph molecules are rapidly metabolized into more complex lipids68,69, and  
therefore cells might  be able to  partially compensate for the rapid increase in Sph levels upon 
its addition to cells, particularly when lower concentrations of Sph were used. This might justify 
why changes in fluorescence anisotropy were not observed for the lowest concentration of Sph 
tested. In addition, significant changes in the measured fluorescence parameters are only 
expected if a substantial fraction of the Sph molecules become involved in the formation of 
ordered phases, since the probes display an equal partition between ordered and disordered 
phases. It should be stressed that higher Sph concentrations induced an immediate decrease in 
membrane fluidity of CHO-K1 cells (2 and 10 µM Sph) and WT neuroblastoma cells (2 µM Sph), 
thus suggesting its involvement in the formation of ordered specialized membrane domains at 
the PM level. For longer incubation periods after Sph addition, a lower decrease in the fluidity 
of CHO-K1 cell membranes, and an increase in the fluidity of neuroblastoma cells, consistent to 
what was observed for NPC neuroblastoma cells, were perceived. This might be related with 
Sph metabolization, the accumulation of other lipid species or even the partition of Sph to 
internal membranes. As observed in model membranes, differences in membrane lipid 
composition and the protonation state of Sph in the acidic environment of the lysosomes can 
account for different Sph-induced biophysical changes18,19. In fact, if we consider that Sph 
abnormal accumulation is a first event in the development of NPC disease, followed by the 
accumulation of other lipid species (4-8h later)6, and that a rearrangement of the cell 
membranes occurs, with changes in membrane lipid composition during different steps of the 
cell cycle70, this time/concentration dependent effect would be expected.  
Although the involvement of other lipid species that also accumulate in NPC cannot be 
ruled out, particularly of Chol, this study clearly shows that Sph has an important role in 
changing the biophysical properties of biological membranes which certainly would influence 
membrane associated cellular processes, such as lipid and protein trafficking, sorting and 
recycling. For this reason, further investigation on the biophysical changes resulting from the 
abnormal Sph accumulation would be of great importance for a better understanding of the 
molecular mechanisms underlying NPC disease.  
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6. Concluding remarks 
The present study shows that NPC cells present altered biophysical properties that are 
complex and cell type dependent. Sph, in particular, seems to be very important in inducing 
these membrane biophysical changes, although other lipid species might also be involved. This 
study gives support to the hypothesis that Sph biological action might be related to Sph-
induced biophysical changes in living cell membranes. This could be of great importance when 
considering that these biophysical changes are likely to affect several cellular processes, some 
of them probably involved in the pathophysiology of human disease, as in the case of NPC 
disease where calcium homeostasis6,69, fusion and trafficking defects6 occur in the endocytic 
pathway. 
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8. Supporting information for: Biophysical impact of lipid abnormal accumulation in NPC1 cell 
models 
 
 
 
 
 
 
 
 
 
 
Figure S1 – Filipin staining showing the effect of 2 µM Sph on CHO-K1 cholesterol. The cells were 
incubated with Sph for 24h, at 37 °C, before staining. Scale bars, 10 µm 
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CHAPTER V – FINAL CONCLUSIONS 
Previous studies performed by other authors1–7 had explored the impact of Sph in the 
biophysical properties of membranes, mostly in artificial model membranes, though the 
complete picture of the biophysical properties and the molecular mechanisms underlying the 
biological roles of this remarkable bioactive lipid are still far from being fully elucidated. In the 
present work, further studies were performed regarding the biophysical impact of Sph in model 
membrane systems that allow to circumvent some of the difficulties and limitations of studying 
lipid-lipid interactions in vivo by using a well-defined and controlled number and proportion of 
lipids (or other membrane components)8. In addition, studies were also performed in the more 
complex biological environment of living cells. 
The comprehensive characterization of Sph properties was performed by studying the 
interplay of Sph with other membrane lipids. The effect of Sph in simple fluid model 
membranes composed by POPC, a common membrane phospholipid (Chapter II); the influence 
of Sph in the biophysical behavior of model membranes containing Chol and SM, lipids that are 
commonly associated to membrane compartmentalization, through the formation of 
specialized ordered (lo phase) membrane domains – raft domains (Chapters II and III); the effect 
of pH in modulating the Sph biophysical properties (Chapters II and III); the Sph-induced effect 
in membrane permeability (Chapter III) and the impact of Sph in the biophysical properties of 
living cell membranes (Chapter IV) were analyzed in the sequence of this work. In order to 
achieve these goals, a multi-probe and multi-parameter approach was applied and 
complementary techniques such as fluorescence spectroscopy and microscopy, ELS and DLS 
were used. The use of probes with different phase partition properties enabled the 
identification of different lipid phases. For instance, t-PnA partitions equally among ld and lo 
phases, similarly to DPH, however, it has the particularity to present a higher quantum yield 
and partition when in the presence of gel phases which makes this probe very useful when 
trying to identify such membrane phases9,10.   
In Chapter II the biophysical properties of POPC/Sph and POPC/SM/Chol/Sph vesicles 
were characterized, both at neutral (pH 7.4) and acidic (pH 5.0) conditions. Based in the 
thermotropic studies with POPC/Sph mixtures a partial binary phase diagram was determined, 
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which provides important information regarding the phase behavior of membranes composed 
by Sph and fluid lipids. An example of this could be the extrapolation for other temperatures 
(e.g. physiological temperature) of the biophysical state of Sph-containing membranes. In this 
study it was possible to conclude that Sph, in resemblance to other SLs, such as ceramide9,11 
and glucosylceramide (GlcCer)12–14, has the ability to change the biophysical properties of 
membranes, by decreasing  membrane fluidity and segregating into gel domains, depending on 
the membrane lipid composition and the pH of the surrounding environment. Our studies 
revealed that Sph has a membrane ordering effect that is more pronounced at higher Sph 
concentrations and at neutral pH. This effect seems to be related to alteration of the 
protonation and hydrogen bonding states of Sph in both pH environments. It is, therefore, 
plausible to expect that Sph can drive strong changes in the surface charge of membranes in a 
manner that depends both on the membrane lipid composition and on the pH.  Accordingly, it 
would not be surprising that local membrane enrichment in Sph would affect the electrostatic 
membrane-proteins interactions and consequently protein activity.  
Sph ability to drive gel-fluid phase separation was enhanced in ternary POPC/SM/Chol 
mixtures compared to binary POPC/Sph mixtures. Nonetheless, the composition of the ternary 
mixtures also dictates Sph phase behavior, and an increase in Chol/SM content decreases Sph-
induced gel domain formation, as observed for ceramide9 and GlcCer14.  However, differences 
regarding the interaction of these lipids with raft mixtures can be pointed. Sph similarly to 
GlcCer14 seems to have a lower ability to drive the formation of gel phases in raft mixtures, 
since higher amounts of these lipids (ap. 10 mol%) are needed to promote comparable effects 
to the ones induced by approximately 4 mol% of ceramide9.  
Chapter III, addressed the development of a new synthetic system that more closely 
resembles the lysosome - the LMVs - and the importance of the development of such mimetic 
systems. The effect of Sph abnormal accumulation in membrane structure/permeability and 
biophysical properties was assessed in standard liposomes (no pH gradient) and in LMVs 
representing physiological (lower SM, Chol content) and NPC-like conditions (higher SM, Chol 
content). The results showed a higher impact of Sph in the properties of NPC-LMVs (higher SM, 
Chol content), highlighting the relevance of the LMVs as a more appropriated system to study 
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the events occurring in that sub-cellular location. In addition, it was possible to conclude that 
Sph causes a shift in vesicle surface charge, increases membrane order and promote a rapid 
increase in membrane permeability, particularly in NPC-LMVs.  This study suggested that the 
abnormal accumulation of lipids observed in NPC disease, might contribute to an impairment of 
the cell function, through significant alterations in the lysosomal membrane structure and 
integrity. 
In Chapter IV we further investigate how the abnormal accumulation of lipids in NPC 
disease affects the biophysical properties of biological membranes. Considering that NPC 
organs/tissues are affected to different extents15, distinct cell lines were used: CHO-K1 cells, SH-
SY5Y neuroblastoma cells and their mutant counterparts lacking (CHO-M12) or down-
expressing (NPC neuroblastoma cell line) the NPC1 locus. The results showed that the changes 
in the biophysical properties of membranes arising from lipid abnormal accumulation in NPC 
cells are highly complex and cell type dependent. The treatment of healthy cells with U18666A 
or Sph was also analyzed since it was previously associated with the induction of the NPC 
phenotype16. Both treatments had impact in the biophysical properties of living cells 
membranes, by decreasing membrane fluidity. Despite the involvement of other lipid species 
that also abnormally accumulate in NPC disease cannot be ruled out, this study clearly shows 
that Sph has an important effect in the biophysical properties of biological membranes. This 
almost immediate effect that seems to occur in a first instance at the PM level, suggests that 
Sph might integrate specialized membrane domains, and might interfere with different cellular 
processes, such as calcium homeostasis and endocytic trafficking that are affected in NPC 
disease16,17.  These results are in accordance with the model membrane data that predicted an 
impact of Sph on membrane organization and fluidity, depending on the Sph concentration and 
membrane lipid composition. Overall the results suggest that membrane biophysical properties 
might have a role in the molecular mechanisms underlying NPC pathophysiology. 
In summary, it can be concluded that: 
i) Sph decreases the fluidity  of  POPC membranes; 
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ii) Sph modulates the properties of raft like membranes, suggesting its involvement in the 
formation of specialized membrane domains that are involved in the regulation of different 
biological processes; 
iii) Sph has a pH dependent ordering effect, which is more pronounced at neutral pH and 
for higher Sph concentrations; 
iv) Sph effect in the membrane biophysical properties is strongly regulated by Sph charge; 
v) The development of artificial model membrane systems that more closely mimic 
physiological situations, are of crucial importance  to better extrapolate the results obtained 
with these synthetic systems to the more complex biological membranes;   
vi) Sph effects in membrane biophysical properties and permeability are more pronounced 
in LMV´s containing higher Chol and SM content, as observed in NPC disease; 
vii)  The biophysical changes arising from lipid abnormal accumulation in NPC cells are 
complex and cell type dependent; 
viii)  Sph has an important impact in the biophysical properties of biological membranes, 
leading to a decrease in the fluidity of the membrane of living cells in a concentration and time 
dependent manner. 
 
The evidence obtained in the present work supports the hypothesis that Sph biological 
actions might in part be related to Sph-induced biophysical changes in biological membranes. 
New insights were obtained regarding the behavior of this lipid when integrated in membranes 
(artificial and biological) with different compositions. The impact of Sph in the modulation of 
membrane domains, suggests that Sph abnormal accumulation might directly affect the 
distribution of other membrane components and consequently affect cell signaling pathways 
and their related cellular events. Therefore, it is tempting to hypothesize that Sph-induced 
alterations in the biophysical properties of biological membranes might be one of the triggering 
mechanisms underlying NPC disease16. Additional studies addressing the relation between 
membrane biophysical changes and NPC are needed, in order to further test this hypothesis. 
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CHAPTER VI – FUTURE PERSPECTIVES 
Sph is an important bioactive lipid with roles in cellular processes, such as apoptosis1 and 
cell proliferation2 and has been implicated in different pathologies, as a triggering3 or 
preventive agent4–6. The mechanism by which Sph exerts its biological actions are still 
unclarified, but it has been suggested that Sph-induced alterations in the membrane 
biophysical properties might be a possible mechanism that would influence protein sorting and 
thus cell signaling events7,8.  
The main goal of this PhD project was to characterize, from a multidisciplinary 
perspective, the alterations that occur upon Sph accumulation in NPC. In a first approach we 
characterized the effect of different Sph concentrations on the biophysical properties, 
electrostatic properties and permeability of model membrane systems composed of different 
membrane lipids, mimicking different cellular pH environments. After this, studies were also 
performed at the cell level. It was concluded that Sph decreases membrane fluidity and that it 
might drive the formation of lipid domains. To complement the studies that were performed in 
this dissertation work, other model systems could be characterized in future experiments, in 
order to gain further insights regarding Sph interaction with other bioactive lipids and how 
those interactions would influence the membrane properties. An example of this would be the 
characterization of the interaction of Sph with SLs that also accumulate in NPC, such as, GSLs 
derived from GlcCer9. These lipids are highly abundant in the nervous system10, one of the 
systems most affected in NPC11. In resemblance with the previous studies a 
multiprobe/multiparameter combined fluorescence spectroscopy approach can be used 
complemented by confocal microscopy studies with GUVs, which allow to image shape and 
phase separation. 
In addition to those studies, a further characterization of the biophysical properties of cell 
membranes and vesicles prepared from lipid extracts of patient cells could be performed. In 
particular, it would be interesting to explore changes in the membrane properties of cells 
derived from patients with different ages of onset, with only systemic manifestations and with 
both systemic and neurological disease, since this is a disease with an extremely heterogeneous 
clinical presentation11. In addition, organelle purification could also be performed to analyze if 
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changes in membrane properties are more pronounced in specific subcellular locations. In 
particular, studies with purified lysosomes, the organelles where the accumulation of different 
lipid species occurs, including Sph, and therefore, where more notorious changes in membrane 
properties are expected. A methodological approach based on magnetic separation is currently 
being implemented in our lab to perform such studies (see appendix for further details). The 
studies will be developed to understand the impact of Sph abnormal accumulation, and the 
other lipid species, on lysosomal function.  
The results to be obtained on the above suggested studies in conjugation with the ones 
obtained during this dissertation work are expected to provide important information regarding 
how Sph affects membrane organization in different cell types and in different subcellular 
locations, providing a better understanding of the effect of Sph abnormal accumulation in cells 
of NPC patients. This knowledge might contribute to the identification of new therapeutic 
targets and the developments of new treatments for NPC patients. 
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APPENDIX - Lysosomal purification from different cell lines 
 
1. Introduction 
The lysosome was discovered in the early 50´s by Christian De Duve1. Lysosomes are 
cytoplasmic organelles responsible to degrade and recycle cellular waste. While the 
extracellular material reach the lysosome mainly through endocytosis2 and phagocytosis3, the 
delivery of intracellular materials is mediated by autophagy4,5. In addition to cellular clearance, 
lysosomes are also now recognized by their involvement in multiple biological processes such 
as secretion6, PM repair7, cholesterol transport8, nutrient sensing and gene regulation9. Due to 
its cellular function the lysosomes contain a variety of different hydrolytic enzymes, such as 
phosphatases, phospholipases, proteases and nucleases, in an acidic environment (pH 4.5-5 
approximately), which can breakdown the macromolecules to their simplest subunits10. When 
alterations occur in lysosomal enzymatic activity, transporter proteins, membrane proteins or 
activator proteins, the accumulation of the material meant for lysosomal degradation occurs, as 
in the case of Niemann-Pick diseases types A, B and C, Gaucher disease and Tay-Sachs disease. 
The accumulation of different types of SLs in these diseases10,11, cause irreversible cell 
dysfunction and damaging in multiple organs12. Duo to the severity of LSDs, lysosomal research 
assume an important role in trying to better understand the molecular mechanisms underlying 
lysosomal dysfunction and develop potential therapies for LSDs patients. The study of 
lysosomes in an isolated environment has been hampered due to difficulties in purifying these 
organelles. Density gradient centrifugation  techniques13,14 have been commonly used but the 
contamination with other organelles and the lack of structural function is related with the low 
success of these techniques. This is especially relevant in the case of LSDs where the abnormal 
accumulation of macromolecules, such as lipids,  causes changes in the buoyant density of the 
lysosomes15. Magnetic separation methods for purifying lysosomes appeared as alternative 
promising techniques. Pioneering work in this field was performed by Winchester16, Ioannou17 
and Krise18 groups and recently improved by Lloyd-Evans group15. In this later version the 
magnetic separation of lysosomes from whole cells is performed with ferrofluid solution from 
Liquids Research Ltd. containing superparamagnetic nanoparticles conjugated to dextran and 
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provides, depending on the cell line, a greater yield of pure, functional lysosomes when 
compared to the previous methodologies15. This technique is now being implemented in our 
lab, in order to further characterize the impact of Sph on the biophysical properties of biological 
membranes, in this case lysosomal membranes purified from different cell lines. 
 
2. Experimental procedures  
2.1. Cell Culture 
CHO-K1, SH-SY5Y and CHO-M12 cells were grown in DMEM Ham F-12 (Sigma-Aldrich, MO, 
USA) and HEK 293 cells were grown in DMEM (Sigma-Aldrich, MO, USA). The Medium was 
supplemented with 10% fetal bovine serum (Sigma-Aldrich, MO, USA), heat inactivated at 60°C 
for 1 hour, 1% L-glutamine (100x) (Life Technologies, CA, USA) and 1% pen-strep (Life 
Technologies, CA, USA). The cells were grown as monolayers at 37 °C with 5% CO2 in a 
humidified incubator. 
 
2.2. Lysosomal purification protocol 
Lysosomal purification was performed as described by15. Briefly, the cells (2 x T75 flasks or 
1 T175 flask at ap. 85% confluence) were treated with 10 or 20 mL of pulse medium 
(appropriate cell culture medium with 10% ferrofluid solution (Liquids Research Ltd, Gwynedd, 
UK),  and 10 mM HEPES pH 7.2) for 24h. The pulse medium was then removed and the cells 
were washed two/three times with PBS 1x, before the addition of regular medium and a period 
of 24 h chase at 37 °C. After this period, the cells were washed twice with ice cold PBS and all 
the subsequent steps were performed on ice. The cells were re-suspended with 4 mL (1 T75 
flask, double volume for a T175 flask) of hypotonic buffer A (15 mM KCL, 1.5 mM MgAc, 1 mM 
DTT, 10 mM HEPES, 1 to 3 µL of protease inhibitor cocktail (Sigma-Aldrich, MO, USA), make up 
with dH2O to 50 mL), with the aid of a scraper. The cell suspension was then homogenized on 
ice using a tight dounce homogenizer for 30 strokes and the homogenate was passed through a 
23 gauge needle eight times.  After this step 1 mL (or 2 mL if using a T175 flask) of hypertonic 
buffer B solution (220 mM Hepes pH 7.2, 0.1 mM sucrose, 375 mM KCl, 22.5 mM MgAc, 1 mM 
DTT, 25 U/mL DnaseI (Life Technologies, CA, USA), make up with dH2O to 5 mL) was added to 
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the cell suspension and mixed by inversion five times, followed by a 5 minutes incubation at 37 
°C. The suspension was centrifuged at 1500 rpm for 10 minutes at 4 °C and the resulting 
supernatant was passed through the magnetic separation column (Miltenyi Biotec, Bergisch 
Gladbach, Germany) in the next step. 
The LS column was placed onto the QuadroMACS magnetic separator (Miltenyi Biotec, 
Bergisch Gladbach, Germany) and the column was equilibrated with 1 mL of 0.5% bovine serum 
albumin (BSA) in PBS at room temperature. The supernatant from the previous centrifugation 
was passed through the column and the flow-through was collected in a sample tube. The 
column was then washed with 1 mL Dnase I solution (25 U prepared in PBS)) and left to stand 
for 10 minutes. After this, the column was washed twice with 1 mL PBS.  The column was 
removed from the magnet and the lysosomes were eluted to a sample tube with 0.5 mL of PBS 
(supplemented with 0.1 mM sucrose) using the supplied plunger. This step was repeated in an 
attempt to increase the yield of lysosomes. The samples were then used in other experiments 
or frozen for the protein assay and western blots. Protein inhibitor cocktail (Sigma-Aldrich, MO, 
USA) was added to the samples to avoid protein degradation during storage at -20 °C.  
 
2.3. Protein assay 
Micro BCA protein assay kit (Life Technologies, CA, USA) was used to quantify the total 
protein in sample according to the manufacturer´s instructions. Samples were incubated in 96 
well plate and absorbance (562 nm) was measured using an absorbance reader. 
 
2.4. Western-blotting 
A standard Western-blot protocol was used. Briefly, after quantifying the protein present 
in the lysosomal and the rest of the cell fractions, 5 µg protein (dilution in dH2O) per sample 
was used for denaturation. For each 3 µL protein/water, 1 µL of sample buffer (4x; 10g Glycerol, 
0.785g Tris-HCl, 0.004g Bromophenol Blue, 2g SDS, 2 mL β-mercaptoethanol in 25 mL total 
volume – make up with dH2O) was used. The samples were then put in the oven at 60 °C for 1h. 
After, the samples were placed in the fridge while waiting for the gels. 
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The samples were fractionated by SDS-PAGE on a 10% gel along with the protein ladder 
(NZY colour Protein Marker II; NZYTech, Lisbon, Portugal) and transferred to a polyvinylidene 
difluoride (PVDF) (Bio-Rad, CA, USA) membrane using a transfer apparatus according to the 
manufacturer’s protocols (Bio-Rad, CA, USA). After incubation with 5% nonfat milk (VWR, PA, 
USA) in 1x TBST (10x stock solution, pH 7.5: 60.55g Tris, 87.66g NaCl, 10 mL Tween20, make up 
to 1L with dH2O) for 60 minutes at room temperature, the membrane was washed three times 
(10 minutes each) with 1x TBST and incubated with antibodies (dilution in 1% blocking solution) 
against β-actin (1:500; sc-47778, SantaCruz, KS, USA), calnexin (1:1000; Novus Biologicals, CO, 
USA); EEA1 (1:2500; NBP1-30914, Novus Biologicals), Rab7 (1:250; NBP1-87174, Novus 
Biologicals), FTCD (1:200; sc-271788, SantaCruz) and NPC2 (1:200; sc-33776, SantaCruz) at 4 °C 
for 16 h. Membranes were washed three times for 10 minutes with 1x TBST and incubated with 
a 1:5000 dilution of horseradish peroxidase-conjugated anti-mouse or anti-rabbit antibodies 
(SantaCruz) for 2 h. Blots were washed with 1x TBST three times and developed with the ECL 
system (Life Technologies, CA, USA) according to the manufacturer’s protocols, and visualized 
with a ImageQuant LAS 500 imager (GE Healthcare, IL, USA). 
 
3. Preliminary Results 
The lysosomal purification protocol was performed for different cell lines: CHO-K1 cells, 
SH-SY5Y neuroblastoma cells, HEK 293 cells and CHO-M12 cells. Table 1 shows the lysosomal 
yield obtained for each cell line, which revealed to be quite low, especially considering that all 
the lysosomal purifications were from a T175 confluent flask or 2 T75 flasks.  It was previously 
described that a single confluent T175 flask of CHO cells could yield up to 300-400 µg of 
lysosomal material15, which was not the case in these preliminary experiments at least for the 
CHO-K1 cells. Details in the experimental procedures, e.g. homogenization technique, 
centrifugation speeds,  are probably related with this low yield as discussed previously15 and 
need to be re-adjusted.  
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Table 1 – Lysosomal purification from different cell lines. 
Cell line Lysosomal yield (µg) Number of experiments 
CHO-K1 101.7 ± 72.0 n = 3 
HEK 293 128.7 ± 32.3 n = 3 
SH-SY5Y 114.0 ± 91.9 n = 2 
CHO-M12 277.0 n = 1 
 
In addition to the low lysosomal yield, the lysosomal fractions were not pure and revealed 
to be contaminated with other cell organelles such as ER and LE (Fig. 1). Moreover, some of the 
antibodies used did not work (SantaCruz antibodies used to detect the lysosomal protein NPC2 
and Formiminotransferase Cyclodeaminase (FTCD) from the Golgi compex) and alternative 
antibodies need to be tested. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1 – Western blots performed for samples obtained from CHO-K1 and HEK 293 cells, after 
24 h incubation with ferrofluid solution and 24h chase. Legend: PL – Protein ladder; RC1 – Rest 
of the cell (1st recovery); RC2 – Rest of the cell (2nd recovery); Lys F – Lysosomal fraction.  
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4. Conclusion 
Lysosomal purification is in fact of great importance for the study of lysosomal function 
and the lysosome related cellular processes. Different methodologies can be applied, including 
diverse magnetic separation methods that differ in the final yield, lysosomal functionality, purity 
and toxicity15. Every methodology has their own nuances and different experimental parameters 
that need to be considered and carefully adjusted to obtain good results. Examples of this are 
the composition of the buffers (isotonic solutions), the homogenization techniques, and 
centrifugation speeds15. Other important aspects to consider are the choice of the most suitable 
superparamagnetic iron oxide nanoparticles (SPIONs), the maintenance of its magnetic 
properties and the selection of the cell type that better suit the purpose of our experiments15.  
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